EurekaMag PDF full texts Chapter 53,709

Harzstark, A.L.; Small, E.J. 2009: Immunotherapeutics in development for prostate cancer. Oncologist 14(4): 391-398

Jain-Gupta, N.; Contreras-Rodriguez, A.; Smith, G.P.; Garg, V.K.; Witonsky, S.G.; Isloor, S.; Vemulapalli, R.; Boyle, S.M.; Sriranganathan, N. 2014: Immunotherapeutics to prevent the replication of Brucella in a treatment failure mouse model. Vaccine 32(8): 918-923

Joob, B.; Wiwanitkit, V. 2014: Immunotherapies and influenza vaccination. Multiple Sclerosis 20(13): 1794

Rousseau, B.ît.; Champiat, S.ép.; Loirat, D.; Arrondeau, J.; Lemoine, N.; Soria, J.-C. 2014: Immunotherapies and targeted therapies in medical oncology. Bulletin du Cancer 101(1): 31-39

Morrow, T. 2014: Immunotherapies can't keep market forces at arm's length. Managed Care 23(8): 55-56

Kasamon, Y.L.; Ambinder, R.F. 2008: Immunotherapies for Hodgkin's lymphoma. Critical Reviews in Oncology/Hematology 66(2): 135-144

Deresinski, S.; Herrera, V. 2010: Immunotherapies for Staphylococcus aureus: current challenges and future prospects. Infection Control and Hospital Epidemiology 31(Suppl 1): S45-S47

Montoya, I. 2008: Immunotherapies for drug addictions. Adicciones 20(2): 111-115

Thomas, A.; Hassan, R. 2012: Immunotherapies for non-small-cell lung cancer and mesothelioma. LANCET. Oncology 13(7): E301-E310

Park, J.H.; Brentjens, R.J. 2013: Immunotherapies in CLL. Advances in Experimental Medicine and Biology 792: 241-257

Pett, S.L. 2009: Immunotherapies in HIV-1 infection. Current Opinion in HIV and Aids 4(3): 188-193

Tuma, R.S. 2011: Immunotherapies in clinical trials: do they demand different evaluation tools?. Journal of the National Cancer Institute 103(10): 780-781

Fallen, R.S.; Terpstra, C.R.; Lima, H.C. 2012: Immunotherapies in dermatologic disorders. Medical Clinics of North America 96(3): 565-582 X-XI

Gupta, S. 2012: Immunotherapies in diabetes mellitus type 1. Medical Clinics of North America 96(3): 621

Kak, V.; Sundareshan, V.; Modi, J.; Khardori, N.M. 2012: Immunotherapies in infectious diseases. Medical Clinics of North America 96(3): 455-474 Ix

Graves, D.; Vernino, S. 2012: Immunotherapies in neurologic disorders. Medical Clinics of North America 96(3): 497-523 X

Miller, A.V.; Ranatunga, S.K.M. 2012: Immunotherapies in rheumatologic disorders. Medical Clinics of North America 96(3): 475-496 IX-X

Olberg, H.K.; Cox, R.J.; Nostbakken, J.K.; Aarseth, J.H.; Vedeler, C.A.; Myhr, K.-M. 2014: Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study. Multiple Sclerosis 20(8): 1074-1080

Wu, Y.-L.; Liang, J.; Zhang, W.; Tanaka, Y.; Sugiyama, H. 2012: Immunotherapies: the blockade of inhibitory signals. International Journal of Biological Sciences 8(10): 1420-1430

Osguthorpe, J.D. 2010: Immunotherapy. Current Opinion in Otolaryngology and Head and Neck Surgery 18(3): 206-212

Wu, A.Y.-Y. 2012: Immunotherapy - Vaccines for allergic diseases. Journal of Thoracic Disease 4(2): 198-202

Kostadinova, A.I.; Willemsen, L.E.M.; Knippels, L.éo.M.J.; Garssen, J. 2013: Immunotherapy - risk/benefit in food allergy. Pediatric Allergy and Immunology: Official Publication of the European Society of Pediatric Allergy and Immunology 24(7): 633-644

Jamshidi, S.; Avizeh, R.; Mohebali, M.; Bokaie, S. 2011: Immunotherapy Using Autoclaved L. major Antigens and M. vaccae with Meglumine Antimoniate, for the Treatment of Experimental Canine Visceral Leishmaniasis. Iranian Journal of Parasitology 6(3): 26-34

Reardon, D.A.; Freeman, G.; Wu, C.; Chiocca, E.A.; Wucherpfennig, K.W.; Wen, P.Y.; Fritsch, E.F.; Curry, W.T.; Sampson, J.H.; Dranoff, G. 2014: Immunotherapy advances for glioblastoma. Neuro-Oncology 16(11): 1441-1458

Bresson, D.; von Herrath, M. 2004: Immunotherapy after recent-onset type 1 diabetes: combinatorial treatment for achieving long-term remission in humans?. Review of Diabetic Studies: Rds 1(3): 108-112

Groeneveld, K.M.; Leenen, L.P.H.; Koenderman, L.; Kesecioglu, J. 2011: Immunotherapy after trauma: timing is essential. Current Opinion in Anaesthesiology 24(2): 219-223

Rakover, I.; Arbel, M.; Solomon, B. 2007: Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels. Neuro-Degenerative Diseases 4(5): 392-402

Comoli, P.; Zecca, M.; Maccario, R. 2010: Immunotherapy against EBV-lymphoma in recipients of HSCT. Expert Review of Hematology 3(5): 625-632

Bagarazzi, M.L.; Yan, J.; Morrow, M.P.; Shen, X.; Parker, R.Lamar.; Lee, J.C.; Giffear, M.; Pankhong, P.; Khan, A.S.; Broderick, K.E.; Knott, C.; Lin, F.; Boyer, J.D.; Draghia-Akli, R.; White, C.Jo.; Kim, J.Joseph.; Weiner, D.B.; Sardesai, N.Y. 2012: Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses. Science Translational Medicine 4(155): 155ra138

Everson, R.G.; Graner, M.W.; Gromeier, M.; Vredenburgh, J.J.; Desjardins, A.; Reardon, D.A.; Friedman, H.S.; Friedman, A.H.; Bigner, D.D.; Sampson, J.H. 2008: Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma. Expert Review of Anticancer Therapy 8(5): 717-732

Santos, F.N.; Borja-Cabrera, G.P.; Miyashiro, L.M.; Grechi, J.; Reis, A.B.; Moreira, M.A.B.; Martins Filho, O.A.; Luvizotto, M.C.R.; Menz, I.; Pessôa, L.M.; Gonçalves, P.R.; Palatnik, M.; Palatnik-de-Sousa, C.B. 2007: Immunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune vaccine. Vaccine 25(33): 6176-6190

Guzmán M, Mía.Antonieta.; Salinas L, J.; Toche P, P.; Marinovic M, Mía.Angélica.; Gallardo O, A.María. 2007: Immunotherapy against hymenoptera venom: report of ten patients. Revista Medica de Chile 135(12): 1566-1571

Lehrnbecher, T.; Tramsen, L.; Koehl, U.; Schmidt, S.; Bochennek, K.; Klingebiel, T. 2011: Immunotherapy against invasive fungal diseases in stem cell transplant recipients. Immunological Investigations 40(7-8): 839-852

Antachopoulos, C.; Katragkou, A.; Roilides, E. 2012: Immunotherapy against invasive mold infections. ImmunoTherapy 4(1): 107-120

Matsumoto, A.; Haraguchi, K.; Takahashi, T.; Azuma, T.; Kanda, Y.; Tomita, K.; Kurokawa, M.; Ogawa, S.; Takahashi, K.; Chiba, S.; Kitamura, T. 2007: Immunotherapy against metastatic renal cell carcinoma with mature dendritic cells. International Journal of Urology: Official Journal of the Japanese Urological Association 14(4): 277-283

Cantini, G.; Pisati, F.; Pessina, S.; Finocchiaro, G.; Pellegatta, S. 2012: Immunotherapy against the radial glia marker GLAST effectively triggers specific antitumor effectors without autoimmunity. Oncoimmunology 1(6): 884-893

Yao, L.-C.; Yang, R.-J. 2007: Immunotherapy against tumor with dendritic cell sensitized by necrotic tumor tissue after microwave coagulation therapy. Zhonghua Yi Xue Za Zhi 87(36): 2552-2556

Dorostkar, M.M.; Burgold, S.; Filser, S.; Barghorn, S.; Schmidt, B.; Anumala, U.R.; Hillen, H.; Klein, C.; Herms, J. 2014: Immunotherapy alleviates amyloid-associated synaptic pathology in an Alzheimer's disease mouse model. Brain: a Journal of Neurology 137(Part 12): 3319-3326

Arai, H. 2010: Immunotherapy and Alzheimer's disease. Nihon Shinkei Seishin Yakurigaku Zasshi 30(4): 173-176

Roatt, B.M.; Aguiar-Soares, R.D.d.O.; Coura-Vital, W.; Ker, H.G.; Moreira, N.ád.d.D.; Vitoriano-Souza, J.; Giunchetti, R.C.; Carneiro, C.áu.M.; Reis, A.B. 2014: Immunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease. Frontiers in Immunology 5: 272

Yasukawa, M. 2009: Immunotherapy and cell therapy for myeloid leukemia. Nihon Rinsho. Japanese Journal of Clinical Medicine 67(10): 1938-1943

Lage, A. 2014: Immunotherapy and complexity: overcoming barriers to control of advanced cancer. Medicc Review 16(3-4): 65-72

Sokoloff, M.H.; Belldegrun, A. 1996: Immunotherapy and gene therapy for genitourinary malignancies. International Journal of Urology: Official Journal of the Japanese Urological Association 3(1 Suppl): S4-18

Nishisaka, N.; Jones, R.F.; Maini, A.; Morse, P.; Wang, C.Y.; Haas, G.P. 1997: Immunotherapy and gene therapy for renal cell carcinoma. Urologic Oncology 3(5-6): 148-153

Takeda, T.; Akita, H.; Takeda, T.; Nakamura, K.; Kobayashi, S.; Takeda, H. 2013: Immunotherapy and hyperthermia for the treatment of patients with advanced or recurrent colorectal cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(12): 1606-1608

Mazzolini, G.; Murillo, O.; Atorrasagasti, C.; Dubrot, J.; Tirapu, I.ñi.; Rizzo, M.; Arina, A.; Alfaro, C.; Azpilicueta, A.; Berasain, C.; Perez-Gracia, J.é L.; Gonzalez, A.; Melero, I. 2007: Immunotherapy and immunoescape in colorectal cancer. World Journal of Gastroenterology 13(44): 5822-5831

Krcméry, S.; Hromec, J.; Gábrisová, Z.; Tahotný, R. 2010: Immunotherapy and long-term chemoprophylaxis in prevention of recurrent urinary infections in women. Vnitrni Lekarstvi 56(9 Suppl): 955-960

Bourdette, D.; Whitham, R. 2010: Immunotherapy and multiple sclerosis: the devil is in the details. Neurology 74(18): 1410-1411

Neff, F.; Wei, X.; Nölker, C.; Bacher, M.; Du, Y.; Dodel, R. 2008: Immunotherapy and naturally occurring autoantibodies in neurodegenerative disorders. Autoimmunity Reviews 7(6): 501-507

Banks, W.A. 2010: Immunotherapy and neuroimmunology in Alzheimer's disease: a perspective from the blood-brain barrier. ImmunoTherapy 2(1): 1-3

Sharon, E.; Polley, M.-Y.; Bernstein, M.B.; Ahmed, M. 2014: Immunotherapy and radiation therapy: considerations for successfully combining radiation into the paradigm of immuno-oncology drug development. Radiation Research 182(2): 252-257

Giuliani, J.; Drudi, F. 2012: Immunotherapy and targeted therapies in metastatic renal cell carcinoma: is there a preferred sequence?. Cancer BioTherapy and Radiopharmaceuticals 27(8): 513-518

Singh, O.P.; Sundar, S. 2014: Immunotherapy and targeted therapies in treatment of visceral leishmaniasis: current status and future prospects. Frontiers in Immunology 5: 296

Merghoub, T.; Wolchok, J.D. 2014: Immunotherapy and the belly of the beast. Journal of Experimental Medicine 211(12): 2327-2328

Singh, B.Harpreet.; Gulley, J.L. 2014: Immunotherapy and therapeutic vaccines in prostate cancer: an update on current strategies and clinical implications. Asian Journal of Andrology 16(3): 364-371

Mori, A.; Izuhara, K. 2013: Immunotherapy and tolerance—cutting edge. Allergology International: Official Journal of the Japanese Society of Allergology 62(4): 401-402

Emery, V.C.; Einsele, H.; Atabani, S.; Haque, T. 2011: Immunotherapy and vaccination after transplant: the present, the future. Hematology/Oncology Clinics of North America 25(1): 215-229

Goihman-Yahr, M.; Goldblum, O.M. 2008: Immunotherapy and warts: a point of view. Clinics in Dermatology 26(2): 223-225

Fadel, T.R.; Fahmy, T.M. 2014: Immunotherapy applications of carbon nanotubes: from design to safe applications. Trends in Biotechnology 32(4): 198-209

Johnson, L.A.; Sampson, J.H. 2010: Immunotherapy approaches for malignant glioma from 2007 to 2009. Current Neurology and Neuroscience Reports 10(4): 259-266

Onishi, H.; Morisaki, T.; Katano, M. 2012: Immunotherapy approaches targeting regulatory T-cells. Anticancer Research 32(3): 997-1003

Holt, G.E.; Podack, E.R.; Raez, L.E. 2011: Immunotherapy as a strategy for the treatment of non-small-cell lung cancer. Therapy 8(1): 43-54

Okwor, I.; Uzonna, J.E. 2009: Immunotherapy as a strategy for treatment of leishmaniasis: a review of the literature. ImmunoTherapy 1(5): 765-776

Kalani, A.D.; Jack, A.; Montenegro, G.; Degliuomini, J.; Wallack, M.K. 2008: Immunotherapy as an adjuvant therapy in the management of advanced, surgically resected, melanoma. Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 143(1): 59-70

Hawkes, C.A.; McLaurin, J. 2007: Immunotherapy as treatment for Alzheimer's disease. Expert Review of Neurotherapeutics 7(11): 1535-1548

Gaberel, T.; Macrez, R.; Gauberti, M.; Montagne, A.; Hebert, M.; Petersen, K.-U.; Touze, E.; Agin, V.ér.; Emery, E.; Ali, C.; Vivien, D. 2013: Immunotherapy blocking the tissue plasminogen activator-dependent activation of N-methyl-D-aspartate glutamate receptors improves hemorrhagic stroke outcome. Neuropharmacology 67: 267-271

Ringdén, O. 2007: Immunotherapy by allogeneic stem cell transplantation. Advances in Cancer Research 97: 25-60

Bridle, B.W.; Li, J.; Jiang, S.; Chang, R.; Lichty, B.D.; Bramson, J.L.; Wan, Y. 2010: Immunotherapy can reject intracranial tumor cells without damaging the brain despite sharing the target antigen. Journal of Immunology 184(8): 4269-4275

Frazier, J.L.; Han, J.E.; Lim, M.; Olivi, A. 2010: Immunotherapy combined with chemotherapy in the treatment of tumors. Neurosurgery Clinics of North America 21(1): 187-194

Heimberger, A.B.; Sampson, J.H. 2011: Immunotherapy coming of age: what will it take to make it standard of care for glioblastoma?. Neuro-Oncology 13(1): 3-13

Kündig, T.M. 2011: Immunotherapy concepts under investigation. Allergy 66(Suppl 95): 60-62

Lutz, E.R.; Wu, A.A.; Bigelow, E.; Sharma, R.; Mo, G.; Soares, K.; Solt, S.; Dorman, A.; Wamwea, A.; Yager, A.; Laheru, D.; Wolfgang, C.L.; Wang, J.; Hruban, R.H.; Anders, R.A.; Jaffee, E.M.; Zheng, L. 2014: Immunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulation. Cancer Immunology Research 2(7): 616-631

Mekić, M.; Smilić, L. 2008: Immunotherapy effect in allergic rhinitis. Medicinski Arhiv 62(5-6): 259-260

Bouchlaka, M.N.; Redelman, D.; Murphy, W.J. 2010: Immunotherapy following hematopoietic stem cell transplantation: potential for synergistic effects. ImmunoTherapy 2(3): 399-418

Jiang, B.S.; Beasley, G.M.; Speicher, P.J.; Mosca, P.J.; Morse, M.A.; Hanks, B.; Salama, A.; Tyler, D.S. 2014: Immunotherapy following regional chemotherapy treatment of advanced extremity melanoma. Annals of Surgical Oncology 21(8): 2525-2531

Curley, C.; Hill, G.R.; McLean, A.; Kennedy, G.A. 2014: Immunotherapy following relapse of acute leukaemia after T-cell-replete allogeneic peripheral blood progenitor cell transplantation: importance of new onset chronic graft-versus-host disease. International Journal of Laboratory Hematology 36(2): 197-204

Gouras, G.K. 2009: Immunotherapy for Alzheimer disease. Mabs 1(2): 112-114

Solomon, B.; Frenkel, D. 2010: Immunotherapy for Alzheimer's disease. Neuropharmacology 59(4-5): 303-309

Steinitz, M. 2009: Immunotherapy for Alzheimer's disease. ImmunoTherapy 1(3): 461-469

Morgan, D. 2011: Immunotherapy for Alzheimer's disease. Journal of Internal Medicine 269(1): 54-63

Wang, W.; Fan, L.; Xu, D.'e.; Wen, Z.; Yu, R.; Ma, Q. 2012: Immunotherapy for Alzheimer's disease. Acta Biochimica et Biophysica Sinica 44(10): 807-814

Farlow, M.R.; Brosch, J.R. 2013: Immunotherapy for Alzheimer's disease. Neurologic Clinics 31(3): 869-878

Wisniewski, T.; Goñi, F. 2014: Immunotherapy for Alzheimer's disease. Biochemical Pharmacology 88(4): 499-507

Davtyan, H.; Petrushina, I.; Ghochikyan, A. 2014: Immunotherapy for Alzheimer's disease: DNA- and protein-based epitope vaccines. Methods in Molecular Biology 1143: 259-281

Panza, F.; Frisardi, V.; Solfrizzi, V.; Imbimbo, B.P.; Logroscino, G.; Santamato, A.; Greco, A.; Seripa, D.; Pilotto, A. 2012: Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies. ImmunoTherapy 4(2): 213-238

Coico, R.; Woodruff-Pak, D.S. 2008: Immunotherapy for Alzheimer's disease: harnessing our knowledge of T cell biology using a cholesterol-fed rabbit model. Journal of Alzheimer's Disease: Jad 15(4): 657-671

Lemere, C.A. 2013: Immunotherapy for Alzheimer's disease: hoops and hurdles. Molecular Neurodegeneration 8: 36

Spencer, B.; Masliah, E. 2014: Immunotherapy for Alzheimer's disease: past, present and future. Frontiers in Aging Neuroscience 6: 114

Boulassel, M.-R.; Galal, A. 2012: Immunotherapy for B-Cell Neoplasms using T Cells expressing Chimeric Antigen Receptors: from antigen choice to clinical implementation. Sultan Qaboos University Medical Journal 12(3): 273-285

Nagler, A.; Shimoni, A. 2010: Immunotherapy for B-cell lymphoma. Leukemia and Lymphoma 51(1): 7-9

Hollander, N. 2012: Immunotherapy for B-cell lymphoma: current status and prospective advances. Frontiers in Immunology 3: 3

Merlo, A.; Turrini, R.; Dolcetti, R.; Zanovello, P.; Rosato, A. 2011: Immunotherapy for EBV-associated malignancies. International Journal of Hematology 93(3): 281-293

Long, H.M.; Parsonage, G.; Fox, C.P.; Lee, S.P. 2010: Immunotherapy for Epstein-Barr virus-associated malignancies. Drug News and Perspectives 23(4): 221-228

Salvi, M. 2014: Immunotherapy for Graves' ophthalmopathy. Current Opinion in Endocrinology Diabetes and Obesity 21(5): 409-414

Alshekhlee, A.; Hussain, Z.; Sultan, B.; Katirji, B. 2008: Immunotherapy for Guillain-Barré syndrome in the US hospitals. Journal of Clinical Neuromuscular Disease 10(1): 4-10

Lang, K.; Weiner, D.B. 2008: Immunotherapy for HCV infection: next steps. Expert Review of Vaccines 7(7): 915-923

Weiss, R.A. 2014: Immunotherapy for HIV Infection. New England Journal of Medicine 370(4): 379-380

Newsom-Davis, T.; Ahamed, E.; Bower, M. 2009: Immunotherapy for HIV-associated non-Hodgkin's lymphoma. Expert Opinion on Biological Therapy 9(10): 1313-1324

Lunn, M.P.T.; Nobile-Orazio, E. 2012: Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies. Cochrane Database of Systematic Reviews 5: Cd002827

Mostafa, A.A.; Morris, D.G. 2014: Immunotherapy for Lung Cancer: Has it Finally Arrived?. Frontiers in Oncology 4: 288

Yamamoto, N.; Suyama, H.; Yamamoto, N. 2008: Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF. Translational Oncology 1(2): 65-72

Yiang, G.-T.; Chou, P.-L.; Tsai, H.-F.; Chen, L.-A.; Chang, W.-J.; Yu, Y.-L.; Wei, C.-W. 2012: Immunotherapy for SV40 T/t antigen-induced breast cancer by recombinant adeno-associated virus serotype 2 carrying interleukin-15 in mice. International Journal of Molecular Medicine 29(5): 809-814

Doherty, T.Mark. 2012: Immunotherapy for TB. ImmunoTherapy 4(6): 629-647

Pozzilli, P.; Strollo, R. 2012: Immunotherapy for Type 1 diabetes: getting beyond a negative first impression. ImmunoTherapy 4(7): 655-658

Simonart, T. 2013: Immunotherapy for acne vulgaris: current status and future directions. American Journal of Clinical Dermatology 14(6): 429-435

Berry, M.; Clatworthy, M.R. 2012: Immunotherapy for acute kidney injury. ImmunoTherapy 4(3): 323-334

Liang, S.; Fan, M. 2009: Immunotherapy for adenoid cystic carcinoma of salivary glands: cancer/testis antigens and 5-aza-2'-deoxycytidine. Medical Hypotheses 73(5): 768-769

Roman, R.-A. 2011: Immunotherapy for advanced melanoma. Clinical Journal of Oncology Nursing 15(5): E58-E65

Vieweg, J. 2007: Immunotherapy for advanced prostate cancer. Reviews in Urology 9(Suppl 1): S29-S38

Peskin, S.R. 2011: Immunotherapy for advanced prostate cancer: a novel treatment option to improve survival. Managed Care 20(9 Suppl 5: 3-4; 6-11

Hall, A.G.; deShazo, R.D. 2012: Immunotherapy for allergic fungal sinusitis. Current Opinion in Allergy and Clinical Immunology 12(6): 629-634

Walker, S.M.; Durham, S.R.; Till, S.J.; Roberts, G.; Corrigan, C.J.; Leech, S.C.; Krishna, M.T.; Rajakulasingham, R.K.; Williams, A.; Chantrell, J.; Dixon, L.; Frew, A.J.; Nasser, S.M. 2011: Immunotherapy for allergic rhinitis. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 41(9): 1177-1200

Ohashi, Y. 2008: Immunotherapy for allergic rhinitis induced by Japanese cedar pollens. Arerugi 57(5): 519-523

Mohapatra, S.S.; Qazi, M.; Hellermann, G. 2010: Immunotherapy for allergies and asthma: present and future. Current Opinion in Pharmacology 10(3): 276-288

Harari, J. 2008: Immunotherapy for anal furunculosis in dogs. Compendium 30(2): 69; 72

Jackson, C.M.; Lim, M.; Drake, C.G. 2014: Immunotherapy for brain cancer: recent progress and future promise. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 20(14): 3651-3659

Lotfi, R.; Schrezenmeier, H.; Lotze, M.T. 2009: Immunotherapy for cancer: promoting innate immunity. Frontiers in Bioscience 14(3): 818-832

Buskas, T.; Thompson, P.; Boons, G.-J. 2009: Immunotherapy for cancer: synthetic carbohydrate-based vaccines. Chemical Communications 36: 5335-5349

Sonpavde, G.; Kantoff, P.W. 2012: Immunotherapy for castration-resistant prostate cancer. Urologic Clinics of North America 39(4): 465-481

Su, J.-H.; Wu, A.; Scotney, E.; Ma, B.; Monie, A.; Hung, C.-F.; Wu, T.-C. 2010: Immunotherapy for cervical cancer: Research status and clinical potential. Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 24(2): 109-129

Kanwar, V.S. 2012: Immunotherapy for childhood aplastic anemia in India: a case for universal healthcare?. Indian Pediatrics 49(5): 354-355

Dasher, D.A.; Burkhart, C.N.; Morrell, D.S. 2009: Immunotherapy for childhood warts. Pediatric Annals 38(7): 373-379

Abe, M.; Onji, M. 2011: Immunotherapy for chronic hepatitis due to HBV. Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 4): 503-506

Tougeron, D.; Fauquembergue, Ém.; Latouche, J.-B. 2013: Immunotherapy for colorectal cancer. Bulletin du Cancer 100(9): 871-885

Koido, S.; Ohkusa, T.; Homma, S.; Namiki, Y.; Takakura, K.; Saito, K.; Ito, Z.; Kobayashi, H.; Kajihara, M.; Uchiyama, K.; Arihiro, S.; Arakawa, H.; Okamoto, M.; Gong, J.; Tajiri, H. 2013: Immunotherapy for colorectal cancer. World Journal of Gastroenterology 19(46): 8531-8542

Hazama, S.; Oka, M. 2011: Immunotherapy for colorectal cancer--the present status and the prospects. Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 3): 569-573

Saw, V.P.J. 2013: Immunotherapy for corneal inflammatory disorders: stepping up and down the ladder. British Journal of Ophthalmology 97(11): 1364-1367

Ibrahim, S.F.; Sambandan, D.; Ratner, D.és.ée. 2011: Immunotherapy for cutaneous malignancy. Dermatologic Surgery: Official Publication for American Society for Dermatologic Surgery 37(10): 1377-1393

Chan, Y.C.; Lo, Y.L.; Chan, E.S.Y. 2012: Immunotherapy for diabetic amyotrophy. Cochrane Database of Systematic Reviews 6: Cd006521

Shen, X.; Kosten, T.R. 2011: Immunotherapy for drug abuse. Cns and Neurological Disorders Drug Targets 10(8): 876-879

Levite, M.; Hart, I.K. 2002: Immunotherapy for epilepsy. Expert Review of Neurotherapeutics 2(6): 809-814

Kennedy-Nasser, A.A.; Bollard, C.M.; Heslop, H.E. 2009: Immunotherapy for epstein-barr virus-related lymphomas. Mediterranean Journal of Hematology and Infectious Diseases 1(2): E2009010

Kurihara, K. 2010: Immunotherapy for food allergy. Allergology International: Official Journal of the Japanese Society of Allergology 59(1): 9-14

Nowak-Wegrzyn, A.; Sicherer, S.H. 2008: Immunotherapy for food and latex allergy. Clinical Allergy and Immunology 21: 429-446

Zorzetto, V.; Maddalo, G.; Basso, D.; Farinati, F. 2012: Immunotherapy for gastric premalignant lesions and cancer. ImmunoTherapy 4(6): 587-599

Elkord, E.; Hawkins, R.E.; Stern, P.L. 2008: Immunotherapy for gastrointestinal cancer: current status and strategies for improving efficacy. Expert Opinion on Biological Therapy 8(4): 385-395

Toomey, P.G.; Vohra, N.A.; Ghansah, T.; Sarnaik, A.A.; Pilon-Thomas, S.A. 2013: Immunotherapy for gastrointestinal malignancies. Cancer Control: Journal of the Moffitt Cancer Center 20(1): 32-42

Weller, M. 2010: Immunotherapy for glioblastoma: a long and winding road. Neuro-Oncology 12(4): 319

Lesniak, M.S. 2011: Immunotherapy for glioblastoma: the devil is in the details. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 29(22): 3105; author reply 3105-6

Izumoto, S.-i.; Yoshimine, T. 2008: Immunotherapy for glioma. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(6): 926-930

Dietrich, P.-Y.; Dutoit, V.ér.; Walker, P.R. 2014: Immunotherapy for glioma: from illusion to realistic prospects?. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting 2014: 51-59

Finocchiaro, G.; Pellegatta, S. 2011: Immunotherapy for glioma: getting closer to the clinical arena?. Current Opinion in Neurology 24(6): 641-647

Han, S.J.; Zygourakis, C.; Lim, M.; Parsa, A.T. 2012: Immunotherapy for glioma: promises and challenges. Neurosurgery Clinics of North America 23(3): 357-370

Davidson, H.C.; Leibowitz, M.S.; Lopez-Albaitero, A.; Ferris, R.L. 2009: Immunotherapy for head and neck cancer. Oral Oncology 45(9): 747-751

Turksma, A.W.; Braakhuis, B.J.; Bloemena, E.; Meijer, C.J.; Leemans, C.R.é; Hooijberg, E. 2013: Immunotherapy for head and neck cancer patients: shifting the balance. ImmunoTherapy 5(1): 49-61

De Costa, A.-M.; Young, M.R.I. 2011: Immunotherapy for head and neck cancer: advances and deficiencies. Anti-Cancer Drugs 22(7): 674-681

Yasukawa, M. 2012: Immunotherapy for hematological neoplasms. Japanese Journal of Clinical Hematology 53(10): 1759-1767

Guo, Q.; Lan, P.; Yu, X.; Han, Q.; Zhang, J.; Tian, Z.; Zhang, C. 2014: Immunotherapy for hepatoma using a dual-function vector with both immunostimulatory and pim-3-silencing effects. Molecular Cancer Therapeutics 13(6): 1503-1513

Dixit, S. 2014: Immunotherapy for high-grade glioma. Future Oncology 10(6): 911-915

Van Gool, S. 2013: Immunotherapy for high-grade glioma: how to go beyond Phase I/Ii clinical trials. ImmunoTherapy 5(10): 1043-1046

Biagtan, M.; Viswanathan, R.; Bush, R.K. 2014: Immunotherapy for house dust mite sensitivity: where are the knowledge gaps?. Current Allergy and Asthma Reports 14(12): 482

Méndez-Samperio, P. 2014: Immunotherapy for human TB: evidence for adjuvant activities of some host defense peptides against TB. ImmunoTherapy 6(4): 363-365

Wang, L.; Wen, W.; Yuan, J.; Helfand, B.; Li, Y.; Shi, C.; Tian, F.; Zheng, J.; Wang, F.; Chen, L.; Liang, L.; Zhou, L.; Lee, C.; Chen, Z.; Guo, Y.; Wang, H.; Zhang, Q.; Qin, W. 2010: Immunotherapy for human renal cell carcinoma by adoptive transfer of autologous transforming growth factor beta-insensitive CD8+ T cells. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 16(1): 164-173

Ruëff, F.; Biló, M.B.; Cichocka-Jarosz, E.; Müller, U.; Oude Elberink, H.; Sturm, G. 2013: Immunotherapy for hymenoptera venom allergy: too expensive for European health care?. Allergy 68(4): 407-408

Müller, U.; Golden, D.B.K.; Lockey, R.F.; Shin, B. 2008: Immunotherapy for hymenoptera venom hypersensitivity. Clinical Allergy and Immunology 21: 377-392

Van Eijk, J.; Chan, Y.C.; Russell, J.W. 2013: Immunotherapy for idiopathic lumbosacral plexopathy. Cochrane Database of Systematic Reviews 12: Cd009722

Karaulov, A.V.; Kaliuzhin, O.V. 2013: Immunotherapy for infectious diseases: challenges and prospects. Terapevticheskii Arkhiv 85(11): 100-108

Hirsch, H.H.; Hartmann, A. 2010: Immunotherapy for invasive fungal infections in transplant patients: back to the future?. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 10(8): 1719-1720

Safdar, A. 2013: Immunotherapy for invasive mold disease in severely immunosuppressed patients. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 57(1): 94-100

Matar, P.; Alaniz, L.; Rozados, V.; Aquino, J.B.; Malvicini, M.; Atorrasagasti, C.; Gidekel, M.; Silva, M.; Scharovsky, O.G.; Mazzolini, G. 2009: Immunotherapy for liver tumors: present status and future prospects. Journal of Biomedical Science 16: 30

Hirschowitz, E.A.; Yannelli, J.R. 2009: Immunotherapy for lung cancer. Proceedings of the American Thoracic Society 6(2): 224-232

Declerck, S.; Vansteenkiste, J. 2014: Immunotherapy for lung cancer: ongoing clinical trials. Future Oncology 10(1): 91-105

Ho, M.-Y.; Tang, S.-J.; Sun, K.-H.; Yang, W. 2011: Immunotherapy for lung cancers. Journal of Biomedicine and Biotechnology 2011: 250860

Zeiser, R.; Schnitzler, M.; Andrlova, H.; Hellige, T.; Meiss, F. 2012: Immunotherapy for malignant melanoma. Current Stem Cell Research and Therapy 7(3): 217-228

Grange, J.M.; Krone, B.; Stanford, J.L. 2009: Immunotherapy for malignant melanoma--tracing Ariadne's thread through the labyrinth. European Journal of Cancer 45(13): 2266-2273

Wong, R.M.; Ianculescu, I.; Sharma, S.; Gage, D.L.; Olevsky, O.M.; Kotova, S.; Kostic, M.N.; Grundfest, W.S.; Hou, D.; Cameron, R.B. 2014: Immunotherapy for malignant pleural mesothelioma. Current status and future prospects. American Journal of Respiratory Cell and Molecular Biology 50(5): 870-875

Weber, J. 2011: Immunotherapy for melanoma. Current Opinion in Oncology 23(2): 163-169

Alexandrescu, D.T.; Ichim, T.E.; Riordan, N.H.; Marincola, F.M.; Di Nardo, A.; Kabigting, F.D.; Dasanu, C.A. 2010: Immunotherapy for melanoma: current status and perspectives. Journal of ImmunoTherapy 33(6): 570-590

Ellebaek, E.; Andersen, M.H.; Svane, I.M.; Straten, P.T. 2012: Immunotherapy for metastatic colorectal cancer: present status and new options. Scandinavian Journal of Gastroenterology 47(3): 315-324

Drake, C.G. 2008: Immunotherapy for metastatic prostate cancer. Urologic Oncology 26(4): 438-444

Heidenreich, A. 2012: Immunotherapy for metastatic prostate cancer: do we really need this?. Der Urologe. Ausg. a 51(1): 32-38

Lü, C.; Williams, A.K.; Chalasani, V.; Martínez, C.H.; Chin, J. 2011: Immunotherapy for metastatic prostate cancer: where are we at with sipuleucel-T?. Expert Opinion on Biological Therapy 11(1): 99-108

Guida, M.; Colucci, G. 2007: Immunotherapy for metastatic renal cell carcinoma: is it a therapeutic option yet?. Annals of Oncology: Official Journal of the European Society for Medical Oncology 18(Suppl 6): Vi149-Vi152

Turcotte, S.; Rosenberg, S.A. 2011: Immunotherapy for metastatic solid cancers. Advances in Surgery 45: 341-360

Coop, C.A. 2014: Immunotherapy for mold allergy. Clinical Reviews in Allergy and Immunology 47(3): 289-298

Bunyavanich, S.; Donovan, M.A.; Sherry, J.M.; Diamond, D.V. 2013: Immunotherapy for mouse bite anaphylaxis and allergy. Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 111(3): 223-224

Rosenblatt, J.; Bar-Natan, M.; Munshi, N.C.; Avigan, D.E. 2014: Immunotherapy for multiple myeloma. Expert Review of Hematology 7(1): 91-96

Stüve, O.; Ransohoff, R.M. 2009: Immunotherapy for multiple sclerosis: the curious case of interferon beta. Archives of Neurology 66(10): 1193-1194

Gray, J.C.; Kohler, J.A. 2009: Immunotherapy for neuroblastoma: turning promise into reality. Pediatric Blood and Cancer 53(6): 931-940

Villoslada, P.; Moreno, B.; Melero, I.; Pablos, J.L.; Martino, G.; Uccelli, A.; Montalban, X.; Avila, J.; Rivest, S.; Acarin, L.; Appel, S.; Khoury, S.J.; McGeer, P.; Ferrer, I.; Delgado, M.; Obeso, J.; Schwartz, M. 2008: Immunotherapy for neurological diseases. Clinical Immunology 128(3): 294-305

Shepherd, F.A.; Douillard, J.-Y.; Blumenschein, G.R. 2011: Immunotherapy for non-small cell lung cancer: novel approaches to improve patient outcome. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 6(10): 1763-1773

Thomas, A.; Jakopovic, M. 2014: Immunotherapy for non-small-cell lung cancer. Expert Opinion on Biological Therapy 14(8): 1061-1064

Tsujimoto, T.; Kawaratani, H.; Kitazawa, T.; Yoshiji, H.; Fujimoto, M.; Uemura, M.; Fukui, H. 2009: Immunotherapy for nonalcoholic steatohepatitis using the multiple cytokine production modulator Y-40138. World Journal of Gastroenterology 15(44): 5533-5540

Zsiros, E.; Tanyi, J.; Balint, K.; Kandalaft, L.E. 2014: Immunotherapy for ovarian cancer: recent advances and perspectives. Current Opinion in Oncology 26(5): 492-500

Kandalaft, L.E.; Powell, D.J.; Singh, N.; Coukos, G. 2011: Immunotherapy for ovarian cancer: what's next?. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 29(7): 925-933

Cain, B.S.; Shannon-Cain, J. 2008: Immunotherapy for overinflammatory states. Critical Care Medicine 36(3): 992

Nomura, K. 2008: Immunotherapy for paraneoplastic neurological syndromes. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 97(8): 1830-1837

Vidal, L.; Gafter-Gvili, A.; Shpilberg, O. 2011: Immunotherapy for patients with follicular lymphoma: the contribution of systematic reviews. Acta Haematologica 125(1-2): 23-31

Lee, T.H.; Chan, J.; Lau, V.W.Y.; Lee, W.L.; Lau, P.C.; Lo, M.H. 2014: Immunotherapy for peanut allergy. Hong Kong Medical Journal 20(4): 325-330

Grupp, S.A.; Verneris, M.; Sondel, P.M.; Cooper, L.J.N. 2008: Immunotherapy for pediatric cancer. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 14(1 Suppl 1: 33-43

Gardner, S.L.; Ahmed, N.; Okada, H. 2010: Immunotherapy for pediatric central nervous system tumors. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 16(1 Suppl): S75-S81

Shah, N.N.; Dave, H.; Wayne, A.S. 2013: Immunotherapy for pediatric leukemia. Frontiers in Oncology 3: 166

Van der Burg, S.H.; Arens, R.; Melief, C.J.M. 2011: Immunotherapy for persistent viral infections and associated disease. Trends in Immunology 32(3): 97-103

Didier, A. 2009: Immunotherapy for pollen allergy. Revue des Maladies Respiratoires 26(6): 693-697

Dalianis, T. 2012: Immunotherapy for polyomaviruses: opportunities and challenges. ImmunoTherapy 4(6): 617-628

Fecci, P.E.; Heimberger, A.B.; Sampson, J.H. 2014: Immunotherapy for primary brain tumors: no longer a matter of privilege. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 20(22): 5620-5629

Wood, P. 2012: Immunotherapy for primary immunodeficiency diseases. Medical Clinics of North America 96(3): 433-454 Ix

Li, L.; Napper, S.; Cashman, N.R. 2010: Immunotherapy for prion diseases: opportunities and obstacles. ImmunoTherapy 2(2): 269-282

Kipp, R.T.; McNeel, D.G. 2007: Immunotherapy for prostate cancer - recent progress in clinical trials. Clinical Advances in Hematology and Oncology: H&o 5(6): 465-474; 477-479

Boikos, S.A.; Antonarakis, E.S. 2012: Immunotherapy for prostate cancer enters its golden age. Clinical Medicine Insights. Oncology 6: 263-273

Harzstark, A.L.; Small, E.J. 2007: Immunotherapy for prostate cancer using antigen-loaded antigen-presenting cells: APC8015 (Provenge). Expert Opinion on Biological Therapy 7(8): 1275-1280

Drake, C.G. 2010: Immunotherapy for prostate cancer: an emerging treatment modality. Urologic Clinics of North America 37(1): 121-129 Table of Contents

Westdorp, H.; Sköld, A.E.; Snijer, B.A.; Franik, S.; Mulder, S.F.; Major, P.P.; Foley, R.; Gerritsen, W.R.; de Vries, I.J.M. 2014: Immunotherapy for prostate cancer: lessons from responses to tumor-associated antigens. Frontiers in Immunology 5: 191

Gulley, J.L.; Drake, C.G. 2011: Immunotherapy for prostate cancer: recent advances, lessons learned, and areas for further research. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 17(12): 3884-3891

Schweizer, M.T.; Drake, C.G. 2014: Immunotherapy for prostate cancer: recent developments and future challenges. Cancer Metastasis Reviews 33(2-3): 641-655

Drake, C.G. 2009: Immunotherapy for prostate cancer: walk, don't run. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 27(25): 4035-4037

Rivas-Santiago, C.E.; Hernández-Pando, R.; Rivas-Santiago, B. 2013: Immunotherapy for pulmonary TB: antimicrobial peptides and their inducers. ImmunoTherapy 5(10): 1117-1126

Bach, B.C.; Leal, D.B.R.; Ruchel, J.B.; Souza, V.d.C.G.ça.; Maboni, G.; Dal Pozzo, M.; Schlemmer, K.B.; Alves, S.H.; Santurio, J.M. 2010: Immunotherapy for pythiosis: Effect on NTPDase activity in lymphocytes of an experimental model. Biomedicine and PharmacoTherapy 64(10): 718-722

Wong, L.F.; Porter, T.F.; Scott, J.R. 2014: Immunotherapy for recurrent miscarriage. Cochrane Database of Systematic Reviews 10: Cd000112

Bronte, G.; Cicero, G.; Sortino, G.; Pernice, G.; Catarella, M.Teresa.; D'Alia, P.; Cusenza, S.; Lo Dico, S.; Bronte, E.; Sprini, D.; Midiri, M.; Firenze, A.; Fiorentino, E.; Bazan, V.; Rolfo, C.; Russo, A. 2014: Immunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy?. Expert Opinion on Biological Therapy 14(1): 103-114

Coppin, C. 2008: Immunotherapy for renal cell cancer in the era of targeted therapy. Expert Review of Anticancer Therapy 8(6): 907-919

Abecassis, I.J.; Morton, R.P.; Nerva, J.D.; Kim, L.J. 2014: Immunotherapy for secondary glioblastoma multiforme: toward an isocitrate dehydrogenase vaccine. World Neurosurgery 82(6): 933-935

Hotchkiss, R.S.; Opal, S. 2010: Immunotherapy for sepsis--a new approach against an ancient foe. New England Journal of Medicine 363(1): 87-89

Saied, A.; Pillarisetty, V.G.; Katz, S.C. 2014: Immunotherapy for solid tumors--a review for surgeons. Journal of Surgical Research 187(2): 525-535

Rosenmann, H. 2013: Immunotherapy for targeting tau pathology in Alzheimer's disease and tauopathies. Current Alzheimer Research 10(3): 217-228

Leentjens, J.; Kox, M.; van der Hoeven, J.G.; Netea, M.G.; Pickkers, P. 2013: Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. time for a paradigm change?. American Journal of Respiratory and Critical Care Medicine 187(12): 1287-1293

Rewers, M.; Gottlieb, P. 2009: Immunotherapy for the prevention and treatment of type 1 diabetes: human trials and a look into the future. Diabetes Care 32(10): 1769-1782

Bresson, D.; von Herrath, M. 2009: Immunotherapy for the prevention and treatment of type 1 diabetes: optimizing the path from bench to bedside. Diabetes Care 32(10): 1753-1768

Hansrani, M.; Stanford, J.; McIntyre, G.; Bottasso, O.; Stansby, G. 2010: Immunotherapy for the prevention of myointimal hyperplasia after experimental balloon injury of the rat carotid artery. Angiology 61(5): 437-442

Thomas, A.A.; Ernstoff, M.S.; Fadul, C.E. 2012: Immunotherapy for the treatment of glioblastoma. Cancer Journal 18(1): 59-68

Boghossian, S.; Robinson, S.; Von Delwig, A.; Manas, D.; White, S. 2012: Immunotherapy for treating metastatic colorectal cancer. Surgical Oncology 21(2): 67-77

Ma, Y. 2009: Immunotherapy for tuberculosis. Zhonghua Jie he He Hu Xi Za Zhi 32(8): 565-567

Guo, S.; Zhao, J. 2012: Immunotherapy for tuberculosis: what's the better choice?. Frontiers in Bioscience 17: 2684-2690

Chaisson, R.E.; Post, W.S. 2014: Immunotherapy for tuberculous pericarditis. New England Journal of Medicine 371(12): 1155-1157

Skyberg, J.A. 2013: Immunotherapy for tularemia. Virulence 4(8): 859-870

Van der Torren, C.R.; Roep, B.O. 2012: Immunotherapy for type 1 diabetes mellitus (DM1). Nederlands Tijdschrift Voor Geneeskunde 156(15): A4268

Kitamura, H.; Tsukamoto, T. 2011: Immunotherapy for urothelial carcinoma: current status and perspectives. Cancers 3(3): 3055-3072

Qin, P.; Loraine, A.E.; McCormick, S. 2018: Cell-specific cis-natural antisense transcripts (cis-NATs) in the sperm and the pollen vegetative cells of Arabidopsis thaliana. F1000research 7: 93

Paolino, A. 2007: Immunotherapy holds promise for HRPC. LANCET. Oncology 8(8): 676

Oude Elberink, J.N.G.; van der Heide, S.; Guyatt, G.H.; Dubois, A.E.J. 2009: Immunotherapy improves health-related quality of life of adult patients with dermal reactions following yellow jacket stings. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 39(6): 883-889

Huang, S.-w.; Chen, J.; Ouyang, B.; Yang, C.-h.; Chen, M.-y.; Guan, X.-d. 2009: Immunotherapy improves immune homeostasis and increases survival rate of septic patients. Chinese Journal of Traumatology 12(6): 344-349

McBride, D. 2009: Immunotherapy improves survival for patients with neuroblastoma. Ons Connect 24(8): 17

Von Bernhardi, R. 2010: Immunotherapy in Alzheimer's disease: where do we stand? Where should we go?. Journal of Alzheimer's Disease: Jad 19(2): 405-421

Cagnani, C.E.Baena.; Lockey, R.F.; Passalacqua, G.; Canonica, G.Walter. 2008: Immunotherapy in Latin America. From the past to the future. Revista Alergia Mexico 55(1): 33-37

Saraceni, M.M.; Khushalani, N.I.; Jarkowski, A. 2015: Immunotherapy in Melanoma: Recent Advances and Promising new Therapies. Journal of Pharmacy Practice 28(2): 193-203

Papetti, L.; Spalice, A.; Nicita, F.; Ursitti, F.; Iannetti, P. 2013: Immunotherapy in Rasmussen's encephalitis: when should it be taken into account?. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 34(7): 1247-1248

Vasilevko, V.; Head, E. 2009: Immunotherapy in a natural model of Abeta pathogenesis: the aging beagle. Cns and Neurological Disorders Drug Targets 8(2): 98-113

Leung, W. 2009: Immunotherapy in acute leukemia. Seminars in Hematology 46(1): 89-99

Doellman, M.S.; Dion, G.R.; Weitzel, E.Kent.; Reyes, E.Gonzalez. 2013: Immunotherapy in allergic fungal sinusitis: The controversy continues. A recent review of literature. Allergy and Rhinology 4(1): E32-E35

Calamita, Z.; Potthast, S.Bernardino. 2013: Immunotherapy in allergies: an update. Inflammation and Allergy Drug Targets 12(1): 12-18

Chirumbolo, S. 2014: Immunotherapy in allergy and cellular tests: state of art. Human Vaccines and Immunotherapeutics 10(6): 1595-1610

Warrington, R. 2010: Immunotherapy in asthma. ImmunoTherapy 2(5): 711-725

Weigmann, B.; Franke, R.K.; Daniel, C. 2012: Immunotherapy in autoimmune type 1 diabetes. Review of Diabetic Studies: Rds 9(2-3): 68-81

Dubsky, P.C.; Curigliano, G. 2012: Immunotherapy in breast cancer - towards a new understanding of both tumor and host. Breast Care 7(4): 258-260

Garcia, J.A.; Dreicer, R. 2011: Immunotherapy in castration-resistant prostate cancer: integrating sipuleucel-T into our current treatment paradigm. Oncology 25(3): 242-249

Röder, E.; Berger, M.Y.; de Groot, H.; van Wijk, R.G. 2008: Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: a systematic review. Pediatric Allergy and Immunology: Official Publication of the European Society of Pediatric Allergy and Immunology 19(3): 197-207

Guilhot, F.ço.; Roy, L.; Martineua, G.; Guilhot, J.ël.; Millot, F. 2007: Immunotherapy in chronic myelogenous leukemia. Clinical Lymphoma and Myeloma 7(Suppl 2): S64-S70

Khardori, N.Misri.; Khardori, R. 2012: Immunotherapy in clinical medicine. Medical Clinics of North America 96(3): Xiii-Xxiv

Shahani, L.; Singh, S.; Khardori, N.M. 2012: Immunotherapy in clinical medicine: historical perspective and current status. Medical Clinics of North America 96(3): 421

Pal, V.V.; Gaikwad, G.; Khamaar, B.M.; Ganapati, R. 2002: Immunotherapy in clinical practice--an evaluation. Indian Journal of Dermatology Venereology and Leprology 68(4): 248

Reshetnikov, E.A.; Baranov, G.A.; Chuvanov, M.V.; Skalozub, O.I. 2008: Immunotherapy in complex treatment of surgical sepsis. Khirurgiia 7: 11-14

Kuypers, D.R.J. 2009: Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions. Drugs and Aging 26(9): 715-737

Lavoué, V.; Foucher, F.; Henno, S.; Bauville, E.; Catros, V.; Cabillic, F.; Levêque, J. 2014: Immunotherapy in epithelial ovarian carcinoma: hope and reality. Journal de Gynecologie Obstetrique et Biologie de la Reproduction 43(3): 198-210

Kamdar, T.; Bryce, P.J. 2010: Immunotherapy in food allergy. ImmunoTherapy 2(3): 329-338

Sato, S.; Yanagida, N.; Ogura, K.; Asaumi, T.; Okada, Y.; Koike, Y.; Iikura, K.; Syukuya, A.; Ebisawa, M. 2014: Immunotherapy in food allergy: towards new strategies. Asian Pacific Journal of Allergy and Immunology 32(3): 195-202

Matsueda, S.; Graham, D.Y. 2014: Immunotherapy in gastric cancer. World Journal of Gastroenterology 20(7): 1657-1666

Agada, F.O.; Alhamarneh, O.; Stafford, N.D.; Greenman, J. 2009: Immunotherapy in head and neck cancer: current practice and future possibilities. Journal of Laryngology and Otology 123(1): 19-28

Slavin, S.; Ackerstein, A.; Or, R.; Shapira, M.Y.; Gesundheit, B.; Askenasy, N.; Morecki, S. 2010: Immunotherapy in high-risk chemotherapy-resistant patients with metastatic solid tumors and hematological malignancies using intentionally mismatched donor lymphocytes activated with rIL-2: a phase i study. Cancer Immunology Immunotherapy: Cii 59(10): 1511-1519

Szabo, A.T.; Carpentier, A.F. 2011: Immunotherapy in human glioblastoma. Revue Neurologique (Paris) 167(10): 668-672

Ahluwalia, J.P. 2012: Immunotherapy in inflammatory bowel disease. Medical Clinics of North America 96(3): 525

Van De Velde, A.L.R.; Anguille, S.; Berneman, Z.N. 2012: Immunotherapy in leukaemia. Acta Clinica Belgica 67(6): 399-402

Morrison, B.J.; Steel, J.C.; Morris, J.C. 2013: Immunotherapy in lung cancer: the potential of cancer stem cells in future therapies. Future Oncology 9(5): 623-625

Gonzales, M.; Fratianni, C.; Mamillapali, C.; Khardori, R. 2012: Immunotherapy in miscellaneous medical disorders Graves ophthalmopathy, asthma, and regional painful syndrome. Medical Clinics of North America 96(3): 635

Cohen-Wolkowiez, M.; Benjamin, D.K.; Capparelli, E. 2009: Immunotherapy in neonatal sepsis: advances in treatment and prophylaxis. Current Opinion in Pediatrics 21(2): 177-181

Paolini, F.; Massa, S.; Manni, I.; Franconi, R.; Venuti, A. 2013: Immunotherapy in new pre-clinical models of HPV-associated oral cancers. Human Vaccines and Immunotherapeutics 9(3): 534-543

Bogart, J.A.; Gajra, A. 2014: Immunotherapy in non-small-cell lung cancer: a good start?. LANCET. Oncology 15(1): 5-6

Van den Heuvel, M.M.; Burgers, S.A.; van Zandwijk, N. 2009: Immunotherapy in non-small-cell lung carcinoma: from inflammation to vaccination. Clinical Lung Cancer 10(2): 99-105

Ghafouri-Fard, S.; Ghafouri-Fard, S. 2012: Immunotherapy in nonmelanoma skin cancer. ImmunoTherapy 4(5): 499-510

Mantia-Smaldone, G.M.; Corr, B.; Chu, C.S. 2012: Immunotherapy in ovarian cancer. Human Vaccines and Immunotherapeutics 8(9): 1179-1191

Angeles, M.B. 2010: Immunotherapy in patients allergic to bee venom. Revista Alergia Mexico 57(2): 57-59

Recchia, F.; Candeloro, G.; Necozione, S.; Bisegna, R.; Bratta, M.; Rea, S. 2009: Immunotherapy in patients with less than complete response to chemotherapy. Anticancer Research 29(2): 567-572

Capitini, C.M.; Otto, M.; DeSantes, K.B.; Sondel, P.M. 2014: Immunotherapy in pediatric malignancies: current status and future perspectives. Future Oncology 10(9): 1659-1678

Ciprandi, G.; Melioli, G.; Passalacqua, G.; Canonica, G.W. 2012: Immunotherapy in polysensitized patients: new chances for the allergists?. Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 109(6): 392-394

Brivio, F.; Fumagalli, L.; Chiarelli, M.; Denova, M.; Bertolini, A.; Cetta, M.; Nespoli, A. 2007: Immunotherapy in radical surgery of colorectal carcinoma. Chirurgia Italiana 59(5): 635-640

Heine, A.; Holderried, T.A.W.; Brossart, P. 2009: Immunotherapy in renal cell carcinoma. ImmunoTherapy 1(1): 97-107

Kher, A.; Kher, V. 2012: Immunotherapy in renal diseases. Medical Clinics of North America 96(3): 545-564 X

Wilky, B.A.; Goldberg, J.M. 2014: Immunotherapy in sarcoma: a new frontier. Discovery Medicine 17(94): 201-206

Lankester, A.C.; Ball, L.M.; Lang, P.; Handgretinger, R. 2010: Immunotherapy in the context of hematopoietic stem cell transplantation: the emerging role of natural killer cells and mesenchymal stromal cells. Pediatric Clinics of North America 57(1): 97-121

Shih, Y.-C.T.; Elting, L.S.; Pavluck, A.L.; Stewart, A.; Halpern, M.T. 2010: Immunotherapy in the initial treatment of newly diagnosed cancer patients: utilization trend and cost projections for non-Hodgkin's lymphoma, metastatic breast cancer, and metastatic colorectal cancer. Cancer Investigation 28(1): 46-53

Gérard, C.; Debruyne, C. 2009: Immunotherapy in the landscape of new targeted treatments for non-small cell lung cancer. Molecular Oncology 3(5-6): 409-424

Djavan, B.; Nelson, K.; Kazzazi, A.; Bruhn, A.; Sadri, H.; Gomez-Pinillos, A.; Ferrari, A.C. 2011: Immunotherapy in the treatment of advanced prostate cancer. Canadian Journal of Urology 18(5): 5865-5874

Enrique, E. 2009: Immunotherapy in the treatment of food allergy. Does it have a future?. Allergologia et Immunopathologia 37(3): 143-145

Vickery, B.P.; Burks, A.W. 2009: Immunotherapy in the treatment of food allergy: focus on oral tolerance. Current Opinion in Allergy and Clinical Immunology 9(4): 364-370

Sundar, R.; Soong, R.; Cho, B.-C.; Brahmer, J.R.; Soo, R.A. 2014: Immunotherapy in the treatment of non-small cell lung cancer. Lung Cancer 85(2): 101-109

Bonifacio, E. 2012: Immunotherapy in type 1 diabetes: a shorter but more winding road?. Diabetes 61(9): 2214-2215

Bergman, P.J. 2014: Immunotherapy in veterinary oncology. Veterinary Clinics of North America. Small Animal Practice 44(5): 925-939

Dreborg, S.; Lee, T.H.; Kay, A.B.; Durham, S.R. 2012: Immunotherapy is allergen-specific: a double-blind trial of mite or timothy extract in mite and grass dual-allergic patients. International Archives of Allergy and Immunology 158(1): 63-70

Propst, K.L.; Troyer, R.M.; Kellihan, L.M.; Schweizer, H.P.; Dow, S.W. 2010: Immunotherapy markedly increases the effectiveness of antimicrobial therapy for treatment of Burkholderia pseudomallei infection. Antimicrobial Agents and ChemoTherapy 54(5): 1785-1792

Polci, R.; Feriozzi, S. 2011: Immunotherapy mechanisms in glomerulonephritis. Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 28(6): 612-621

Rose, S. 2012: Immunotherapy network launches first trial. Cancer Discovery 2(9): 760

Alatrash, G.; Molldrem, J.J. 2010: Immunotherapy of AML. Cancer Treatment and Research 145: 237-255

Matsumoto, S-ei.; Tabira, T. 2009: Immunotherapy of Alzheimer's disease by Abeta vaccination. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 134(2): 59-63

Panjideh, H.; Müller, G.; Koch, M.; Wilde, F.; Scheu, S.; Moldenhauer, G.; Lipp, M. 2014: Immunotherapy of B-cell non-Hodgkin lymphoma by targeting the chemokine receptor CXCR5 in a preclinical mouse model. International Journal of Cancer 135(11): 2623-2632

Parekh, P.; Kamble, S.; Zhao, N.; Zeng, Z.; Portier, B.P.; Zu, Y. 2013: Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer. Biomaterials 34(35): 8909-8917

Greten, T.F.; Manns, M.P.; Korangy, F. 2008: Immunotherapy of HCC. Reviews on Recent Clinical Trials 3(1): 31-39

Qasim, W.; Brunetto, M.; Gehring, A.J.; Xue, S.-A.; Schurich, A.; Khakpoor, A.; Zhan, H.; Ciccorossi, P.; Gilmour, K.; Cavallone, D.; Moriconi, F.; Farzhenah, F.; Mazzoni, A.; Chan, L.; Morris, E.; Thrasher, A.; Maini, M.K.; Bonino, F.; Stauss, H.; Bertoletti, A. 2015: Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient. Journal of Hepatology 62(2): 486-491

Yamamoto, N.; Ushijima, N.; Koga, Y. 2009: Immunotherapy of HIV-infected patients with Gc protein-derived macrophage activating factor (GcMAF). Journal of Medical Virology 81(1): 16-26

Zhao, J.; Zeng, W.; Cao, Y.; Liang, X.; Huang, B. 2014: Immunotherapy of HPV infection-caused genital warts using low dose cyclophosphamide. Expert Review of Clinical Immunology 10(6): 791-799

Nizard, M.; Sandoval, F.; Badoual, C.; Pere, H.; Terme, M.; Hans, S.; Benhamouda, N.; Granier, C.; Brasnu, D.; Tartour, E. 2013: Immunotherapy of HPV-associated head and neck cancer: Critical parameters. Oncoimmunology 2(6): E24534

Reiniš, M. 2010: Immunotherapy of MHC class I-deficient tumors. Future Oncology 6(10): 1577-1589

Cheuk, A.T.C.; Guinn, B.-a. 2008: Immunotherapy of acute myeloid leukaemia: development of a whole cell vaccine. Frontiers in Bioscience: a Journal and Virtual Library 13: 2022-2029

Gertner-Dardenne, J.; Fauriat, C.; Vey, N.; Olive, D. 2012: Immunotherapy of acute myeloid leukemia based on γδ T cells. Oncoimmunology 1(9): 1614-1616

Smits, E.L.J.M.; Berneman, Z.N.; Van Tendeloo, V.F.I. 2009: Immunotherapy of acute myeloid leukemia: current approaches. Oncologist 14(3): 240-252

Cebon, J.; Gedye, C.; John, T.; Davis, I.D. 2007: Immunotherapy of advanced or metastatic melanoma. Clinical Advances in Hematology and Oncology: H&o 5(12): 994-1006

Denis, M.; Ghadirian, E. 1993: Immunotherapy of airborne tuberculosis in mice via the lung-specific delivery of cytokines. Canadian Journal of Infectious Diseases 4(1): 38-42

Spiewak, R. 2011: Immunotherapy of allergic contact dermatitis. ImmunoTherapy 3(8): 979-996

Klimek, L.; Willers, J.; Schendzielorz, P.; Kündig, T.M.; Senti, G. 2013: Immunotherapy of allergic rhinitis without allergens? : new options for immunomodulation by vaccination with virus-like particles and CpG motifs. Hno 61(10): 826-833

Klimek, L.; Schendzielorz, P.; Mueller, P.; Saudan, P.; Willers, J. 2013: Immunotherapy of allergic rhinitis: new therapeutic opportunities with virus-like particles filled with CpG motifs. American Journal of Rhinology and Allergy 27(3): 206-212

Wang, H.; Yang, J.; Jin, L.; Feng, J.; Lu, Y.; Sun, Y.; Li, T.; Cao, R.; Wu, J.; Fan, H.; Liu, J. 2009: Immunotherapy of autoimmune diabetes by nasal administration of tandem glutamic acid decarboxylase 65 peptides. Immunological Investigations 38(8): 690-703

Kamigaki, T.; Kaneko, T.; Naitoh, K.; Takahara, M.; Kondo, T.; Ibe, H.; Matsuda, E.; Maekawa, R.; Goto, S. 2013: Immunotherapy of autologous tumor lysate-loaded dendritic cell vaccines by a closed-flow electroporation system for solid tumors. Anticancer Research 33(7): 2971-2976

Ge, L.; Hoa, N.; Bota, D.A.; Natividad, J.; Howat, A.; Jadus, M.R. 2010: Immunotherapy of brain cancers: the past, the present, and future directions. Clinical and Developmental Immunology 2010: 296453

Marshall, D.; Mitchell, D.A.; Graner, M.W.; Bigner, D.D. 2012: Immunotherapy of brain tumors. Handbook of Clinical Neurology 104: 309-330

Wright, S.E. 2012: Immunotherapy of breast cancer. Expert Opinion on Biological Therapy 12(4): 479-490

Yu, Y.-L.; Wei, C.-W.; Chen, Y.-L.; Chen, M.H.-C.; Yiang, G.-T. 2010: Immunotherapy of breast cancer by single delivery with rAAV2-mediated interleukin-15 expression. International Journal of Oncology 36(2): 365-370

Borghaei, H.; Smith, M.R.; Campbell, K.S. 2009: Immunotherapy of cancer. European Journal of Pharmacology 625(1-3): 41-54

Weiss, J.M.; Subleski, J.J.; Wigginton, J.M.; Wiltrout, R.H. 2007: Immunotherapy of cancer by IL-12-based cytokine combinations. Expert Opinion on Biological Therapy 7(11): 1705-1721

Kirkwood, J.M.; Butterfield, L.H.; Tarhini, A.A.; Zarour, H.; Kalinski, P.; Ferrone, S. 2012: Immunotherapy of cancer in 2012. Ca: a Cancer Journal for Clinicians 62(5): 309-335

Gammaitoni, L.; Leuci, V.; Mesiano, G.; Giraudo, L.; Todorovic, M.; Carnevale-Schianca, F.; Aglietta, M.; Sangiolo, D. 2014: Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective. Expert Opinion on Biological Therapy 14(9): 1259-1270

Li, W.; Chen, W.; Herberman, R.B.; Plotnikoff, N.P.; Youkilis, G.; Griffin, N.; Wang, E.; Lu, C.; Shan, F. 2014: Immunotherapy of cancer via mediation of cytotoxic T lymphocytes by methionine enkephalin (MENK). Cancer Letters 344(2): 212-222

Vinay, D.S.; Kwon, B.S. 2012: Immunotherapy of cancer with 4-1BB. Molecular Cancer Therapeutics 11(5): 1062-1070

Van Nuffel, A.M.T.; Corthals, J.; Neyns, B.; Heirman, C.; Thielemans, K.; Bonehill, A. 2010: Immunotherapy of cancer with dendritic cells loaded with tumor antigens and activated through mRNA electroporation. Methods in Molecular Biology 629: 405-452

Archer, E.; Pavela, G.; McDonald, S.; Lavie, C.J.; Hill, J.O. 2018: Cell-Specific "Competition for Calories" Drives Asymmetric Nutrient-Energy Partitioning, Obesity, and Metabolic Diseases in Human and Non-human Animals. Frontiers in Physiology 9: 1053

Darrasse-Jèze, G.; Klatzmann, D. 2011: Immunotherapy of cancer: light at the end of the tunnel?. Medecine Sciences: M/S 27(10): 795-797

Payne, K.K.; Toor, A.A.; Wang, X-Yang.; Manjili, M.H. 2012: Immunotherapy of cancer: reprogramming tumor-immune crosstalk. Clinical and Developmental Immunology 2012: 760965

Lifshitz, V.; Weiss, R.; Benromano, T.; Kfir, E.; Blumenfeld-Katzir, T.; Tempel-Brami, C.; Assaf, Y.; Xia, W.; Wyss-Coray, T.; Weiner, H.L.; Frenkel, D. 2012: Immunotherapy of cerebrovascular amyloidosis in a transgenic mouse model. Neurobiology of Aging 33(2): 432.E1-432.E13

Klimek, R.; Klimek, M.; Jasiczek, D. 2011: Immunotherapy of cervical cancer as a biological dissipative structure. Neuro Endocrinology Letters 32(4): 380-388

Wayne, A.S.; Capitini, C.M.; Mackall, C.L. 2010: Immunotherapy of childhood cancer: from biologic understanding to clinical application. Current Opinion in Pediatrics 22(1): 2-11

Fuller, M.J.; Callendret, B.; Zhu, B.; Freeman, G.J.; Hasselschwert, D.L.; Satterfield, W.; Sharpe, A.H.; Dustin, L.B.; Rice, C.M.; Grakoui, A.; Ahmed, R.; Walker, C.M. 2013: Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1). Proceedings of the National Academy of Sciences of the United States of America 110(37): 15001-15006

Eftimov, F.; van Schaik, I.N. 2008: Immunotherapy of chronic inflammatory demyelinating polyradiculoneuropathy. Expert Opinion on Biological Therapy 8(5): 643-655

Vonka, V.ír. 2010: Immunotherapy of chronic myeloid leukemia: present state and future prospects. ImmunoTherapy 2(2): 227-241

Grauer, O.M.; Wesseling, P.; Adema, G.J. 2009: Immunotherapy of diffuse gliomas: biological background, current status and future developments. Brain Pathology 19(4): 674-693

Wesseling, P.; Adema, G.J. 2009: Immunotherapy of diffuse gliomas: helping the brain fight back!. Brain Pathology 19(4): 672-673

Schadendorf, D.; Algarra, S.M.; Bastholt, L.; Cinat, G.; Dreno, B.; Eggermont, A.M.M.; Espinosa, E.; Guo, J.; Hauschild, A.; Petrella, T.; Schachter, J.; Hersey, P. 2009: Immunotherapy of distant metastatic disease. Annals of Oncology: Official Journal of the European Society for Medical Oncology 20(Suppl 6): Vi41-Vi50

Lee, W.T.; Tamai, H.; Cohen, P.; Teker, A.M.; Shu, S. 2008: Immunotherapy of established murine squamous cell carcinoma using fused dendritic-tumor cell hybrids. Archives of Otolaryngology--Head and Neck Surgery 134(6): 608-613

Knutson, K.L.; Salazar, L.; Schiffman, K.; Disis, M.L. 2003: Immunotherapy of glioblastoma multiforme. Expert Review of Neurotherapeutics 3(4): 511-523

Lee, S.C.; López-Albaitero, A.és.; Ferris, R.L. 2009: Immunotherapy of head and neck cancer using tumor antigen-specific monoclonal antibodies. Current Oncology Reports 11(2): 156-162

Schuler, P.J.; Hoffmann, T.K.; Gauler, T.C.; Bergmann, C.; Brandau, S.; Lang, S. 2013: Immunotherapy of head and neck cancer. Current developments. Hno 61(7): 559-572

Hoffmann, T.K. 2011: Immunotherapy of head and neck cancer. Identification of a novel mechanism for anti-EGFR mAb anti-tumor effects. Hno 59(3): 224-229

Rapidis, A.D.; Wolf, G.T. 2009: Immunotherapy of head and neck cancer: current and future considerations. Journal of Oncology 2009: 346345

Korangy, F.; Höchst, B.; Manns, M.P.; Greten, T.F. 2010: Immunotherapy of hepatocellular carcinoma. Expert Review of Gastroenterology and Hepatology 4(3): 345-353

Zhang, W.; Liu, J.; Wu, Y.; Xiao, F.; Wang, Y.; Wang, R.; Yang, H.; Wang, G.; Yang, J.; Deng, H.; Li, J.; Wen, Y.; Wei, Y. 2008: Immunotherapy of hepatocellular carcinoma with a vaccine based on xenogeneic homologous alpha fetoprotein in mice. Biochemical and Biophysical Research Communications 376(1): 10-14

Kabilova, T.O.; Kovtonyuk, L.V.; Zonov, E.V.; Ryabchikova, E.I.; Popova, N.A.; Nikolin, V.P.; Kaledin, V.I.; Zenkova, M.A.; Vlassov, V.V.; Chernolovskaya, E.L. 2014: Immunotherapy of hepatocellular carcinoma with small double-stranded RNA. Bmc Cancer 14: 338

Pardee, A.D.; Butterfield, L.H. 2012: Immunotherapy of hepatocellular carcinoma: Unique challenges and clinical opportunities. Oncoimmunology 1(1): 48-55

Cany, J.; Tran, L.; Gauttier, V.; Judor, J.-P.; Vassaux, G.; Ferry, N.; Conchon, S. 2011: Immunotherapy of hepatocellular carcinoma: is there a place for regulatory T-lymphocyte depletion?. ImmunoTherapy 3(4 Suppl): 32-34

Tan, G.-H.; Huang, F.-Y.; Wang, H.; Huang, Y.-H.; Lin, Y.-Y.; Li, Y.-N. 2007: Immunotherapy of hepatoma with a monoclonal antibody against murine endoglin. World Journal of Gastroenterology 13(17): 2479-2483

Vera, J.F.; Brenner, M.K.; Dotti, G. 2009: Immunotherapy of human cancers using gene modified T lymphocytes. Current Gene Therapy 9(5): 396-408

Van der Burg, S.H. 2012: Immunotherapy of human papilloma virus induced disease. Open Virology Journal 6: 257-263

Hirata, H.; Fukuda, T. 2008: Immunotherapy of hymenoptera allergy. Arerugi 57(5): 491-498

Katragkou, A.; Roilides, E. 2012: Immunotherapy of infections caused by rare filamentous fungi. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 18(2): 134-139

Sheviakov, M.A. 2013: Immunotherapy of infectious and inflammatory diseases of the urinary tract and its effectiveness. Urologiia 2: 98

Dalakas, M.C. 2011: Immunotherapy of inflammatory myopathies: practical approach and future prospects. Current Treatment Options in Neurology 13(3): 311-323

Lehrnbecher, T.; Schmidt, S.; Tramsen, L.; Klingebiel, T. 2013: Immunotherapy of invasive fungal infection in hematopoietic stem cell transplant recipients. Frontiers in Oncology 3: 17

Grivas, P.D.; Redman, B.G. 2011: Immunotherapy of kidney cancer. Current Clinical Pharmacology 6(3): 151-163

Wojas-Krawczyk, K.; Krawczyk, Pł.; Buczkowski, Jław.; Walkowska, A.; Jankowska, O.; Czekajska-Chehab, Eżbieta.; Milanowski, J. 2012: Immunotherapy of lung adenocarcinoma patient with Peptide-pulsed dendritic cells: a case report. Archivum Immunologiae et Therapiae Experimentalis 60(1): 69-77

Nagorsen, D.; Bargou, R.; Ruttinger, D.; Kufer, P.; Baeuerle, P.A.; Zugmaier, G. 2009: Immunotherapy of lymphoma and leukemia with T-cell engaging BiTE antibody blinatumomab. Leukemia and Lymphoma 50(6): 886-891

Yu, K.; Hu, Y.; Tan, Y.; Shen, Z.; Jiang, S.; Qian, H.; Liang, B.; Shan, D. 2008: Immunotherapy of lymphomas with T cells modified by anti-CD20 scFv/CD28/CD3zeta recombinant gene. Leukemia and Lymphoma 49(7): 1368-1373

Campoli, M.; Ferris, R.; Ferrone, S.; Wang, X. 2010: Immunotherapy of malignant disease with tumor antigen-specific monoclonal antibodies. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 16(1): 11-20

Hofman, F.M.; Stathopoulos, A.; Kruse, C.A.; Chen, T.C.; Schijns, V.E.J.C. 2010: Immunotherapy of malignant gliomas using autologous and allogeneic tissue cells. Anti-Cancer Agents in Medicinal Chemistry 10(6): 462-470

Kim, D.S.; Kim, D.H.; Goo, B.; Cho, Y.H.; Park, J.M.; Lee, T.H.; Kim, H.O.; Kim, H.-S.; Lee, H.; Lee, J.D.; Byamba, D.; Je, J.H.; Lee, M.-G. 2011: Immunotherapy of malignant melanoma with tumor lysate-pulsed autologous monocyte-derived dendritic cells. Yonsei Medical Journal 52(6): 990-998

Hersey, P. 2010: Immunotherapy of melanoma. Asia-Pacific Journal of Clinical Oncology 6 Suppl. 1: S2-S8

Wang, J.; Zhao, F.; Dou, J.; He, X.F.; Chu, L.; Cao, M.; Liu, C.; Li, Y.; Gu, N. 2011: Immunotherapy of melanoma by GPI-anchored IL-21 tumour vaccine involves down-regulating regulatory T cells in mouse model. International Journal of Immunogenetics 38(1): 21-29

Li, S.-Y.; Liu, Y. 2013: Immunotherapy of melanoma with the immune costimulatory monoclonal antibodies targeting CD137. Clinical Pharmacology: Advances and Applications 5(Suppl 1): 47-53

Homsi, J.; Grimm, J.C.; Hwu, P. 2011: Immunotherapy of melanoma: an update. Surgical Oncology Clinics of North America 20(1): 145-163

Zimmer, L.; Vaubel, J.; Schadendorf, D. 2012: Immunotherapy of melanomas. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 63(12): 952-958

Yvon, E.; Del Vecchio, M.; Savoldo, B.; Hoyos, V.; Dutour, A.él.; Anichini, A.; Dotti, G.; Brenner, M.K. 2009: Immunotherapy of metastatic melanoma using genetically engineered GD2-specific T cells. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 15(18): 5852-5860

McDermott, D.F. 2009: Immunotherapy of metastatic renal cell carcinoma. Cancer 115(10 Suppl): 2298-2305

Eftimov, F.; Van Schaik, I.N. 2011: Immunotherapy of multifocal motor neuropathy. Expert Opinion on Biological Therapy 11(3): 329-342

Meuth, S.G.; Bittner, S.; Wiendl, H. 2009: Immunotherapy of multiple sclerosis. Acta Neuropsychiatrica 21(Suppl 2): 27-34

Tovey, M.G. 2010: Immunotherapy of multiple sclerosis. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 30(10): 713-714

Cheung, B.K.W.; Chan, M.M.P.; Yim, H.C.H.; Chan, L.L.; Li, J.C.B.; Lee, D.C.W.; Lau, A.S.-y. 2009: Immunotherapy of mycobacterial infections: a cell and molecular model. Hong Kong Medical Journal 15(3 Suppl 4: 32-36

Shimizu, J. 2011: Immunotherapy of myositis: future prospects. Rinsho Shinkeigaku 51(11): 967

Croce, M.; Meazza, R.; Orengo, A.M.; Fabbi, M.; Borghi, M.; Ribatti, D.; Nico, B.; Carlini, B.; Pistoia, V.; Corrias, M.V.; Ferrini, S. 2008: Immunotherapy of neuroblastoma by an Interleukin-21-secreting cell vaccine involves survivin as antigen. Cancer Immunology Immunotherapy: Cii 57(11): 1625-1634

Bienia, B.; Balabanov, R. 2013: Immunotherapy of neuromyelitis optica. Autoimmune Diseases 2013: 741490

Hayashi, A.; Nishida, Y.; Yoshii, S.; Kim, S.Y.; Uda, H.; Hamasaki, T. 2009: Immunotherapy of ovarian cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin: effect of lymphadenectomy. Cancer Science 100(10): 1991-1995

Märten, A. 2008: Immunotherapy of pancreatic carcinoma. Reviews on Recent Clinical Trials 3(2): 121-125

Driggers, L.; Zhang, J-Gang.; Newcomb, E.W.; Ge, L.; Hoa, N.; Jadus, M.R. 2010: Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: a medical hypothesis paper. Journal of Neuro-Oncology 97(2): 159-169

Ströhlein, M.A.; Heiss, M.M. 2007: Immunotherapy of peritoneal carcinomatosis. Cancer Treatment and Research 134: 483-491

Parsons, S.L. 2011: Immunotherapy of peritoneal carcinomatosis with catumaxomab. Onkologie 34(3): 86-87

Ströhlein, M.A.; Lordick, F.; Rüttinger, D.; Grützner, K.-U.; Schemanski, O.C.; Jäger, M.; Lindhofer, H.; Hennig, M.; Jauch, K.-W.; Peschel, C.; Heiss, M.M. 2011: Immunotherapy of peritoneal carcinomatosis with the antibody catumaxomab in colon, gastric, or pancreatic cancer: an open-label, multicenter, phase I/Ii trial. Onkologie 34(3): 101-108

Doehn, C. 2008: Immunotherapy of prostate cancer. European Urology 53(4): 681

Galustian, C.; Vyakarnam, A.; Elhage, O.; Hickman, O.; Dasgupta, P.; Smith, R.A. 2011: Immunotherapy of prostate cancer: identification of new treatments and targets for therapy, and role of WAP domain-containing proteins. Biochemical Society Transactions 39(5): 1433-1436

Chen, G. 2010: Immunotherapy of rheumatoid arthritis targeting inflammatory cytokines and autoreactive T cells. Archivum Immunologiae et Therapiae Experimentalis 58(1): 27-36

Goldberg, J.M. 2013: Immunotherapy of sarcomas. Current Opinion in Oncology 25(4): 390-397

Romanovich, V.M. 1953: Immunotherapy of scarlet fever. Voprosy Pediatrii 21(3): 20-21

Ikeda, H.; Shiku, H. 2012: Immunotherapy of solid tumor: perspectives on vaccine and cell therapy. Nihon Rinsho. Japanese Journal of Clinical Medicine 70(12): 2043-2050

Manno, R.; Boin, F. 2010: Immunotherapy of systemic sclerosis. ImmunoTherapy 2(6): 863-878

Doimo, N.T.S.; Zárate-Bladés, C.R.; Rodrigues, R.F.; Tefé-Silva, C.; Trotte, M.N.S.; Souza, P.íc.R.M.; Soares, L.S.; Rios, W.M.; Floriano, E.M.; Brandão, I.T.; Masson, A.P.; Coelho, V.ôn.; Ramos, S.G.; Silva, C.L. 2014: Immunotherapy of tuberculosis with Mycobacterium leprae Hsp65 as a DNA vaccine triggers cross-reactive antibodies against mammalian Hsp60 but not pathological autoimmunity. Human Vaccines and Immunotherapeutics 10(5): 1238-1243

Li, X.; Wang, Y.; Zhao, Y.; Yang, H.; Tong, A.; Zhao, C.; Shi, H.; Li, Y.; Wang, Z.; Wei, Y. 2014: Immunotherapy of tumor with vaccine based on basic fibroblast growth factor-activated fibroblasts. Journal of Cancer Research and Clinical Oncology 140(2): 271-280

Pawaria, S.; Kropp, L.E.; Binder, R.J. 2012: Immunotherapy of tumors with α2-macroglobulin-antigen complexes pre-formed in vivo. Plos one 7(11): E50365

Li, L.; Yi, Z.; Tisch, R.; Wang, B. 2008: Immunotherapy of type 1 diabetes. Archivum Immunologiae et Therapiae Experimentalis 56(4): 227-236

Boettler, T.; von Herrath, M. 2010: Immunotherapy of type 1 diabetes--how to rationally prioritize combination therapies in T1D. International Immunopharmacology 10(12): 1491-1495

Luo, X.; Herold, K.C.; Miller, S.D. 2010: Immunotherapy of type 1 diabetes: where are we and where should we be going?. Immunity 32(4): 488-499

Klimek, L.; Bachmann, M.F.; Senti, G.; Kündig, T.M. 2014: Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs. Expert Review of Clinical Immunology 10(8): 1059-1067

Bosch, J.J. 2012: Immunotherapy of uveal melanoma. Developments in Ophthalmology 49: 137-149

Hegde, N.R.; Rao, P.P.; Bayry, J.; Kaveri, S.V. 2009: Immunotherapy of viral infections. ImmunoTherapy 1(4): 691-711

Faustman, D.L. 2008: Immunotherapy on trial for new-onset type 1 diabetes. New England Journal of Medicine 359(18): 1956-1958

Chu, C.S.; Kim, S.H.; June, C.H.; Coukos, G. 2008: Immunotherapy opportunities in ovarian cancer. Expert Review of Anticancer Therapy 8(2): 243-257

Esch, R.E.; Plunkett, G.A. 2013: Immunotherapy preparation guidelines, rules, and regulation. Current Allergy and Asthma Reports 13(4): 406-413

Barrett, A.J.; Le Blanc, K. 2010: Immunotherapy prospects for acute myeloid leukaemia. Clinical and Experimental Immunology 161(2): 223-232

Urra, J.M.; Carrasco, P.; Feo-Brito, F.; De La Roca, F.; Guerra, F.; Cabrera, C.M. 2014: Immunotherapy reduces CD40L expression and modifies cytokine production in the CD4 cells of pollen allergy patients. Journal of Investigational Allergology and Clinical Immunology 24(2): 98-105

Aroca, R.; Chamorro, C.; Vega, A.; Ventura, I.; Gómez, E.; Pérez-Cano, R.ón.; Blanca, M.; Monteseirín, J. 2014: Immunotherapy reduces allergen-mediated CD66b expression and myeloperoxidase levels on human neutrophils from allergic patients. Plos one 9(4): E94558

Schroeter, S.; Khan, K.; Barbour, R.; Doan, M.; Chen, M.; Guido, T.; Gill, D.; Basi, G.; Schenk, D.; Seubert, P.; Games, D. 2008: Immunotherapy reduces vascular amyloid-beta in PDAPP mice. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 28(27): 6787-6793

Gilles, R.; de Geus-Oei, L.-F.; Mulders, P.F.A.; Oyen, W.J.G. 2013: Immunotherapy response evaluation with (18)F-FDG-PET in patients with advanced stage renal cell carcinoma. World Journal of Urology 31(4): 841-846

Mittal, M.; Hammond, N.; G Lynch, S. 2010: Immunotherapy responsive autoimmune subacute encephalitis: a report of two cases. Case Reports in Medicine 2010: 837371

Antozzi, C.; Binelli, S.; Frassoni, C.; Ciano, C.; Vincent, A.; Andreetta, F.; Panzica, F.; Franceschetti, S.; Confalonieri, P.; Mantegazza, R. 2009: Immunotherapy responsive startle with antibodies to voltage gated potassium channels. BMJ Case Reports

Vetter, C. 2014: Immunotherapy seems to help in the fight against cancer. Medizinische Monatsschrift für Pharmazeuten 37(9): 342-343

Locke, F.L.; Nishihori, T.; Alsina, M.; Kharfan-Dabaja, M.A. 2013: Immunotherapy strategies for multiple myeloma: the present and the future. ImmunoTherapy 5(9): 1005-1020

Bae, J.; Munshi, N.C.; Anderson, K.C. 2014: Immunotherapy strategies in multiple myeloma. Hematology/Oncology Clinics of North America 28(5): 927-943

Soliman, H. 2013: Immunotherapy strategies in the treatment of breast cancer. Cancer Control: Journal of the Moffitt Cancer Center 20(1): 17-21

Koido, S.; Homma, S.; Takahara, A.; Namiki, Y.; Komita, H.; Uchiyama, K.; Ito, M.; Gong, J.; Ohkusa, T.; Tajiri, H. 2012: Immunotherapy synergizes with chemotherapy targeting pancreatic cancer. ImmunoTherapy 4(1): 5-7

Bollard, C.M.; Cooper, L.J.; Heslop, H.E. 2008: Immunotherapy targeting EBV-expressing lymphoproliferative diseases. Best Practice and Research. Clinical Haematology 21(3): 405-420

Kawakami, Y.; Matsushita, M.; Ueda, R.; Tsukamoto, N.; Ohta, S. 2012: Immunotherapy targeting cancer stem cells. Nihon Rinsho. Japanese Journal of Clinical Medicine 70(12): 2142-2146

Iovino, F.; Meraviglia, S.; Spina, M.; Orlando, V.; Saladino, V.; Dieli, F.; Stassi, G.; Todaro, M. 2011: Immunotherapy targeting colon cancer stem cells. ImmunoTherapy 3(1): 97-106

Lees, J.G.; Duffy, S.S.; Moalem-Taylor, G. 2013: Immunotherapy targeting cytokines in neuropathic pain. Frontiers in Pharmacology 4: 142

Wen, Y.; Wang, C.-T.; Ma, T.-T.; Li, Z.-Y.; Zhou, L.-N.; Mu, B.; Leng, F.; Shi, H.-S.; Li, Y.-O.; Wei, Y.-Q. 2010: Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model. Cancer Science 101(11): 2325-2332

Wen, Y.; Graybill, W.S.; Previs, R.A.; Hu, W.; Ivan, C.; Mangala, L.S.; Zand, B.; Nick, A.M.; Jennings, N.B.; Dalton, H.J.; Sehgal, V.; Ram, P.; Lee, J.-S.; Vivas-Mejia, P.E.; Coleman, R.L.; Sood, A.K. 2015: Immunotherapy targeting folate receptor induces cell death associated with autophagy in ovarian cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 21(2): 448-459

Li, Z.; Lee, J.-W.; Mukherjee, D.; Ji, J.; Jeswani, S.P.; Black, K.L.; Yu, J.S. 2012: Immunotherapy targeting glioma stem cells--insights and perspectives. Expert Opinion on Biological Therapy 12(2): 165-178

Williams, E.L.; Tutt, A.L.; Beers, S.A.; French, R.R.; Chan, C.H.T.; Cox, K.L.; Roghanian, A.; Penfold, C.A.; Butts, C.é L.; Boross, P.; Verbeek, J.S.; Cragg, M.S.; Glennie, M.J. 2013: Immunotherapy targeting inhibitory Fcγ receptor IIB (CD32b) in the mouse is limited by monoclonal antibody consumption and receptor internalization. Journal of Immunology 191(8): 4130-4140

Kanemaru, K. 2013: Immunotherapy targeting misfolded proteins in neurodegenerative disease. Brain and Nerve 65(4): 469-474

Tabira, T. 2011: Immunotherapy targeting on Abeta for Alzheimer disease. Nihon Rinsho. Japanese Journal of Clinical Medicine 69 Suppl 10 Pt 2: 77-82

Boutajangout, A.; Quartermain, D.; Sigurdsson, E.M. 2010: Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 30(49): 16559-16566

Sigurdsson, E.M. 2008: Immunotherapy targeting pathological tau protein in Alzheimer's disease and related tauopathies. Journal of Alzheimer's Disease: Jad 15(2): 157-168

Hashimoto, N.; Tsuboi, A.; Chiba, Y.; Izumoto, S.; Oka, Y.; Yoshimine, T.; Sugiyama, H. 2009: Immunotherapy targeting the Wilms' tumor 1 gene product for patients with malignant brain tumors. Brain and Nerve 61(7): 805-814

Lindström, V.; Fagerqvist, T.; Nordström, E.; Eriksson, F.; Lord, A.; Tucker, S.; Andersson, J.; Johannesson, M.; Schell, H.; Kahle, P.J.; Möller, C.; Gellerfors, P.är.; Bergström, J.; Lannfelt, L.; Ingelsson, M. 2014: Immunotherapy targeting α-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] α-synuclein mice. Neurobiology of Disease 69: 134-143

Lindström, V.; Ihse, E.; Fagerqvist, T.; Bergström, J.; Nordström, E.; Möller, C.; Lannfelt, L.; Ingelsson, M. 2014: Immunotherapy targeting α-synuclein, with relevance for future treatment of Parkinson's disease and other Lewy body disorders. ImmunoTherapy 6(2): 141-153

Orentas, R.J.; Lee, D.W.; Mackall, C. 2012: Immunotherapy targets in pediatric cancer. Frontiers in Oncology 2: 3

Ferrara, J.; Reddy, P.; Paczesny, S. 2010: Immunotherapy through T-cell receptor gene transfer induces severe graft-versus-host disease. ImmunoTherapy 2(6): 791-794

Finegold, I.; Dockhorn, R.J.; Ein, D.; Dolen, W.K.; Oppenheimer, J.; Potter, L.H. 2010: Immunotherapy throughout the decades: from Noon to now. Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 105(5): 328-336; Quiz 337, 358

Plate, J.M.D.; Fidler, M.Jo. 2010: Immunotherapy to overcome lung tumor cell-induced escape from immunosurveillance. ImmunoTherapy 2(6): 757-760

Sinha, G. 2013: Immunotherapy to treat leukemia possibly ineffective for advanced disease. Journal of the National Cancer Institute 105(15): 1068-1069

Liu, B.; Gu, W. 2013: Immunotherapy treatments of warm autoimmune hemolytic anemia. Clinical and Developmental Immunology 2013: 561852

Flanagan, E.P.; Saito, Y.A.; Lennon, V.A.; McKeon, A.; Fealey, R.D.; Szarka, L.A.; Murray, J.A.; Foxx-Orenstein, A.E.; Fox, J.C.; Pittock, S.J. 2014: Immunotherapy trial as diagnostic test in evaluating patients with presumed autoimmune gastrointestinal dysmotility. Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society 26(9): 1285-1297

Yong, R.L.; Lonser, R.R. 2012: Immunotherapy trials for glioblastoma multiforme: promise and pitfalls. World Neurosurgery 77(5-6): 636-638

Skyler, J.S.; Pugliese, A. 2013: Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth. Diabetes Technology and Therapeutics 15(Suppl 2): S2

Gunturu, K.Soujanya.; Rossi, G.R.; Saif, M.Wasif. 2013: Immunotherapy updates in pancreatic cancer: are we there yet?. Therapeutic Advances in Medical Oncology 5(1): 81-89

Nishimoto, N. 2008: Immunotherapy using IL-6 receptor as the target. Nihon Rinsho Men'eki Gakkai Kaishi 31(5): 399-404

Epaulard, O.; Derouazi, M.; Pelletier, L.; Polack, B.; Toussaint, B. 2008: Immunotherapy using P. aeruginosa: type IIi secretion system-based live bacterial vector. Medecine et Maladies Infectieuses 38(Suppl 2): S87-S89

Lee, W.T.; Tan, C.; Koski, G.; Shu, S.; Cohen, P. 2010: Immunotherapy using allogeneic squamous cell tumor-dendritic cell fusion hybrids. Head and Neck 32(9): 1209-1216

Nguyen-Pham, T.-N.; Lee, Y.-K.; Kim, H.-J.; Lee, J.-J. 2012: Immunotherapy using dendritic cells against multiple myeloma: how to improve?. Clinical and Developmental Immunology 2012: 397648

Zhou, F.; Ciric, B.; Zhang, G.-X.; Rostami, A. 2014: Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis. Clinical and Experimental Immunology 178(3): 447-458

Imai, K. 2008: Immunotherapy using specific antigens as the targets. Nihon Rinsho Men'eki Gakkai Kaishi 31(5): 355

Martínez-Cañavate Burgos, A.; Valenzuela-Soria, A.; Rojo-Hernández, A. 2007: Immunotherapy with Alternaria alternata: present and future. Allergologia et Immunopathologia 35(6): 259-263

Sharma, P.; Gaur, S.N.; Arora, N. 2015: Immunotherapy with B cell epitopes ameliorates inflammatory responses in Balb/c mice. Clinical and Experimental Immunology 179(1): 128-136

Pedras-Vasconcelos, J.ão.A.; Puig, M.; Sauder, C.; Wolbert, C.; Ovanesov, M.; Goucher, D.; Verthelyi, D. 2008: Immunotherapy with CpG oligonucleotides and antibodies to TNF-alpha rescues neonatal mice from lethal arenavirus-induced meningoencephalitis. Journal of Immunology 180(12): 8231-8240

Buhmann, R.; Michael, S.; Juergen, H.; Horst, L.; Peschel, C.; Kolb, H.-J. 2013: Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-driven, open-label, non-randomized, uncontrolled, dose-escalating Phase I/II-trial. Journal of Translational Medicine 11: 160

Foy, K.C.; Miller, M.J.; Moldovan, N.; Bozanovic, T.; Carson, W.E.; Kaumaya, P.T.P. 2012: Immunotherapy with HER-2 and VEGF peptide mimics plus metronomic paclitaxel causes superior antineoplastic effects in transplantable and transgenic mouse models of human breast cancer. Oncoimmunology 1(7): 1004-1016

Dobrzanski, M.J.; Rewers-Felkins, K.A.; Samad, K.A.; Quinlin, I.S.; Phillips, C.A.; Robinson, W.; Dobrzanski, D.J.; Wright, S.E. 2012: Immunotherapy with IL-10- and IFN-γ-producing CD4 effector cells modulate "Natural" and "Inducible" CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancer. Cancer Immunology Immunotherapy: Cii 61(6): 839-854

Khalili, G.; Dobakhti, F.; Mahmoudzadeh-Niknam, H.; Khaze, V.; Partovi, F. 2011: Immunotherapy with Imiquimod increases the efficacy of Glucantime therapy of Leishmania major infection. Iranian Journal of Immunology: Iji 8(1): 45-51

Marshall, N.A.; Galvin, K.C.; Corcoran, A.-M.B.; Boon, L.; Higgs, R.; Mills, K.H.G. 2012: Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-γ+IL-17+ polyfunctional T cells that mediate rejection of murine tumors. Cancer Research 72(3): 581-591

Botrel, T.E.A.; Clark, O.; Pompeo, A.C.L.; Bretas, F.F.H.; Sadi, M.V.; Ferreira, U.; Reis, R.B.d. 2012: Immunotherapy with Sipuleucel-T (APC8015) in patients with metastatic castration-refractory prostate cancer (mCRPC): a systematic review and meta-analysis. International Braz J Urol: Official Journal of the Brazilian Society of Urology 38(6): 717-727

Stärck, L.; Popp, K.; Pircher, H.; Uckert, W. 2014: Immunotherapy with TCR-redirected T cells: comparison of TCR-transduced and TCR-engineered hematopoietic stem cell-derived T cells. Journal of Immunology 192(1): 206-213

Ceuppens, J.L.; Bullens, D.; Kleinjans, H.; van der Werf, J.; Bruggink, T.M.; Jansen, A.P.H.; Piessens, M.; Roovers, M.H.W.; Stevens, W.; Taveirne, M.; Van Durme, P.; Zijlker, T.D. 2009: Immunotherapy with a modified birch pollen extract in allergic rhinoconjunctivitis: clinical and immunological effects. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 39(12): 1903-1909

Nouri, H.R.; Sankian, M.; Afsharzadeh, D.; Varasteh, A. 2013: Immunotherapy with a recombinant hybrid molecule alleviates allergic responses more efficiently than an allergenic cocktail or pollen extract in a model of chenopodium album allergy. International Archives of Allergy and Immunology 161(4): 325-332

Larché, M. 2007: Immunotherapy with allergen peptides. Allergy Asthma and Clinical Immunology: Official Journal of the Canadian Society of Allergy and Clinical Immunology 3(2): 53-59

Klöß, S.; Köhl, U. 2012: Immunotherapy with allogeneic NK cells after stem cell transplantation: harnessing a potent "killer" of tumor cells. Pharmazie in Unserer Zeit 41(3): 239-245

Fujii, S-Ichiro.; Shimizu, K. 2013: Immunotherapy with artificial adjuvant vector cells: Harnessing both arms of the immune response. Oncoimmunology 2(4): E23432

Suminoe, A.; Matsuzaki, A.; Hattori, H.; Koga, Y.; Hara, T. 2009: Immunotherapy with autologous dendritic cells and tumor antigens for children with refractory malignant solid tumors. Pediatric Transplantation 13(6): 746-753

Hanna, M.G. 2012: Immunotherapy with autologous tumor cell vaccines for treatment of occult disease in early stage colon cancer. Human Vaccines and Immunotherapeutics 8(8): 1156-1160

Henson, M.S.; Curtsinger, J.M.; Larson, V.S.; Klausner, J.S.; Modiano, J.F.; Mescher, M.F.; Miller, J.S. 2011: Immunotherapy with autologous tumour antigen-coated microbeads (large multivalent immunogen), IL-2 and GM-CSF in dogs with spontaneous B-cell lymphoma. Veterinary and Comparative Oncology 9(2): 95-105

Garfall, A.L.; Fraietta, J.A.; Maus, M.V. 2014: Immunotherapy with chimeric antigen receptors for multiple myeloma. Discovery Medicine 17(91): 37-46

Goldberg, A.; Shefler, I.; Panasoff, J.; Paitan, Y.; Confino-Cohen, R. 2013: Immunotherapy with commercial venoms is efficacious for anaphylactic reactions to Vespa orientalis stings. International Archives of Allergy and Immunology 161(2): 174-180

Olioso, P.; Giancola, R.; Di Riti, M.; Contento, A.; Accorsi, P.; Iacone, A. 2009: Immunotherapy with cytokine induced killer cells in solid and hematopoietic tumours: a pilot clinical trial. Hematological Oncology 27(3): 130-139

Zhao, H.; Fan, Y.; Li, H.; Yu, J.; Liu, L.; Cao, S.; Ren, B.; Yan, F.; Ren, X. 2013: Immunotherapy with cytokine-induced killer cells as an adjuvant treatment for advanced gastric carcinoma: a retrospective study of 165 patients. Cancer BioTherapy and Radiopharmaceuticals 28(4): 303-309

Su, X.; Zhang, L.; Jin, L.; Ye, J.; Guan, Z.; Chen, R.; Guo, T. 2010: Immunotherapy with cytokine-induced killer cells in metastatic renal cell carcinoma. Cancer BioTherapy and Radiopharmaceuticals 25(4): 465-470

Aleixo, A.é A.R.; Michelin, M.ár.A.; Murta, E.F.C. 2013: Immunotherapy with dendritic cells as a cancer treatment: perspectives and therapeutic potential. Recent Patents on Endocrine Metabolic and Immune Drug Discovery 7(3): 226-232

Michelin, M.A.; Murta, E.F.C. 2012: Immunotherapy with dendritic cells for gynecological neoplasias: a new therapeutic approach?. European Journal of Gynaecological Oncology 33(6): 598-600

Chang, J.W.C.; Hsieh, J.-J.; Shen, Y.-C.; Ho, E.; Chuang, C.-K.; Chen, Y.-R.; Liao, S.-K.; Chen, J.-S.; Leong, S.P.L.; Hou, M.-M.; Chang, N.-J.; Wang, C.-H. 2009: Immunotherapy with dendritic cells pulsed by autologous dactinomycin-induced melanoma apoptotic bodies for patients with malignant melanoma. Melanoma Research 19(5): 309-315

Pfaar, O.; Robinson, D.S.; Sager, A.; Emuzyte, R. 2010: Immunotherapy with depigmented-polymerized mixed tree pollen extract: a clinical trial and responder analysis. Allergy 65(12): 1614-1621

Oelke, M.; Schneck, J. 2004: Immunotherapy with enhanced self immune cells. Discovery Medicine 4(22): 203-207

Hallner, A.; Aurelius, J.; Thorén, F.Bergh.; Sander, F.Ewald.; Brune, M.; Hellstrand, K.; Martner, A. 2015: Immunotherapy with histamine dihydrochloride and low-dose interleukin-2 favors sustained lymphocyte recovery in acute myeloid leukemia. European Journal of Haematology 94(3): 279-280

Martner, A.; Thorén, F.B.; Aurelius, J.; Söderholm, J.; Brune, M.; Hellstrand, K. 2010: Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia. Expert Review of Hematology 3(4): 381-391

Takeda, T.; Takeda, T.; Kobayashi, S.; Takeda, H. 2012: Immunotherapy with hyperthermia for advanced or recurrent breast cancer patients in whom standard therapy showed no effect or was refused. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(12): 1766-1769

Soranno, D.E.; Lu, H.D.; Weber, H.M.; Rai, R.; Burdick, J.A. 2014: Immunotherapy with injectable hydrogels to treat obstructive nephropathy. Journal of Biomedical Materials Research. Part a 102(7): 2173-2180

Yamada, N.; Hata, M.; Ohyama, H.; Yamanegi, K.; Kogoe, N.; Nakasho, K.; Futani, H.; Okamura, H.; Terada, N. 2009: Immunotherapy with interleukin-18 in combination with preoperative chemotherapy with ifosfamide effectively inhibits postoperative progression of pulmonary metastases in a mouse osteosarcoma model. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 30(4): 176-184

Majid, I.; Imran, S. 2013: Immunotherapy with intralesional Candida albicans antigen in resistant or recurrent warts: a study. Indian Journal of Dermatology 58(5): 360-365

Hus, I.; Kawiak, J.; Tabarkiewicz, J.; Radej, S.; Hoser, G.; Bojarska-Junak, A.; Schmitt, M.; Giannopoulos, K.; Dmoszynska, A.; Rolinski, J. 2008: Immunotherapy with irradiated autologous leukemic cells in patients with B-CLL in early stages. Oncology Reports 20(2): 443-451

Ogura, M. 2007: Immunotherapy with monoclonal antibody of malignant lymphoma. Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 1): 545-560

Rodriguez-García, M.; Boros, P.; Bromberg, J.S.; Ochando, J.C. 2010: Immunotherapy with myeloid cells for tolerance induction. Current Opinion in Organ Transplantation 15(4): 416-421

Dlugovitzky, D.; Notario, R.; Martinel-Lamas, D.; Fiorenza, G.; Farroni, M.; Bogue, C.; Stanford, C.; Stanford, J. 2010: Immunotherapy with oral, heat-killed, Mycobacterium vaccae in patients with moderate to advanced pulmonary tuberculosis. ImmunoTherapy 2(2): 159-169

Moldaver, D.; Larché, M. 2011: Immunotherapy with peptides. Allergy 66(6): 784-791

Senju, S.; Matsunaga, Y.; Fukushima, S.; Hirata, S.; Motomura, Y.; Fukuma, D.; Matsuyoshi, H.; Nishimura, Y. 2011: Immunotherapy with pluripotent stem cell-derived dendritic cells. Seminars in Immunopathology 33(6): 603-612

Yu, H.-Q.; Liu, Z.-G.; Yu, K.-Y.; Xu, Z.-Q.; Qiu, J. 2006: Immunotherapy with recombinant house dust mite group 2 allergen vaccine inhibits allergic airway inflammation in mice. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 24(6): 414-419

Peters, J.H.; Koenen, H.J.P.M.; Hilbrands, L.B.; Joosten, I. 2009: Immunotherapy with regulatory T cells in transplantation. ImmunoTherapy 1(5): 855-871

Saguna, C.; Mut, I.D.; Lupu, A.R.; Tevet, M.; Bumbea, H.; Dragan, C. 2011: Immunotherapy with rituximab in follicular lymphomas. Maedica 6(2): 100-108

Lissoni, P.; Ardizzoia, A.; Barni, S.; Tancini, G.; Muttini, M. 1996: Immunotherapy with subcutaneous low dose interleukin-2 plus melatonin as salvage therapy of heavily chemotherapy-pretreated ovarian cancer. Oncology Reports 3(5): 947-949

Borja-Cabrera, G.P.; Santos, F.N.; Santos, F.B.; Trivellato, F.A.d.A.; Kawasaki, J.K.A.; Costa, A.C.; Castro, T.; Nogueira, F.S.; Moreira, M.A.B.; Luvizotto, M.C.R.; Palatnik, M.; Palatnik-de-Sousa, C.B. 2010: Immunotherapy with the saponin enriched-Leishmune vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasis. Vaccine 28(3): 597-603

Hermansson, A.; Johansson, D.K.; Ketelhuth, D.F.J.; Andersson, J.; Zhou, X.; Hansson, Göran.K. 2011: Immunotherapy with tolerogenic apolipoprotein B-100-loaded dendritic cells attenuates atherosclerosis in hypercholesterolemic mice. Circulation 123(10): 1083-1091

Azadmehr, A.; Pourfathollah, A.A.; Amirghofran, Z.; Hassan, Z.M.; Moazzeni, S.M. 2013: Immunotherapy with tumor cell lysate-pulsed CD8α+ dendritic cells modulates intra-tumor and spleen lymphocyte subpopulations. Neoplasma 60(5): 525-532

Sundstedt, A.; Celander, M.; Ohman, M.W.én.; Forsberg, G.ör.; Hedlund, G. 2009: Immunotherapy with tumor-targeted superantigens (TTS) in combination with docetaxel results in synergistic anti-tumor effects. International Immunopharmacology 9(9): 1063-1070

Brasch, J.; Maidusch, T. 2009: Immunotherapy with wasp venom is accompanied by wide-ranging immune responses that need further exploration. Acta Dermato-Venereologica 89(5): 466-469

Nishiki, K.; Yasuda, T.; Shiozaki, H. 2011: Immunotherapy, vaccination. Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 6): 392-398

Wilcock, D.M.; Colton, C.A. 2009: Immunotherapy, vascular pathology, and microhemorrhages in transgenic mice. Cns and Neurological Disorders Drug Targets 8(1): 50-64

Koshkareva, Y.A.; Krouse, J.H. 2011: Immunotherapy--traditional. Otolaryngologic Clinics of North America 44(3): 741

Hospital, M.-A.; Viala, K.; Dragomir, S.; Levy, V.; Cohen-Aubart, F.; Neil, J.; Musset, L.; Choquet, S.; Leger, J.-M.; Leblond, V.ér. 2013: Immunotherapy-based regimen in anti-MAG neuropathy: results in 45 patients. Haematologica 98(12): E155-E157

Gathings, R.; Lewallen, R.; Yosipovitch, G. 2015: Immunotherapy-induced leukoderma from treatment of melanoma with IL-2: a case report and a review of the literature. Acta Dermato-Venereologica 95(2): 197-200

Tofaris, G.K.; Irani, S.R.; Cheeran, B.J.; Baker, I.W.S.; Cader, Z.M.; Vincent, A. 2012: Immunotherapy-responsive chorea as the presenting feature of LGI1-antibody encephalitis. Neurology 79(2): 195-196

McKeon, A.; Lennon, V.A.; Pittock, S.J. 2010: Immunotherapy-responsive dementias and encephalopathies. Continuum 16(2 Dementia): 80-101

Markakis, I.; Alexopoulos, H.; Poulopoulou, C.; Akrivou, S.; Papathanasiou, A.; Katsiva, V.; Lyrakos, G.; Gekas, G.; Dalakas, M.C. 2014: Immunotherapy-responsive limbic encephalitis with antibodies to glutamic acid decarboxylase. Journal of the Neurological Sciences 343(1-2): 192-194

Meeusen, J.W.; Lennon, V.A.; Klein, C.J. 2012: Immunotherapy-responsive pain in an abattoir worker with fluctuating potassium channel-complex IgG. Neurology 79(17): 1824-1825

Irani, S.R.; Buckley, C.; Vincent, A.; Cockerell, O.C.; Rudge, P.; Johnson, M.R.; Smith, S. 2008: Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology 71(20): 1647-1648

Spinazzi, M.; Argentiero, V.; Zuliani, L.; Palmieri, A.; Tavolato, B.; Vincent, A. 2008: Immunotherapy-reversed compulsive, monoaminergic, circadian rhythm disorder in Morvan syndrome. Neurology 71(24): 2008-2010

Swami, M. 2010: Immunotherapy: Enlisting the enemy. Nature reviews. Cancer 10(10): 667

Cleton-Jansen, A.-M.; Buddingh, E.P.; Lankester, A.C. 2012: Immunotherapy: Is it different for sarcomas?. Oncoimmunology 1(2): 255-257

Wood, N.J. 2011: Immunotherapy: Therapeutic potential of genetically modified HBV-specific T cells for chronic HBV infection and HBV-related HCC. Nature Reviews. Gastroenterology and Hepatology 8(2): 61

Bron, L.; Romero, P. 2007: Immunotherapy: a new alternative treatment for head and neck squamous cell carcinoma. Bulletin du Cancer 94(9): 793-797

Praticò, A.D.; Mistrello, G.; La Rosa, M.; Del Giudice, M.M.; Marseglia, G.; Salpietro, C.; Leonardi, S. 2014: Immunotherapy: a new horizon for egg allergy?. Expert Review of Clinical Immunology 10(5): 677-686

Sarig, G.; Garach-Jehoshua, O.; Deutch, V.; Winder, A.; Hyam, E.; Katz, B.Z.; Lahav, J.; Cassel, A.; Zivelin, A.; Souroujon, M.; Shimron, O. 2010: Laboratory evaluation of lupus anticoagulant in Israel. Harefuah 149(5): 288-290; 336

Loughlin, K.R. 2008: Immunotherapy: a new paradigm for androgen-refractory prostate cancer. Urologic Oncology 26(6): 575

Kullberg, B.-J.; van de Veerdonk, F.; Netea, M.G. 2014: Immunotherapy: a potential adjunctive treatment for fungal infection. Current Opinion in Infectious Diseases 27(6): 511-516

Pracht, M.; Herrera, F.; Tawadros, T.; Berthold, D. 2013: Immunotherapy: a therapeutic revolution against prostate cancer?. Revue Medicale Suisse 9(387): 1070-1075

Kwitniewski, M.; Juzeniene, A.; Glosnicka, R.; Moan, J. 2008: Immunotherapy: a way to improve the therapeutic outcome of photodynamic therapy?. Photochemical and Photobiological Sciences: Official Journal of the European Photochemistry Association and the European Society for Photobiology 7(9): 1011-1017

Mansi, L.; Thiery-Vuillemin, A.; Kalbacher, E.; Nguyen, T.; Maurina, T.; Nallet, J.ér.ém.; Kim, S.; Borg, C.; Kleinclauss, F.ço.; Pivot, X.; Adotevi, O. 2012: Immunotherapy: an emerging strategies against prostate castration resistant cancer. Bulletin du Cancer 99(Suppl 1): S57-S65

Bousquet, P.J.; Demoly, P.; Passalacqua, G.; Canonica, G.W.; Bousquet, J. 2007: Immunotherapy: clinical trials--optimal trial and clinical outcomes. Current Opinion in Allergy and Clinical Immunology 7(6): 561-566

Saint-Amant, S. 1986: Immunotherapy: critical appraisal, effectiveness and cost/benefit ratio. Canadian Family Physician Medecin de Famille Canadien 32: 119-122

Stoeckle, C.; Gleske, A.-K. 2009: Immunotherapy: from basic research to clinical applications. Cancer Immunology Immunotherapy: Cii 58(7): 1129-1136

Rolfo, C.; Sortino, G.; Smits, E.; Passiglia, F.; Bronte, G.; Castiglia, M.; Russo, A.; Santos, E.S.; Janssens, A.; Pauwels, P.; Raez, L. 2014: Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer?. Expert Review of Anticancer Therapy 14(10): 1173-1187

Pardoll, D. 2014: Immunotherapy: it takes a village. Science 344(6180): 149

Hildebrandt, M.; Peggs, K.; Uharek, L.; Bollard, C.M.; Heslop, H.E. 2014: Immunotherapy: opportunities, risks and future perspectives. CytoTherapy 16(4 Suppl): S120-S129

Yiang, G.-T.; Harn, H.-J.; Yu, Y.-L.; Hu, S.-C.; Hung, Y.-T.; Hsieh, C.-J.; Lin, S.-Z.; Wei, C.-W. 2009: Immunotherapy: rAAV2 expressing interleukin-15 inhibits Hela cell tumor growth in mice. Journal of Biomedical Science 16: 47

Soni, A.; Irani, S.R.; Lang, B.; Taghipour, K.; Mann, R.; Vincent, A.; Collins, D. 2009: Immunotherapy: responsive autoimmune encephalopathy associated with bullous pemphigoid. Journal of Neurology Neurosurgery and Psychiatry 80(12): 1412-1413

Finegold, I.; Oppenheimer, J. 2010: Immunotherapy: the next 100 years. Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 105(5): 394-398

Casale, T.B.; Stokes, J.R. 2014: Immunotherapy: what lies beyond. Journal of Allergy and Clinical Immunology 133(3): 612-9: Quiz 620

Finegold, I. 2007: Immunotherapy: when to initiate treatment in children. Allergy and Asthma Proceedings 28(6): 698-705

Li, W.; Yue, W.J.; Yue, Q.; Yang, D.W.; Meng, Q.G. 2010: Immunotolerance reaction for allograft-limb in rats induced by gene-modified cell transfusion. Panminerva Medica 52(4): 289-295

Patra, P.H.; Bandyopadhyay, S.; Bandyopadhyay, M.C.; Mandal, T.K. 2013: Immunotoxic and genotoxic potential of arsenic and its chemical species in goats. Toxicology International 20(1): 6-10

Zheng, L.; Dong, G.-H.; Jin, Y.-H.; He, Q.-C. 2009: Immunotoxic changes associated with a 7-day oral exposure to perfluorooctanesulfonate (PFOS) in adult male C57BL/6 mice. Archives of Toxicology 83(7): 679-689

Montero, M.; González, B.; Zimmer, J. 2009: Immunotoxic depletion of microglia in mouse hippocampal slice cultures enhances ischemia-like neurodegeneration. Brain Research 1291: 140-152

Wagner, V. 1949: Immunotoxic diseases. Casopis Lekaru Ceskych 88(34): 981-985

Ren, R.; Wang, M.-q.; Zheng, J.; Zhang, Y. 2009: Immunotoxic effect of herbicide simazine exposure in BALB/c mice. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 27(10): 601-603

Benchalgo, N.; Gagné, F.ço.; Fournier, M. 2014: Immunotoxic effects of an industrial waste incineration site on groundwater in rainbow trout (Oncorhynchus mykiss). Journal of Environmental Sciences 26(5): 981-990

Legrand, J.-J.; Bouchez, C.; Mimouni, C.éc.; N'Guyen, A.; Bouchard, J.; Ameller, T.; Descotes, J. 2013: Immunotoxic effects of cyclophosphamide and cyclosporine in the dog. Journal of Immunotoxicology 10(1): 90-95

Tauscher, S.; Nakagawa, H.; Völker, K.; Werner, F.; Krebes, L.; Potapenko, T.; Doose, S.ör.; Birkenfeld, A.L.; Baba, H.A.; Kuhn, M. 2018: β Cell-specific deletion of guanylyl cyclase A, the receptor for atrial natriuretic peptide, accelerates obesity-induced glucose intolerance in mice. Cardiovascular Diabetology 17(1): 103

Fang, X.; Zhang, L.; Feng, Y.; Zhao, Y.; Dai, J. 2008: Immunotoxic effects of perfluorononanoic acid on BALB/c mice. Toxicological Sciences: An Official Journal of the Society of Toxicology 105(2): 312-321

Gagné, F.; André, C.; Fortier, Mène.; Fournier, M. 2012: Immunotoxic potential of aeration lagoon effluents for the treatment of domestic and hospital wastewaters in the freshwater mussel Elliptio complanata. Journal of Environmental Sciences 24(5): 781-789

Cai, P.; Khan, M.Firoze.; Kaphalia, B.S.; Ansari, G.A.S. 2005: Immunotoxic response of oleic acid anilide and its hydrolysis products in female MRL (+/+) mice. Journal of Immunotoxicology 2(4): 231-236

Moon, H.-I.; Zee, O. 2011: Immunotoxic sesquiterpene lactone from Carpesium rosulatum Miq. Immunopharmacology and Immunotoxicology 33(2): 338-341

Davies, G.E. 1983: Immunotoxicity Undesirable effects of inappropriate responses. Immunology Today 4(1): 1-2

Chung, I.-M.; Ahmad, A.; Kim, E.-H.; Kim, S.-H.; Jung, W.-S.; Kim, J.-H.; Nayeem, A.; Nagella, P. 2012: Immunotoxicity activity from the essential oils of coriander (Coriandrum sativum) seeds. Immunopharmacology and Immunotoxicology 34(3): 499-503

Chung, I.-M.; Kim, E.-H.; Lee, J.-H.; Lee, Y.-C.; Moon, H.-I. 2012: Immunotoxicity activity from various essential oils of Angelica genus from South Korea against Aedes aegypti L. Immunopharmacology and Immunotoxicology 34(1): 42-45

Lim, J.-D.; Chung, I.-M.; Moon, H.-I. 2011: Immunotoxicity activity from various organic solvents extract of Allium genus from South Korea against Aedes aegypti L. Immunopharmacology and Immunotoxicology 33(3): 484-487

Chung, I.-M.; Moon, H.-I. 2011: Immunotoxicity activity of 1,2,4-trimethoxybenzene from the Paulownia coreana Uyeki. against Aedes aegypti L. Immunopharmacology and Immunotoxicology 33(1): 97-99

Lee, S.-J.; Moon, H.-I. 2010: Immunotoxicity activity of 2,6,10,15-tetrame-heptadecane from the essential oils of Clerodendron trichotomum Thunb. against Aedes aegypti L. Immunopharmacology and Immunotoxicology 32(4): 705-707

Chung, I.-M.; Kim, S.-J.; Yeo, M.-A.; Park, S.-W.; Moon, H.-I. 2011: Immunotoxicity activity of natural furocoumarins from milky sap of Ficus carica L. against Aedes aegypti L. Immunopharmacology and Immunotoxicology 33(3): 515-518

Moon, H.-I.; Cho, S.-B.; Lee, J.-H.; Paik, H.-D.; Kim, S.-K. 2011: Immunotoxicity activity of sesquiterpenoids from black galingale (Kaempferia parviflora Wall. Ex. Baker) against Aedes aegypti L. Immunopharmacology and Immunotoxicology 33(2): 380-383

Lee, S.-J.; Moon, H.-I. 2010: Immunotoxicity activity of the major essential oil of Filipendula glaberrima against Aedes aegypti L. Immunopharmacology and Immunotoxicology 32(4): 617-619

Chung, I.-M.; Kim, E.-H.; Moon, H.-I. 2011: Immunotoxicity activity of the major essential oils of Valeriana fauriei Briq against Aedes aegypti L. Immunopharmacology and Immunotoxicology 33(1): 107-110

Anderson, S.E.; Franko, J.; Anderson, K.L.; Munson, A.E.; Lukomska, E.; Meade, B.J. 2013: Immunotoxicity and allergic potential induced by topical application of dimethyl carbonate (DMC) in a murine model. Journal of Immunotoxicology 10(1): 59-66

Burchiel, S.W.; Mitchell, L.A.; Lauer, F.T.; Sun, X.; McDonald, J.D.; Hudson, L.G.; Liu, K.Jian. 2009: Immunotoxicity and biodistribution analysis of arsenic trioxide in C57Bl/6 mice following a 2-week inhalation exposure. Toxicology and Applied Pharmacology 241(3): 253-259

Nain, S.; Bour, A.; Chalmers, C.; Smits, J.E.G. 2011: Immunotoxicity and disease resistance in Japanese quail (Corturnix coturnix japonica) exposed to malathion. Ecotoxicology 20(4): 892-900

Tulinska, J.; Kazimirova, A.; Kuricova, M.; Barancokova, M.; Liskova, A.; Neubauerova, E.; Drlickova, M.; Ciampor, F.; Vavra, I.; Bilanicova, D.; Pojana, G.; Staruchova, M.; Horvathova, M.; Jahnova, E.; Volkovova, K.; Bartusova, M.; Cagalinec, M.; Dusinska, M. 2015: Immunotoxicity and genotoxicity testing of PLGA-PEO nanoparticles in human blood cell model. Nanotoxicology 9 Suppl. 1: 33-43

Emara, A.M.; Abo El-Noor, M.M.; Hassan, N.A.; Wagih, A.A. 2010: Immunotoxicity and hematotoxicity induced by tetrachloroethylene in egyptian dry cleaning workers. Inhalation Toxicology 22(2): 117-124

Bhogal, N. 2010: Immunotoxicity and immunogenicity of biopharmaceuticals: design concepts and safety assessment. Current Drug Safety 5(4): 293-307

Hannam, M.L.; Bamber, S.D.; Moody, A.J.; Galloway, T.S.; Jones, M.B. 2010: Immunotoxicity and oxidative stress in the Arctic scallop Chlamys islandica: effects of acute oil exposure. Ecotoxicology and Environmental Safety 73(6): 1440-1448

El-Gharabawy, R.M.; El-Maddah, E.I.; Oreby, M.M.; Salem, H.S.A.; Ramadan, M.O. 2013: Immunotoxicity and pulmonary toxicity induced by paints in Egyptian painters. Journal of Immunotoxicology 10(3): 270-278

Di Gioacchino, M.; Verna, N.; Di Giampaolo, L.; Di Claudio, F.; Turi, M.C.; Perrone, A.; Petrarca, C.; Mariani-Costantini, R.; Sabbioni, E.; Boscolo, P. 2007: Immunotoxicity and sensitizing capacity of metal compounds depend on speciation. International Journal of Immunopathology and Pharmacology 20(2 Suppl 2: 15-22

Fu, K.; Cheng, Q.; Liu, Z.; Chen, Z.; Wang, Y.; Ruan, H.; Zhou, L.; Xiong, J.; Xiao, R.; Liu, S.; Zhang, Q.; Yang, D. 2014: Immunotoxicity assessment of rice-derived recombinant human serum albumin using human peripheral blood mononuclear cells. Plos one 9(8): E104426

Shakthi Devan, R.K.; Prabu, P.C.; Panchapakesan, S. 2015: Immunotoxicity assessment of sub-chronic oral administration of acetamiprid in Wistar rats. Drug and Chemical Toxicology 38(3): 328-336

Peer, D. 2012: Immunotoxicity derived from manipulating leukocytes with lipid-based nanoparticles. Advanced Drug Delivery Reviews 64(15): 1738-1748

Herzyk, D.J.; Holsapple, M. 2007: Immunotoxicity evaluation by immune function tests: focus on the T-dependent antibody response (TDAR) [Overview of a Workshop Session at the 45th Annual Meeting of the Society of Toxicology (SOT) March 5-9, 2006 San Diego, CA. Journal of immunotoxicology 4(2): 143-147

Cima, F.; Ballarin, L. 2012: Immunotoxicity in ascidians: antifouling compounds alternative to organotins: III--the case of copper(I) and Irgarol 1051. Chemosphere 89(1): 19-29

Fukuyama, T.; Kosaka, T.; Hayashi, K.; Miyashita, L.; Tajima, Y.; Wada, K.; Nishino, R.; Ueda, H.; Harada, T. 2013: Immunotoxicity in mice induced by short-term exposure to methoxychlor, parathion, or piperonyl butoxide. Journal of Immunotoxicology 10(2): 150-159

Hassuneh, M.R.; Albini, M.' A.; Talib, W.H. 2012: Immunotoxicity induced by acute subtoxic doses of paraquat herbicide: implication of shifting cytokine gene expression toward T-helper (T(H))-17 phenotype. Chemical Research in Toxicology 25(10): 2112-2116

Biró, A.; Fodor, Z.án.; Major, J.; Tompa, A. 2011: Immunotoxicity monitoring of hospital staff occupationally exposed to cytostatic drugs. Pathology Oncology Research: Por 17(2): 301-308

Li, X.-Y.; Miao, X.-Q.; Zhang, L.-F.; Wang, J.-J. 2012: Immunotoxicity of 1-methyl-3-octylimidazolium bromide on brocarded carp (Cyprinus carpio L.). Ecotoxicology and Environmental Safety 75(1): 180-186

Fang, J.; Liang, C.L.; Jia, X.D.; Li, N. 2014: Immunotoxicity of acrylamide in female BALB/c mice. Biomedical and Environmental Sciences: Bes 27(6): 401-409

Zhu, Y.; Li, Y.; Miao, L.; Wang, Y.; Liu, Y.; Yan, X.; Cui, X.; Li, H. 2014: Immunotoxicity of aluminum. Chemosphere 104: 1-6

Chen, J.Y.; Song, Y.; Zhang, L.S. 2013: Immunotoxicity of atrazine in Balb/c mice. Journal of Environmental Science and Health. Part. B Pesticides Food Contaminants and Agricultural Wastes 48(8): 637-645

Stefanidou, M.; Loutsidou, A.C.; Chasapis, C.T.; Spiliopoulou, C.A. 2011: Immunotoxicity of cocaine and crack. Current Drug Abuse Reviews 4(2): 95-97

Smith, M.J.; Germolec, D.R.; Luebke, R.W.; Sheth, C.M.; Auttachoat, W.; Guo, T.L.; White, K.L. 2010: Immunotoxicity of dibromoacetic acid administered via drinking water to female B₆C₃F₁ mice. Journal of Immunotoxicology 7(4): 333-343

Hartmann, C.B.; Harrison, M.Travis.; McCoy, K.L. 2005: Immunotoxicity of gallium arsenide on antigen presentation: comparative study of intratracheal and intraperitoneal exposure routes. Journal of Immunotoxicology 2(1): 1-9

Yao, C.; Wang, L.; Zhang, J.; Zhou, X.; Zhang, C. 2007: Immunotoxicity of hydrocortisone on Th1/Th2-related cytokine production is associated with yang-deficient state in traditional Chinese medicine. Cellular and Molecular Immunology 4(5): 383-388

Descotes, J. 2009: Immunotoxicity of monoclonal antibodies. Mabs 1(2): 104-111

Di Gioacchino, M.; Petrarca, C.; Lazzarin, F.; Di Giampaolo, L.; Sabbioni, E.; Boscolo, P.; Mariani-Costantini, R.; Bernardini, G. 2011: Immunotoxicity of nanoparticles. International Journal of Immunopathology and Pharmacology 24(1 Suppl): 65S-71S

Turabekova, M.; Rasulev, B.; Theodore, M.; Jackman, J.; Leszczynska, D.; Leszczynski, J. 2014: Immunotoxicity of nanoparticles: a computational study suggests that CNTs and C60 fullerenes might be recognized as pathogens by Toll-like receptors. Nanoscale 6(7): 3488-3495

Riahi, B.; Rafatpanah, H.; Mahmoudi, M.; Memar, B.; Brook, A.; Tabasi, N.; Karimi, G. 2010: Immunotoxicity of paraquat after subacute exposure to mice. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 48(6): 1627-1631

Zhang, Y.; Zhao, M.; Jin, M.; Xu, C.; Wang, C.; Liu, W. 2010: Immunotoxicity of pyrethroid metabolites in an in vitro model. Environmental Toxicology and Chemistry 29(11): 2505-2510

Taylor, M.J.; Reddy, R.V.; Sharma, R.P. 1985: Immunotoxicity of repeated low level exposure to T-2 toxin, a trichothecene mycotoxin, in CD-1 mice. Mycotoxin Research 1(2): 57-64

Vandebriel, R.J.; Tonk, E.Cm.; de la Fonteyne-Blankestijn, L.J.; Gremmer, E.R.; Verharen, H.W.; van der Ven, L.T.; van Loveren, H.; de Jong, W.H. 2014: Immunotoxicity of silver nanoparticles in an intravenous 28-day repeated-dose toxicity study in rats. Particle and Fibre Toxicology 11: 21

Gust, M.; Fortier, M.; Garric, J.; Fournier, M.; Gagné, F. 2013: Immunotoxicity of surface waters contaminated by municipal effluents to the snail Lymnaea stagnalis. Aquatic Toxicology 126: 393-403

Hayashi, K.; Fukuyama, T.; Ohnuma, A.; Tajima, Y.; Kashimoto, Y.; Yoshida, T.; Kosaka, T. 2013: Immunotoxicity of the organochlorine pesticide methoxychlor in female ICR, BALB/c, and C3H/He mice. Journal of Immunotoxicology 10(2): 119-124

Salah-Abbès, J.Ben.; Abbès, S.; Abdel-Wahhab, M.; Oueslati, R. 2010: Immunotoxicity of zearalenone in Balb/c mice in a high subchronic dosing study counteracted by Raphanus sativus extract. Immunopharmacology and Immunotoxicology 32(4): 628-636

Wehner, N.G.; Gasper, C.; Shopp, G.; Nelson, J.; Draper, K.; Parker, S.; Clarke, J. 2009: Immunotoxicity profile of natalizumab. Journal of Immunotoxicology 6(2): 115-129

Arakawa, Y. 2014: Immunotoxicity risk assessment for chemicals and regulatory science. Industrial Health 52(2): 87-89

Grote-Wessels, S.; Frings, W.; Smith, C.A.; Weinbauer, G.F. 2010: Immunotoxicity testing in nonhuman primates. Methods in Molecular Biology 598: 341-359

Liang, C.-l.; Li, Y.-n.; Zhang, X.-p.; Song, Y.; Wang, W.; Fang, J.; Cui, W.-m.; Jia, X.-d. 2012: Immunotoxicologic assessment of genetically modified drought-resistant wheat T349 with GmDREB1. Zhonghua Yu Fang Yi Xue Za Zhi 46(6): 556-560

Rafferty, P.; Egenolf, D.; Brosnan, K.; Makropoulos, D.; Jordan, J.; Meshaw, K.; Walker, M.; Volk, A.; Bugelski, P.J. 2012: Immunotoxicologic effects of cyclosporine on tumor progression in models of squamous cell carcinoma and B-cell lymphoma in C3H mice. Journal of Immunotoxicology 9(1): 43-55

Abbès, S.; Ben Salah-Abbès, J.; Abdel-Wahhab, M.A.; Ouslati, R. 2010: Immunotoxicological and biochemical effects of aflatoxins in rats prevented by Tunisian montmorillonite with reference to HSCAS. Immunopharmacology and Immunotoxicology 32(3): 514-522

Shelley, L.K.; Balfry, S.K.; Ross, P.S.; Kennedy, C.J. 2009: Immunotoxicological effects of a sub-chronic exposure to selected current-use pesticides in rainbow trout (Oncorhynchus mykiss). Aquatic Toxicology 92(2): 95-103

Müller, C.; Ruby, S.; Brousseau, P.; Cyr, D.; Fournier, M.; Gagné, F. 2009: Immunotoxicological effects of an activated-sludge-treated effluent on rainbow trout (Oncorhynchus mykiss). Comparative Biochemistry and Physiology. Toxicology and Pharmacology: Cbp 150(3): 390-394

Song, Y.; Liang, C.; Wang, W.; Fang, J.; Sun, N.; Jia, X.; Li, N. 2014: Immunotoxicological evaluation of corn genetically modified with Bacillus thuringiensis Cry1Ah gene by a 30-day feeding study in BALB/c mice. Plos one 9(2): E78566

Liang, C.L.; Zhang, X.P.; Song, Y.; Jia, X.D. 2013: Immunotoxicological evaluation of wheat genetically modified with TaDREB4 gene on BALB/c mice. Biomedical and Environmental Sciences: Bes 26(8): 663-670

Wang, X.; Reece, S.P.; Brown, J.M. 2013: Immunotoxicological impact of engineered nanomaterial exposure: mechanisms of immune cell modulation. Toxicology Mechanisms and Methods 23(3): 168-177

Guo, T.L.; Germolec, D.R.; Collins, B.J.; Luebke, R.W.; Auttachoat, W.; Smith, M.J.; White, K.L. 2011: Immunotoxicological profile of chloramine in female B6C3F1 mice when administered in the drinking water for 28 days. Journal of Immunotoxicology 8(4): 381-388

Auttachoat, W.; Germolec, D.R.; Collins, B.J.; Luebke, R.W.; White, K.L.; Guo, T.L. 2009: Immunotoxicological profile of chloroform in female B6C3F1 mice when administered in drinking water. Drug and Chemical Toxicology 32(1): 77-87

Huttunen, K.; Kaarakainen, P.; Meklin, T.; Nevalainen, A.; Hirvonen, M-Riitta. 2010: Immunotoxicological properties of airborne particles at landfill, urban and rural sites and their relation to microbial concentrations. Journal of Environmental Monitoring: Jem 12(6): 1368-1374

Emara, A.M.; Draz, E.I. 2007: Immunotoxicological study of one of the most common over-the-counter pyrethroid insecticide products in Egypt. Inhalation Toxicology 19(12): 997-1009

House, R.V. 2008: Immunotoxicology IV - innovative methods and applications for risk assessment in pharmaceutical development: introduction to the conference. Journal of Immunotoxicology 5(1): 1

Kimber, I. 1988: Immunotoxicology and allergy: Old problems and new approaches. Toxicology in Vitro: An International Journal Published in Association with Bibra 2(4): 309-311

Rooney, A.A.; Luebke, R.W.; Selgrade, M.K.; Germolec, D.R. 2012: Immunotoxicology and its application in risk assessment. Experientia Supplementum 101: 251-287

Cavagnaro, J. 1987: Immunotoxicology and the new biotechnology. Immunology Today 8(4): 102-104

Zeidler-Erdely, P.C.; Erdely, A.; Antonini, J.M. 2012: Immunotoxicology of arc welding fume: worker and experimental animal studies. Journal of Immunotoxicology 9(4): 411-425

Luster, M.I.; Gerberick, G.F. 2010: Immunotoxicology testing: past and future. Methods in Molecular Biology 598: 3-13

Hartung, T.; Corsini, E. 2013: Immunotoxicology: challenges in the 21st century and in vitro opportunities. Altex 30(4): 411-426

McKarns, S.C.; Kerkvliet, N.I.; Dean, J.H.; Bonn, M.B.; Cohen, M.D.; Franko, J.; Laiosa, M.D.; Lawrence, B.Paige.; Luebke, R.W.; Luster, M.I.; Miller, P.G.; Palmer, R.K.; Pfau, J.C.; Raman, P.; Regal, J.F.; Rodgers, K.E.; Schondelmeyer, R.S.; Zhang, X.; Burns-Naas, L.Ann. 2012: Immunotoxicology: fifty years of global scientific progress. Journal of immunotoxicology 9(4): 339-340

Corsini, E.; Roggen, E.L. 2009: Immunotoxicology: opportunities for non-animal test development. Alternatives to Laboratory Animals: Atla 37(4): 387-397

Bogner, C.; Dechow, T.; Ringshausen, I.; Wagner, M.; Oelsner, M.; Lutzny, G.; Licht, T.; Peschel, C.; Pastan, I.; Kreitman, R.J.; Decker, T. 2010: Immunotoxin BL22 induces apoptosis in mantle cell lymphoma (MCL) cells dependent on Bcl-2 expression. British Journal of Haematology 148(1): 99-109

Berger, E.A.; Pastan, I. 2010: Immunotoxin complementation of HAART to deplete persisting HIV-infected cell reservoirs. Plos Pathogens 6(6): E1000803

Wei, H.; Xiang, L.; Wayne, A.S.; Chertov, O.; FitzGerald, D.J.; Bera, T.K.; Pastan, I. 2012: Immunotoxin resistance via reversible methylation of the DPH4 promoter is a unique survival strategy. Proceedings of the National Academy of Sciences of the United States of America 109(18): 6898-6903

Ingham, E.S.; Günhan, E.; Fuller, P.M.; Fuller, C.A. 2009: Immunotoxin-induced ablation of melanopsin retinal ganglion cells in a non-murine mammalian model. Journal of Comparative Neurology 516(2): 125-140

Hashimi, S.M.; Yu, S.; Alqurashi, N.; Ipe, D.S.; Wei, M.Q. 2013: Immunotoxin-mediated targeting of claudin-4 inhibits the proliferation of cancer cells. International Journal of Oncology 42(6): 1911-1918

Inoue, K.-i.; Koketsu, D.; Kato, S.; Kobayashi, K.; Nambu, A.; Takada, M. 2012: Immunotoxin-mediated tract targeting in the primate brain: selective elimination of the cortico-subthalamic "hyperdirect" pathway. Plos one 7(6): E39149

Dosio, F.; Brusa, P.; Cattel, L. 2011: Immunotoxins and anticancer drug conjugate assemblies: the role of the linkage between components. Toxins 3(7): 848-883

Polito, L.; Bortolotti, M.; Pedrazzi, M.; Bolognesi, A. 2011: Immunotoxins and other conjugates containing saporin-s6 for cancer therapy. Toxins 3(6): 697-720

Liu, X.-y.; Pop, L.M.; Schindler, J.; Vitetta, E.S. 2012: Immunotoxins constructed with chimeric, short-lived anti-CD22 monoclonal antibodies induce less vascular leak without loss of cytotoxicity. Mabs 4(1): 57-68

Wayne, A.S.; Fitzgerald, D.J.; Kreitman, R.J.; Pastan, I. 2014: Immunotoxins for leukemia. Blood 123(16): 2470-2477

Pastan, I.; Onda, M.; Weldon, J.; Fitzgerald, D.; Kreitman, R. 2011: Immunotoxins with decreased immunogenicity and improved activity. Leukemia and Lymphoma 52(Suppl 2): 87-90

Risberg, K.; Fodstad, O.; Andersson, Y. 2010: Immunotoxins: a promising treatment modality for metastatic melanoma?. Ochsner Journal 10(3): 193-199

Aruna, G. 2006: Immunotoxins: a review of their use in cancer treatment. Journal of Stem Cells and Regenerative Medicine 1(1): 31-36

Antignani, A.; Fitzgerald, D. 2013: Immunotoxins: the role of the toxin. Toxins 5(8): 1486-1502

Hamilton, P.M. 1937: Immunotransfusion: its use in the Treatment of Communicable Diseases. California and Western Medicine 46(4): 245-248

Brody, J.D.; Goldstein, M.J.; Czerwinski, D.K.; Levy, R. 2009: Immunotransplantation preferentially expands T-effector cells over T-regulatory cells and cures large lymphoma tumors. Blood 113(1): 85-94

Isaykina, N.V.; Perevozchicova, T.V.; Kalinkina, G.I. 2008: Immunotropic activity of plant extract Echinosol. Bulletin of Experimental Biology and Medicine 146(2): 223-225

Sharapova, L.E.; Shul'diakov, A.A.; Liapina, E.P. 2012: Immunotropic agents in therapy of chronic degenerative diseases of the vulva. Antibiotiki i Khimioterapiia 57(3-4): 25-28

Sukhanov, D.S.; Vinogradova, T.I.; Demidik, S.N.; Zabolotnyh, N.V.; Vasilieva, S.N.; Kovalenko, A.L.; Vitovskaya, M.L. 2013: Immunotropic and antihypoxant therapy of experimental drug-sensitive and drug-resistant tuberculosis. Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 1: 65-69

Zhumabaeva, A.N.; Zarishnyak, N.V.; Bekmukhambetov, E.Z. 2014: Immunotropic effects of hexavalent chromium soluble compounds on the thymus and peripheral blood values in a subacute experiment. Bulletin of Experimental Biology and Medicine 156(4): 512-517

Vorobeĭchikov, E.V.; Stepanov, A.V.; Volkov, M.I.; Vasilenko, A.Z.; Ponomarenko, V.M.; Sinitsa, A.V. 2008: Immunotropic effects of probiotic complex bactistatin used simultaneously with antibiotics. Antibiotiki i Khimioterapiia 53(1-2): 3-9

Zhavbert, E.S.; Dugina, I.L.; Épshteĭn, O.I. 2013: Immunotropic properties of anaferon and anaferon pediatric. Antibiotiki i Khimioterapiia 58(5-6): 17-23

Suhanov, D.S. 2013: Immunotropic therapy for tuberculosis infection. Terapevticheskii Arkhiv 85(3): 110-117

Kimirilova, O.G.; Romantsov, M.G.; Kharchenko, G.A. 2013: Immunotropic therapy of arbovirus infections in children. Antibiotiki i Khimioterapiia 58(3-4): 43-48

Cynober, L.; Le Boucher, J.; Giboudeau, J. 1989: Immunoturbidimetric determination of serum transferrin on a Kone Progress autoanalyser. Journal of Automatic Chemistry 11(1): 40-41

Erdag, G.; Schaefer, J.T.; Smolkin, M.E.; Deacon, D.H.; Shea, S.M.; Dengel, L.T.; Patterson, J.W.; Slingluff, C.L. 2012: Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma. Cancer Research 72(5): 1070-1080

Egorova, N.B.; Kurbatova, E.A.; Gruber, I.M.; Semenova, I.B. 2010: Immunovac-VP-4 for prevention of acute respiratory diseases in children's communities. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2010(6): 35-40

Poddubikova, A.M.; Kostinov, M.P. 2010: Immunovac-VP4 vaccine used in complex allergen-specific immunotherapy of patients with hay fever. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 4: 44-48

Hocqueloux, L.; Saez-Cirion, A.; Rouzioux, C. 2013: Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion. JAMA Internal Medicine 173(6): 475-476

Landman, R.; Damond, F.; Gerbe, J.; Brun-Vezinet, F.; Yeni, P.; Matheron, S. 2009: Immunovirological and therapeutic follow-up of HIV-1/HIV-2-dually seropositive patients. Aids 23(3): 426-428

Hunter, M.; Johnson, N.; Hedderwick, S.; McCaughey, C.; Lowry, K.; McConville, J.; Herron, B.; McQuaid, S.; Marston, D.; Goddard, T.; Harkess, G.; Goharriz, H.; Voller, K.; Solomon, T.; Willoughby, R.E.; Fooks, A.R. 2010: Immunovirological correlates in human rabies treated with therapeutic coma. Journal of Medical Virology 82(7): 1255-1265

Pujades-Rodríguez, M.; Schramm, B.; Som, L.; Nerrienet, E.; Narom, P.; Chanchhaya, N.; Ferradini, L.; Balkan, S. 2011: Immunovirological outcomes and resistance patterns at 4 years of antiretroviral therapy use in HIV-infected patients in Cambodia. Tropical Medicine and International Health: Tm and Ih 16(2): 205-213

Tasca, K.I.; Calvi, S.A.; Souza, L.d.R.ár.d. 2012: Immunovirological parameters and cytokines in HIV infection. Revista da Sociedade Brasileira de Medicina Tropical 45(6): 663-669

Ahoua, L.; Guenther, G.; Rouzioux, C.; Pinoges, L.; Anguzu, P.; Taburet, A.-M.; Balkan, S.; Olson, D.M.; Olaro, C.; Pujades-Rodríguez, M. 2011: Immunovirological response to combined antiretroviral therapy and drug resistance patterns in children: 1- and 2-year outcomes in rural Uganda. Bmc Pediatrics 11: 67

Benard, A.; van Sighem, A.; Taieb, A.; Valadas, E.; Ruelle, J.; Soriano, V.; Calmy, A.; Balotta, C.; Damond, F.; Brun-Vezinet, F.ço.; Chene, G.èv.; Matheron, S.; Matheron, S.; Tubiana, R.; Meyohas, M.-C.; Bernasconi, C.él.; Dupin, N.; Slama, L.; Ponscarme, D.; Lascoux-Combe, C.; Timsit, F.ço.-J.; Khuong, M.-A.; Rami, A.; Teichner, E.; Semaille, C.; Quertainmont, Y.; Bloch, M.; Froguel, E.; Genet, P.; Leprêtre, A.; Zucman, D.; Karmochkine, M.; Blum, L.; Chevojon, P.; Olivier, C.; Delassus, J.-L.; Bodard, L.ïc.; Imbert, P.; Boué, F.ço.; Billaud, E.; Drobacheff-Thiébaut, C.; Cotte, L.; Allègre, T.; Bazin, C.; Nau, P.; Debab, Y.; Leclercq, P.; Arvieux, C.éd.; Lafeuillade, A.; Ragnaud, J.-M.; Dutronc, H.é; Perré, P.; Montagne, N.; R 2011: Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: the ACHIEV2E Collaboration Study Group. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 52(10): 1257-1266

Ning, J.; Wakimoto, H.; Rabkin, S.D. 2014: Immunovirotherapy for glioblastoma. Cell Cycle 13(2): 175-176

Cheema, T.A.; Fecci, P.E.; Ning, J.; Rabkin, S.D. 2014: Immunovirotherapy for the treatment of glioblastoma. Oncoimmunology 3(1): E27218

Wei, X.-Y.; Zhao, C.-H.; Liu, Y.-Y.; Wang, Y.-Z.; Ju, G. 2009: Immuohistochemical markers for pituicyte. Neuroscience Letters 465(1): 27-30

Dorisetty, R.-K.; Kiran, S.-G.; Umrani, M.-R.; Boindala, S.; Bhonde, R.-R.; Venkatesan, V. 2008: Immuolocalization of nestin in pancreatic tissue of mice at different ages. World Journal of Gastroenterology 14(46): 7112-7116

Korbet, S.M.; Schwartz, M.M.; Lewis, E.J. 2006: Immuotactoid glomerulopathy (fibrillary glomerulonephritis). Clinical Journal of the American Society of Nephrology: Cjasn 1(6): 1351-1356

Dairkee, S.H.; Sayeed, A.; Luciani, G.; Champion, S.; Meng, Z.; Jakkula, L.R.; Feiler, H.S.; Gray, J.W.; Moore, D.H. 2009: Immutable functional attributes of histologic grade revealed by context-independent gene expression in primary breast cancer cells. Cancer Research 69(19): 7826-7834

Messmer, P.R.; King, I.M. 2007: Imogene M. King over the years. Nursing Science Quarterly 20(3): 198

Clarke, P.N.; Killeen, M.B.; Messmer, P.R.; Leibold Sieloff, C.; King, I.M. 2009: Imogene M. King's scholars reflect on her wisdom and influence on nursing science. Nursing Science Quarterly 22(2): 128-133

Rouault, H.é; Santolini, M.; Schweisguth, F.ço.; Hakim, V. 2014: Imogene: identification of motifs and cis-regulatory modules underlying gene co-regulation. Nucleic Acids Research 42(10): 6128-6145

Guimarães, L.; Enyashin, A.N.; Frenzel, J.; Heine, T.; Duarte, H.él.A.; Seifert, G. 2007: Imogolite nanotubes: stability, electronic, and mechanical properties. Acs Nano 1(4): 362-368

Guimarães, L.; Pinto, Y.N.; Lourenço, M.P.; Duarte, H.él.A. 2013: Imogolite-like nanotubes: structure, stability, electronic and mechanical properties of the phosphorous and arsenic derivatives. Physical Chemistry Chemical Physics: Pccp 15(12): 4303-4309

Rotoli, B.M.; Guidi, P.; Bonelli, B.; Bernardeschi, M.; Bianchi, M.G.; Esposito, S.; Frenzilli, G.; Lucchesi, P.; Nigro, M.; Scarcelli, V.; Tomatis, M.; Zanello, P.P.; Fubini, B.; Bussolati, O.; Bergamaschi, E. 2014: Imogolite: an aluminosilicate nanotube endowed with low cytotoxicity and genotoxicity. Chemical Research in Toxicology 27(7): 1142-1154

Medioni, C.; Ramialison, M.; Ephrussi, A.; Besse, F. 2014: Imp promotes axonal remodeling by regulating profilin mRNA during brain development. Current Biology: Cb 24(7): 793-800

Honegger, B.; Galic, M.; Köhler, K.; Wittwer, F.; Brogiolo, W.; Hafen, E.; Stocker, H. 2008: Imp-L2, a putative homolog of vertebrate IGF-binding protein 7, counteracts insulin signaling in Drosophila and is essential for starvation resistance. Journal of Biology 7(3): 10

Shah, B.N.; Liu, X.; Correll, C.C. 2013: Imp3 unfolds stem structures in pre-rRNA and U3 snoRNA to form a duplex essential for small subunit processing. Rna 19(10): 1372-1383

Bradley-Springer, L. 2012: Impact. Journal of the Association of Nurses in Aids Care: Janac 23(6): 471-472

McMeekin, L.J.; Li, Y.; Fox, S.N.; Rowe, G.C.; Crossman, D.K.; Day, J.J.; Li, Y.; Detloff, P.J.; Cowell, R.M. 2018: Cell-Specific Deletion of PGC-1α from Medium Spiny Neurons Causes Transcriptional Alterations and Age-Related Motor Impairment. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 38(13): 3273-3286

Böni-Schnetzler, M.; Häuselmann, S.ép.P.; Dalmas, E.; Meier, D.T.; Thienel, C.; Traub, S.; Schulze, F.; Steiger, L.; Dror, E.; Martin, P.; Herrera, P.L.; Gabay, C.; Donath, M.Y. 2018: β Cell-Specific Deletion of the IL-1 Receptor Antagonist Impairs β Cell Proliferation and Insulin Secretion. Cell Reports 22(7): 1774-1786

Muse, E.D.; Yu, S.; Edillor, C.R.; Tao, J.; Spann, N.J.; Troutman, T.D.; Seidman, J.S.; Henke, A.; Roland, J.T.; Ozeki, K.A.; Thompson, B.M.; McDonald, J.G.; Bahadorani, J.; Tsimikas, S.; Grossman, T.R.; Tremblay, M.S.; Glass, C.K. 2018: Cell-specific discrimination of desmosterol and desmosterol mimetics confers selective regulation of LXR and SREBP in macrophages. Proceedings of the National Academy of Sciences of the United States of America 115(20): E4680-E4689

Lim, W.; Bae, H.; Bazer, F.W.; Song, G. 2018: Cell-specific expression and signal transduction of C-C motif chemokine ligand 2 and atypical chemokine receptors in the porcine endometrium during early pregnancy. Developmental and Comparative Immunology 81: 312-323

Shen, M.; Hu, M.; Fedak, P.W.M.; Oudit, G.Y.; Kassiri, Z. 2018: Cell-Specific Functions of ADAM17 Regulate the Progression of Thoracic Aortic Aneurysm. Circulation Research 123(3): 372-388

Yung, W.K.Alfred. 2010: Impact Factor number reflects sustained high quality. Neuro-Oncology 12(9): 893

Mohapatra, P.R.; Mishra, B. 2008: Impact Factor of the IJMR: what more we really need?. Indian Journal of Medical Research 127(2): 198-199

Scully, C.; Jenkins, S. 2010: Impact Factor steadily rising and now 3.123!. Oral Oncology 46(9): 629

Felkner, J.; Tazhibayeva, K.; Townsend, R. 2009: Impact of Climate Change on Rice Production in Thailand. American Economic Review 99(2): 205-210

Edwards, E.P.; Eiden, R.D.; Leonard, K.E. 2004: Impact of Fathers' Alcoholism and Associated Risk Factors on Parent-Infant Attachment Stability from 12 to 18 Months. Infant Mental Health Journal 25(6): 556-579

Anonymous 1921: Impact on Bridges. Science 54(1408): 625

Sanz, J.; Jaramillo, F.J.; Planelles, D.; Montesinos, P.; Lorenzo, I.; Moscardó, F.; Martin, G.; López, F.; Martínez, Jús.; Jarque, I.; Javier de; la Rubia; Larrea, L.; Sanz, M.A.; Sanz, G.F. 2014: Impact on Outcomes of Hla Matching by Allele-Level Typing in Adults with Acute Myeloid Leukemia Undergoing Umbilical Cord Blood Transplantation. Biology of Blood and Marrow Transplantation

Giermaziak, W. 2014: Impact Reimbursement Act on the pharmaceutical market in Poland. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 36(214): 270-273

Kataoka, S.H.H.; Setzer, F.C.; Gondim, E.; Caldeira, C.L. 2014: Impact absorption and force dissipation of protective mouth guards with or without titanium reinforcement. Journal of the American Dental Association 145(9): 956-959

Madsen, M.D. 2007: Impact agricultural safety and health: know producers, know agriculture, and engage in a professional community of practice. Journal of Agricultural Safety and Health 13(2): 115-116

Ludwig, G. 2013: Impact ahead. Obamacare will transform future EMS systems. Jems: a Journal of Emergency Medical Services 38(3): 20

Mukherjee, I.; Arora, S. 2011: Impact analysis of IPM programs in Basmati rice by estimation of pesticide residues. Bulletin of Environmental Contamination and Toxicology 86(3): 307-313

Yu, J.; Li, H.-E. 2013: Impact analysis of Xi'an to the water quality of Weihe River. Huan Jing Ke Xue= Huanjing Kexue 34(5): 1700-1706

Geurts, D.H.F.; Vos, W.; Moll, H.A.; Oostenbrink, R. 2014: Impact analysis of an evidence-based guideline on diagnosis of urinary tract infection in infants and young children with unexplained fever. European Journal of Pediatrics 173(4): 463-468

Zhang, B.; Sha, J.-j.; Wang, X.-w.; Gao, L.-r. 2012: Impact analysis of atmospheric state for target detection in hyperspectral radiance image. Guang Pu Xue Yu Guang Pu Fen Xi 32(8): 2043-2049

Wang, J.; Zhao, Y.; Zhang, J.; Lei, H.; Zhu, G.; Fu, B. 2014: Impact analysis of autoantibody level and NR2 antibody level in neuropsychiatric SLE treated by methylprednisolone combined with MTX and DXM intrathecal injection. Cell Biochemistry and Biophysics 70(2): 1005-1009

Pawar, T.; Anantakrishnan, N.S.; Chaudhuri, S.; Duttagupta, S.P. 2007: Impact analysis of body movement in ambulatory ECG. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2007: 5453-5456

Yan, W.; Hu, W.-x.; Zhang, R. 2012: Impact analysis of comorbidities on prognosis of myelodysplastic syndromes patients. Zhonghua Xue Ye Xue Za Zhi 33(7): 574-576

Araújo, D.V.; Lima, V.C.; Ferraz, M.B. 2007: Impact analysis of drug-eluting stent in the unified health system budget. Arquivos Brasileiros de Cardiologia 88(4): 458-463

Zhi, Y.-J.; Yang, W.; Xie, Y.-M.; Zhang, H.; Yang, H.; Zhuang, Y. 2013: Impact analysis of parenterally administered shuxuetong on abnormal changes of BUN index based on hospital information system data. Zhongguo Zhong Yao Za Zhi 38(18): 3048-3052

Yang, W.; Yi, D.-H.; Xie, Y.-M.; Yang, W.; Dai, Y.; Zhi, Y.-J.; Zhuang, Y.; Yang, H. 2013: Impact analysis of shuxuetong injection on abnormal changes of ALT based on generalized boosted models propensity score weighting. Zhongguo Zhong Yao Za Zhi 38(18): 3039-3047

Stolk, P.; Schneeweiss, S.; Leufkens, H.G.M.; Heerdink, E.R. 2008: Impact analysis of the discontinuation of reimbursement: the case of oral contraceptives. Contraception 78(5): 399-404

Ramos, C.; Coin de Carvalho, Jão.Eduardo.; Corrêa Mangiacavalli, M.Angélica.da.Silveira. 2007: Impact and (im)mobilization: a study of cancer prevention campaigns. Ciencia and Saude Coletiva 12(5): 1387-1396

Belkin, G. 2013: Impact and accountability: improvement as a competency challenges the purposes of bioethics. American Journal of Bioethics: Ajob 13(2): 14-16

Wahl, K.R.; Margolis, A.; Lintner, K.; Hartkopf, K.; Martin, B. 2014: Impact and application of material learned in a pharmacy residency teaching certificate program. American Journal of Pharmaceutical Education 78(6): 123

Guillemette, A.; Langlois, Hélène.; Voisine, M.; Merger, D.; Therrien, R.; Mercier, G.; Lebel, D.; Bussières, J-François. 2014: Impact and appreciation of two methods aiming at reducing hazardous drug environmental contamination: The centralization of the priming of IV tubing in the pharmacy and use of a closed-system transfer device. Journal of Oncology Pharmacy Practice: Official Publication of the International Society of Oncology Pharmacy Practitioners 20(6): 426-432

Wibulpolprasert, B.; Wiratkapun, C.; Jatchavala, J.; Suraseepat, N.; Lertsithichai, P. 2012: Impact and appropriateness of the emergency ultrasonography in a tertiary care hospital. Journal of the Medical Association of Thailand 95(1): 64-72

Kim, G.; Walden, T.A.; Knieps, L.J. 2010: Impact and characteristics of positive and fearful emotional messages during infant social referencing. Infant Behavior and Development 33(2): 189-195

Kikuchi, H.; Mifune, N.; Niino, M.; Ohbu, S.; Kira, J.-i.; Kohriyama, T.; Ota, K.; Tanaka, M.; Ochi, H.; Nakane, S.; Maezawa, M.; Kikuchi, S. 2011: Impact and characteristics of quality of life in Japanese patients with multiple sclerosis. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment Care and Rehabilitation 20(1): 119-131

Levi, M. 2012: Impact and citations. Netherlands Journal of Medicine 70(8): 335-336

Summers, K.M.; Martin, K.E.; Watson, K. 2010: Impact and clinical management of depression in patients with coronary artery disease. PharmacoTherapy 30(3): 304-322

Yuan, C.; Zhu, H.; Song, D.; Wei, W.; Zhu, R.; Mei, X.; Zou, J.; Yang, H. 2014: Impact and clinical significance of pedicle length on spinal canal and intervertebral foramen area. International Journal of Clinical and Experimental Medicine 7(1): 163-169

Labropoulos, N.; Spentzouris, G.; Gasparis, A.P.; Meissner, M. 2010: Impact and clinical significance of recurrent venous thromboembolism. British Journal of Surgery 97(7): 989-999

Manzur, A.; Pujol, M. 2008: Impact and control of methicillin-resistant Staphylococcus aureus (MRSA) in long-term care facilities. Revista Espanola de Geriatria y Gerontologia 43(4): 235-238

Buchmann, K. 2015: Impact and control of protozoan parasites in maricultured fishes. Parasitology 142(1): 168-177

Bovet, P.; Hirsiger, P.; Emery, Fédéric.; De Bernardini, J.; Rossier, C.; Trebeljahr, J.; Hagon-Traub, I. 2011: Impact and cost of a 2-week community-based screening and awareness program for diabetes and cardiovascular risk factors in a Swiss canton. Diabetes Metabolic Syndrome and Obesity: Targets and Therapy 4: 213-223

Prasad, P.; Fishman, J.A. 2014: Impact and cost of the serum galactomannan assay at a tertiary care facility. Transplantation 98(7): 773-780

Clark, A.D.; Griffiths, U.K.; Abbas, S.Shahid.; Rao, K.D.; Privor-Dumm, L.; Hajjeh, R.; Johnson, H.; Sanderson, C.; Santosham, M. 2013: Impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccination in India. Journal of Pediatrics 163(1 Suppl): S60-S72

Yu, Q.; Zhao, G-Ming.; Hong, X-Lin.; Lutz, E.A.; Guo, J-Gang. 2013: Impact and cost-effectiveness of a comprehensive Schistosomiasis japonica control program in the Poyang Lake region of China. International Journal of Environmental Research and Public Health 10(12): 6409-6421

Dowdy, D.W.; Lourenço, M.C.; Cavalcante, S.C.; Saraceni, V.; King, B.; Golub, J.E.; Bishai, D.; Durovni, B.; Chaisson, R.E.; Dorman, S.E. 2008: Impact and cost-effectiveness of culture for diagnosis of tuberculosis in HIV-infected Brazilian adults. Plos one 3(12): E4057

Dowdy, D.W.; Houben, R.; Cohen, T.; Pai, M.; Cobelens, F.; Vassall, A.; Menzies, N.A.; Gomez, G.B.; Langley, I.; Squire, S.B.; White, R. 2014: Impact and cost-effectiveness of current and future tuberculosis diagnostics: the contribution of modelling. International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 18(9): 1012-1018

Knight, G.M.; Griffiths, U.K.; Sumner, T.; Laurence, Y.V.; Gheorghe, A.; Vassall, A.; Glaziou, P.; White, R.G. 2014: Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries. Proceedings of the National Academy of Sciences of the United States of America 111(43): 15520-15525

Schnippel, K.; Long, L.; Meyer-Rath, G.; Sanne, I.; Rosen, S.; Stevens, W. 2013: Impact and costs of algorithms for the diagnosis of adults with pulmonary tuberculosis in South Africa. South African Medical Journal 103(7): 436

Pugh, J.D.; Twigg, D.E.; Giles, M.; Myers, H.; Gelder, L.; Davis, S.M.; King, M. 2015: Impact and costs of home-based trial of void compared with the day care setting. Journal of Advanced Nursing 71(3): 559-569

Khadjesari, Z.; Murray, E.; Kalaitzaki, E.; White, I.R.; McCambridge, J.; Thompson, S.G.; Wallace, P.; Godfrey, C. 2011: Impact and costs of incentives to reduce attrition in online trials: two randomized controlled trials. Journal of Medical Internet Research 13(1): E26

Duda, C.; Mahon, I.; Chen, M.Hsiu.; Snyder, B.; Barr, R.; Chiles, C.; Falk, R.; Fishman, E.K.; Gemmel, D.; Goldin, J.G.; Brown, K.; Munden, R.F.; Vydareny, K.; Aberle, D.R. 2011: Impact and costs of targeted recruitment of minorities to the National Lung Screening Trial. Clinical Trials 8(2): 214-223

Uprety, S.; Jha, N.; Poudel, I.S.; Pokharel, P.K.; Poudel, M.; Niraula, S.R. 2011: Impact and determinants of gender preference in Duhavi VDC of eastern Nepal. Jnma; Journal of the Nepal Medical Association 51(181): 28-33

O'Brien-Pallas, L.; Murphy, G.T.; Shamian, J.; Li, X.; Hayes, L.J. 2010: Impact and determinants of nurse turnover: a pan-Canadian study. Journal of Nursing Management 18(8): 1073-1086

Vesikari, T.; Uhari, M.; Renko, M.; Hemming, M.; Salminen, M.; Torcel-Pagnon, L.; Bricout, Hélène.; Simondon, Fçois. 2013: Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland. Pediatric infectious disease journal 32(12): 1365-1373

Dölle, S.; Harth, K.; John, T.; Stannarius, R. 2014: Impact and embedding of picoliter droplets into freely suspended smectic films. Langmuir: the Acs Journal of Surfaces and Colloids 30(42): 12712-12720

Barnhill, A. 2011: Impact and ethics of excluding sweetened beverages from the SNAP program. American Journal of Public Health 101(11): 2037-2043

Sarwal, K.; Trapido, E.J.; Sutcliffe, S.; Qiao, Y-Lin. 2013: Impact and evaluation of International Cancer Control Congresses. Asian Pacific journal of cancer prevention: APJCP 14(2): 1159-1163

Horgan, A.M.; Leighl, N.B.; Coate, L.; Liu, G.; Palepu, P.; Knox, J.J.; Perera, N.; Emami, M.; Alibhai, S.M.H. 2012: Impact and feasibility of a comprehensive geriatric assessment in the oncology setting: a pilot study. American Journal of Clinical Oncology 35(4): 322-328

Julián-Jiménez, Aín.; Gómez-Hernando, C.; Arrese-Cosculluela, M.Ángeles.; Estebaran-Martín, J. 2012: Impact and health care burden in the emergency department and a tertiary care hospital during the influenza A (H1N1) pandemic. Enfermedades Infecciosas y Microbiologia Clinica 30(3): 169-170

Bilotta, F.F.; Werner, S.M.; Bergese, S.D.; Rosa, G. 2013: Impact and implementation of simulation-based training for safety. Thescientificworldjournal 2013: 652956

Zhao, B.-W.; Xiangli, B.; Lü, Q.-B.; Zhang, G.-F.; Liu, J. 2013: Impact and improvement of the mechanical shutter on large-array filter-type multispectral imaging system. Guang Pu Xue Yu Guang Pu Fen Xi 33(7): 1982-1986

Ugajin, M.; Yamaki, K.; Hirasawa, N.; Kobayashi, T.; Yagi, T. 2013: Impact and indication of early systemic corticosteroids for very severe community-acquired pneumonia. International Journal of General Medicine 6: 693-701

Cirio, P.A. 2012: Impact and influence of relational psychoanalysis. International Journal of Psycho-Analysis 93(3): 495-497

Biswal, M.R.; Prentice, H.M.; Smith, G.W.; Zhu, P.; Tong, Y.; Dorey, C.K.; Lewin, A.S.; Blanks, J.C. 2018: Cell-specific gene therapy driven by an optimized hypoxia-regulated vector reduces choroidal neovascularization. Journal of Molecular Medicine 96(10): 1107-1118

Morgan, R.M.; Cui, C.; Digges, K.H.; Cao, L.; Kan, C.-D.S. 2012: Impact and injury patterns in between-rails frontal crashes of vehicles with good ratings for frontal crash protection. Annals of Advances in Automotive Medicine. Association for the Advancement of Automotive Medicine. Annual Scientific Conference 56: 255-265

Guo, N.L.; Tosun, K.; Horn, K. 2009: Impact and interactions between smoking and traditional prognostic factors in lung cancer progression. Lung Cancer 66(3): 386-392

Yoshikane, Y.; Yoshizato, T.; Maeno, Y.; Nishibatake, M.; Kan, N.; Fusazaki, N.; Hirose, S. 2011: Impact and issues of detecting fetal congenital heart defects in Kyushu, Japan. Journal of Obstetrics and Gynaecology Research 37(7): 775-781

Tian, Y.-G.; Li, Y.; Li, J.-S.; Li, S.-Y.; Jiang, S.-L.; Wang, Y.; Deng, L.; Wang, Y.-Y. 2013: Impact and long-term effect of three prescriptions regulating and tonifying lung and kidney on JAK/STAT signaling in rats. Zhongguo Zhong Yao Za Zhi 38(1): 75-80

Kist, M. 2002: Impact and management of Campylobacter in human medicine--European perspective. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 6(Suppl 3): 3s44-7; Discussion 3s47-48 3s53-58

Pasternack, M.S. 2002: Impact and management of Campylobacter in human medicine--US perspective. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 6(Suppl 3): 3s37-42; Discussion 3s42-43 3s53-58

Chu, P.-Y.; Lee, T.-L.; Chang, S.-Y. 2011: Impact and management of airway obstruction in patients with squamous cell carcinoma of the larynx. Head and Neck 33(1): 98-102

Zeppetella, G. 2009: Impact and management of breakthrough pain in cancer. Current Opinion in Supportive and Palliative Care 3(1): 1-6

Kumar, R.; Singla, V.; Kacharya, S.k. 2008: Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients. Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 29(3): 136-147

Boone, S.L.; Rademaker, A.; Liu, D.; Pfeiffer, C.; Mauro, D.J.; Lacouture, M.E. 2007: Impact and management of skin toxicity associated with anti-epidermal growth factor receptor therapy: survey results. Oncology 72(3-4): 152-159

Scully, C. 2009: Impact and other newer factors. Oral Oncology 45(12): 1005

Cayci, C.; Santner, F.; Jacobson, S.R. 2013: Impact and outcome of human acellular dermal matrix size for immediate and two-stage breast reconstruction. Plastic and Reconstructive Surgery 132(1): 11-18

Dunstan, D.A.; Todd, A.K.; Kennedy, L.M.; Anderson, D.L. 2014: Impact and outcomes of a rural Personal Helpers and Mentors service. Australian Journal of Rural Health 22(2): 50-55

Duncan, M.D.; Leis, A.; Taylor-Brown, J.W. 2008: Impact and outcomes of an Iyengar yoga program in a cancer centre. Current Oncology 15 Suppl. 2: S109.Es72-8

Pugliese, M.S.; Beatty, J.D.; Tickman, R.J.; Allison, K.H.; Atwood, M.K.; Szymonifka, J.; Arthurs, Z.M.; Huynh, P.P.; Dawson, J.H. 2009: Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories. Annals of Surgical Oncology 16(1): 113-120

Sánchez-Navés, J.; Furfaro, L.; Piro, O.; Balle, S. 2008: Impact and permanence of LASIK-induced structural changes in the cornea on pneumotonometric measurements: contributions of flap cutting and stromal ablation. Journal of Glaucoma 17(8): 611-618

Xu, C.-j.; Wang, J.-w.; Song, J.; Wu, J.-z.; Song, T.-t. 2013: Impact and potential mechanism of human α-defensin 1 on low-density lipoprotein oxidation ability of ECV304 cells. Zhonghua Xin Xue Guan Bing Za Zhi 41(5): 406-410

Sato, T.; Teramukai, S.; Kondo, H.; Watanabe, A.; Ebina, M.; Kishi, K.; Fujii, Y.; Mitsudomi, T.; Yoshimura, M.; Maniwa, T.; Suzuki, K.; Kataoka, K.; Sugiyama, Y.; Kondo, T.; Date, H.; Adachi, H.; Hasumi, T.; Suzuki, S.; Matsumura, Y.; Watanabe, T.; Shinohara, H.; Kamiyoshihara, M.; Kawashima, O.; Chida, M.; Takahashi, N.; Ikeda, N.; Kanzaki, M.; Miyamoto, A.; Matsunaga, T.; Horio, H.; Okubo, K.; Hata, Y.; Nakajima, J.; Miura, H.; Satoh, Y.; Iida, T.; Ito, H.; Suzuki, T.; Funai, K.; Tanahashi, M.; Fukumoto, K.; Ito, S.; Yoshioka, H.; Yano, M.; Numanami, H.; Yamada, T.; Iwata, H.; Adachi, K.; Miyazawa, H.; Tsunezuka, Y.; Inoue, S.; Suga, M.; Nish 2014: Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. Journal of Thoracic and Cardiovascular Surgery 147(5): 1604-1611.E3

Kao, J.-H.; Kao, H.-K.; Chen, Y.-W.; Yu, W.-K.; Pan, S.-W.; Wang, J.-H.; Lien, T.-C.; Ho, L.-I.; Kou, Y.R. 2013: Impact and predictors of prolonged chest tube duration in mechanically ventilated patients with acquired pneumothorax. Respiratory Care 58(12): 2093-2100

Aranaz-Andrés, J.M.; Aibar-Remón, C.; Vitaller-Burillo, J.; Requena-Puche, J.; Terol-García, E.; Kelley, E.; Gea-Velazquez de Castro, M.T.; Infante, A.; Polo, M.P.; Casal, J.M.; Sierra, E.; Garcia, M.J.; Agra, Y.; Palanca, I.; Zarco, A.; Soro, C.; Ivorra, F.M.; Bartolome, F.; Limon, R.; Gómez, J.A.; Agulló, V.; Montesinos, M.A.; Garcia, J.R.; Aguado, L.R.; Cortés, M.P.; Misiego, A.; Jiménez, L.; Villaverde, M.V.; Abadía, M.B.; Ceballos, C.; García, E.E.; de la Hoz, C.A.; Jaén, P.; Lechuga, L.; Rebull, J.; Brull, L.; Gombáu, C.; Doménech, M.F.; Gómez, F.; Becerra, D.; Donate, C.; Valero, C.; Martínez, M.D.; Ansede, J.C.; Albeniz, C.; Arias, S.; Carrión, M.; Lobote, M.; Vadillo, P.; Lameiro, F.J.; Jáuregui, M.A.; Sarasa,; 2009: Impact and preventability of adverse events in Spanish public hospitals: results of the Spanish National Study of Adverse Events (ENEAS). International Journal for Quality in Health Care: Journal of the International Society for Quality in Health Care 21(6): 408-414

Jobanputra, K.; Parker, L.Anne.; Azih, C.; Okello, V.; Maphalala, G.; Jouquet, G.; Kerschberger, B.; Mekeidje, C.; Cyr, J.; Mafikudze, A.; Han, W.; Lujan, J.; Teck, R.; Antierens, A.; van Griensven, J.; Reid, T. 2014: Impact and programmatic implications of routine viral load monitoring in Swaziland. Journal of Acquired Immune Deficiency Syndromes 67(1): 45-51

Boustani, M.; Baker, M.S.; Campbell, N.; Munger, S.; Hui, S.L.; Castelluccio, P.; Farber, M.; Guzman, O.; Ademuyiwa, A.; Miller, D.; Callahan, C. 2010: Impact and recognition of cognitive impairment among hospitalized elders. Journal of Hospital Medicine 5(2): 69-75

Baños-Lara, M.D.R.ío.; Harvey, L.; Mendoza, A.; Simms, D.; Chouljenko, V.N.; Wakamatsu, N.; Kousoulas, K.G.; Guerrero-Plata, A. 2015: Impact and regulation of lambda interferon response in human metapneumovirus infection. Journal of Virology 89(1): 730-742

Huang, R.; Ma, G.-s.; Pan, X.-d.; Chen, Z.-p.; Sheng, Z.-l.; Hu, S.-d.; Yao, Y.-y.; Chen, Z. 2013: Impact and related mechanisms of stromal cell-derived factor-1α on serum deprivation-induced cardiac stem cells apoptosis. Zhonghua Xin Xue Guan Bing Za Zhi 41(10): 870-875

Tong, C.-C.; Au, K.-H.; Ngan, R.K.C.; Chow, S.-M.; Cheung, F.-Y.; Fu, Y.-T.; Au, J.S.K.; Law, S.C.K. 2011: Impact and relationship of anterior commissure and time-dose factor on the local control of T1N0 glottic cancer treated by 6 MV photons. Radiation Oncology 6: 53

Zarante, I.; López, M.ía.A.; Caro, A.és.; García-Reyes, J.C.; Ospina, J.C. 2009: Impact and risk factors of craniofacial malformations in a Colombian population. International Journal of Pediatric Otorhinolaryngology 73(10): 1434-1437

Kreuter, M.; Vansteenkiste, J.; Herth, F.J.F.; Fischer, J.ür.R.; Eberhardt, W.; Zuna, I.; Reinmuth, N.; Griesinger, F.; Thomas, M. 2014: Impact and safety of adjuvant chemotherapy on pulmonary function in early stage non-small cell lung cancer. Respiration; International Review of Thoracic Diseases 87(3): 204-210

Gennaro, S. 2010: Impact and scholarship. Journal of Nursing Scholarship: An Official Publication of Sigma Theta Tau International Honor Society of Nursing 42(3): 233

Conaghan, P.G.; Porcheret, M.; Kingsbury, S.R.; Gammon, A.; Soni, A.; Hurley, M.; Rayman, M.P.; Barlow, J.; Hull, R.G.; Cumming, J.; Llewelyn, K.; Moscogiuri, F.; Lyons, J.; Birrell, F. 2015: Impact and therapy of osteoarthritis: the Arthritis Care OA Nation 2012 survey. Clinical Rheumatology 34(9): 1581-1588

Morris, L.F.; Harris, R.S.; Milton, D.ái.R.; Waguespack, S.G.; Habra, M.A.; Jimenez, C.; Vassilopoulou-Sellin, R.; Lee, J.E.; Perrier, N.D.; Grubbs, E.G. 2013: Impact and timing of bilateral adrenalectomy for refractory adrenocorticotropic hormone-dependent Cushing’s syndrome. Surgery 154(6): 1174-1183; Discussion: 1183-1184

Duh, M.S.; Latypova, A.; Greenberg, P. 2006: Impact and treatment of anemia in the elderly: clinical, epidemiological and economic perspectives. Expert Review of Pharmacoeconomics and Outcomes Research 6(5): 577-590

Tannery, N.H.; Epstein, B.A.; Wessel, C.B.; Yarger, F.; LaDue, J.; Klem, M.L. 2011: Impact and user satisfaction of a clinical information portal embedded in an electronic health record. Perspectives in Health Information Management 8: 1d

Malki, A.; Gafsi, R.; Michel, L.; Labarrνre, M.; Lecoy, P. 1996: Impact and vibration detection in composite materials by using intermodal interference in multimode optical fibers. Applied Optics 35(25): 5198-5201

Harry, C.L.; Trivers, C.; Kubba, H.; Clement, W.A.; Simpson, J.H. 2012: Impact and workload implications on service provision with establishment of a neonatal complex airway service in Scotland. Scottish Medical Journal 57(4): 247

Adi, S.; Tong, Z.; Chan, H.-K.; Yang, R.; Yu, A. 2010: Impact angles as an alternative way to improve aerosolisation of powders for inhalation?. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 41(2): 320-327

Mazariegos, G.V. 2011: Impact areas in pediatric transplantation. Current Opinion in Organ Transplantation 16(5): 476

Porter, A.L. 1988: Impact assessment. Science 240(4852): 587

Sengupta, D.; Aktar, M.W.; Alam, S.; Chowdhury, A. 2010: Impact assessment and decontamination of pesticides from meat under different culinary processes. Environmental Monitoring and Assessment 169(1-4): 37-43

Torres, F.A.; Pasarelli, I.; Cutri, A.án.; Ossorio, M.ía.F.; Ferrero, F. 2014: Impact assessment of a decision rule for using antibiotics in pneumonia: a randomized trial. Pediatric Pulmonology 49(7): 701-706

Clauzel, C.él.; Girardet, X.; Foltête, J.-C. 2013: Impact assessment of a high-speed railway line on species distribution: application to the European tree frog (Hyla arborea) in Franche-Comté. Journal of Environmental Management 127: 125-134

Rørbech, J.T.; Vadenbo, C.; Hellweg, S.; Astrup, T.F. 2014: Impact assessment of abiotic resources in LCA: quantitative comparison of selected characterization models. Environmental Science and Technology 48(19): 11072-11081

Campillo, J.A.; Albentosa, M.; Valdés, N.J.; Moreno-González, R.én.; León, V.íc.M. 2013: Impact assessment of agricultural inputs into a Mediterranean coastal lagoon (Mar Menor, SE Spain) on transplanted clams (Ruditapes decussatus) by biochemical and physiological responses. Aquatic Toxicology 142-143: 365-379

Wang, S.; Xing, J.; Jang, C.; Zhu, Y.; Fu, J.S.; Hao, J. 2011: Impact assessment of ammonia emissions on inorganic aerosols in East China using response surface modeling technique. Environmental Science and Technology 45(21): 9293-9300

Aziz, R.; Rafiq, M.T.; Yang, J.; Liu, D.; Lu, L.; He, Z.; Daud, M.K.; Li, T.; Yang, X. 2014: Impact assessment of cadmium toxicity and its bioavailability in human cell lines (Caco-2 and HL-7702). Biomed Research International 2014: 839538

Patil, S.A.; Katpatal, Y.B. 2008: Impact assessment of coal mines in Erai watershed of Chandrapur district using geoinformatics. Journal of Environmental Science and Engineering 50(4): 271-276

Enari, H.; Sakamaki-Enari, H. 2014: Impact assessment of dam construction and forest management for Japanese macaque habitats in snowy areas. American Journal of Primatology 76(3): 271-280

Fenton, L.; Dawe, R.; Ibbotson, S.; Ferguson, J.; Silburn, S.; Moseley, H. 2014: Impact assessment of energy-efficient lighting in patients with lupus erythematosus: a pilot study. British Journal of Dermatology 170(3): 694-698

Yami, A.; Kebede, S.; Mamo, Y. 2010: Impact assessment of gilgel gibe hydroelectric dam on schitosomiasis: a cross sectional study in southwest ethiopia. Ethiopian Journal of Health Sciences 20(2): 129-136

Liu, C.; Zou, C.; Wang, Q.; Hayashi, Y.; Yasunari, T. 2014: Impact assessment of human diet changes with rapid urbanization on regional nitrogen and phosphorus flows--a case study of the megacity Shanghai. Environmental Science and Pollution Research International 21(3): 1905-1914

Qi, G.; Yue, D.; Liu, J.; Li, R.; Shi, X.; He, L.; Guo, J.; Miao, H.; Nie, Y. 2013: Impact assessment of intermediate soil cover on landfill stabilization by characterizing landfilled municipal solid waste. Journal of Environmental Management 128: 259-265

Nedveckaite, T.; Gudelis, A.; Vives i Batlle, J. 2013: Impact assessment of ionizing radiation on human and non-human biota from the vicinity of a near-surface radioactive waste repository. Radiation and Environmental Biophysics 52(2): 221-234

Chanda, E.; Coleman, M.; Kleinschmidt, I.; Hemingway, J.; Hamainza, B.; Masaninga, F.; Chanda-Kapata, P.; Baboo, K.S.; Dürrheim, D.N.; Coleman, M. 2012: Impact assessment of malaria vector control using routine surveillance data in Zambia: implications for monitoring and evaluation. Malaria Journal 11: 437

Morales-Sillero, A.; García, J.é M. 2015: Impact assessment of mechanical harvest on fruit physiology and consequences on oil physicochemical and sensory quality from 'Manzanilla de Sevilla' and 'Manzanilla Cacereña' super-high-density hedgerows. a preliminary study. Journal of the Science of Food and Agriculture 95(12): 2445-2453

Beghi, S.P.; Santos, J.M.ér.; Reis, N.C.; de Sá, L.M.; Goulart, E.V.; de Abreu Costa, E. 2012: Impact assessment of odours emitted by a wastewater treatment plant. Water Science and Technology: a Journal of the International Association on Water Pollution Research 66(10): 2223-2228

Talwar, B.; Pipalatkar, P.; Gajghate, D.G.; Nema, P. 2010: Impact assessment of respirable suspended particulate matter from diesel generator sets used for pumping station. Bulletin of Environmental Contamination and Toxicology 85(4): 437-441

Shryock, T.R. 2012: Impact assessment of risk management interventions. Revue Scientifique et Technique 31(1): 307-315

Ghumman, A.R.; Ghazaw, Y.M.; Niazi, M.F.; Hashmi, H.N. 2011: Impact assessment of subsurface drainage on waterlogged and saline lands. Environmental Monitoring and Assessment 172(1-4): 189-197

Hartmann, M. 2012: Impact assessment of the European Clinical Trials Directive: a longitudinal, prospective, observational study analyzing patterns and trends in clinical drug trial applications submitted since 2001 to regulatory agencies in six EU countries. Trials 13: 53

Hellmann, F.; Verburg, P.H. 2010: Impact assessment of the European biofuel directive on land use and biodiversity. Journal of Environmental Management 91(6): 1389-1396

Cotes, K.; Alvis-Guzmán, N.; Rico, A.; Porras, A.; Cediel, N.; Chocontá Piraquive, L.A.; De la Hoz, F. 2013: Impact assessment of the rotavirus vaccine in Colombia using rapid evaluation methods. Revista Panamericana de Salud Publica 34(4): 220-226

Adah, P.O.; Mafiana, C.F.; Sam-Wobo, S.O. 2009: Impact assessment of the use of insecticide-treated bed nets on parasitaemia and anaemia for malaria control in children, Ogun State, Nigeria. Public Health 123(5): 390-392

Purkait, S.; Ganguly, M.; Aktar, W.; Sengupta, D.; Chowdhury, A. 2009: Impact assessment of various parameters polluting Ganga water in Kolkata Region: a study for quality evaluation and environmental implication. Environmental Monitoring and Assessment 155(1-4): 443-454

Dufek, J.S.; Mercer, J.A.; Teramoto, K.; Mangus, B.C.; Freedman, J.A. 2008: Impact attenuation and variability during running in females: a lifespan investigation. Journal of Sport Rehabilitation 17(3): 230-242

Nkogho Mengue, P.-G.; Abdous, B.; Berbiche, D.; Préville, M.; Voyer, P. 2013: Impact benzodiazepine dependence on the use of health services: senior' health study. Geriatrie et Psychologie Neuropsychiatrie du Vieillissement 11(3): 229-236

Zupanc, G.ün.K.H. 2014: Impact beyond the impact factor. Journal of Comparative Physiology. a Neuroethology Sensory Neural and Behavioral Physiology 200(2): 113-116

Moore, P.; Montero, L.; Triviño, X.; Sirhan, M.; Leiva, L. 2014: Impact beyond the objectives: a qualitative study of a faculty development program in medical education. Revista Medica de Chile 142(3): 336-343

Spoth, R.; Greenberg, M. 2011: Impact challenges in community science-with-practice: lessons from PROSPER on transformative practitioner-scientist partnerships and prevention infrastructure development. American Journal of Community Psychology 48(1-2): 106-119

Forrest, D.; Dufek, J.S.; Mercer, J.A. 2012: Impact characteristics of female children running in adult versus youth shoes of the same size. Journal of Applied Biomechanics 28(5): 593-598

Warlow, C.P. 2012: Impact commentaries. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project, 1981-86. Journal of Neurology Neurosurgery and Psychiatry 83(6): 579

Vincent, A. 2012: Impact commentaries. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. Journal of Neurology Neurosurgery and Psychiatry 83(3): 237-238

Scheltens, P.; van de Pol, L. 2012: Impact commentaries. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. Journal of Neurology Neurosurgery and Psychiatry 83(11): 1038-1040

Wade, D.T. 2012: Impact commentaries. Functional abilities after stroke: measurement, natural history and prognosis. Journal of Neurology Neurosurgery and Psychiatry 83(8): 770

Carson, A.J. 2012: Impact commentaries. Mood disorder as a specific complication of stroke. Journal of Neurology Neurosurgery and Psychiatry 83(9): 859

Lance, J.W. 2012: Impact commentaries. Observations on 500 cases of migraine and allied vascular headache. Journal of Neurology Neurosurgery and Psychiatry 83(7): 673-674

Bolton, C.F. 2012: Impact commentaries. Polyneuropathy in critically ill patients. Journal of Neurology Neurosurgery and Psychiatry 83(5): 475

Sears, T.; Sears, T. 2012: Impact commentaries. Sensory nerve action potentials in patients with peripheral lesions. Journal of Neurology Neurosurgery and Psychiatry 83(12): 1137-1138

Emery, A.E.H. 2013: Impact commentaries. Unusual type of benign X linked muscular dystrophy. Journal of Neurology Neurosurgery and Psychiatry 84(1): 4-5

Kobayashi, H.; Horikawa, K.; Ogawa, K.; Watanabe, K. 2014: Impact compressive and bending behaviour of rocks accompanied by electromagnetic phenomena. Philosophical Transactions. Series A Mathematical Physical and Engineering Sciences 372(2023): 20130292

Kerr, R.A. 2007: Impact cratering. a big splat in the asteroid belt doomed Earth's dinosaurs. Science 317(5843): 1310

Pacheco-Vázquez, F.; Ruiz-Suárez, J.C. 2011: Impact craters in granular media: grains against grains. Physical Review Letters 107(21): 218001

Lam, C.J.; Assinck, P.; Liu, J.; Tetzlaff, W.; Oxland, T.R. 2014: Impact depth and the interaction with impact speed affect the severity of contusion spinal cord injury in rats. Journal of Neurotrauma 31(24): 1985-1997

Sun, S.N.; Urbassek, H.M. 2011: Impact desolvation of polymers embedded in nanodroplets. Journal of Physical Chemistry. B 115(45): 13280-13286

Bates, N.A.; Ford, K.R.; Myer, G.D.; Hewett, T.E. 2013: Impact differences in ground reaction force and center of mass between the first and second landing phases of a drop vertical jump and their implications for injury risk assessment. Journal of Biomechanics 46(7): 1237-1241

Lai, X.; Ma, C.; Hu, J.; Zhou, Q. 2012: Impact direction effect on serious-to-fatal injuries among drivers in near-side collisions according to impact location: focus on thoracic injuries. Accident; Analysis and Prevention 48: 442-450

Cockell, C.S.; Voytek, M.A.; Gronstal, A.L.; Finster, K.; Kirshtein, J.D.; Howard, K.; Reitner, J.; Gohn, G.S.; Sanford, W.E.; Horton, J.Wright.; Kallmeyer, J.; Kelly, L.; Powars, D.S. 2012: Impact disruption and recovery of the deep subsurface biosphere. Astrobiology 12(3): 231-246

Addi, K.; Rodić, A.D. 2010: Impact dynamics in biped locomotion analysis: two modelling and implementation approaches. Mathematical Biosciences and Engineering: Mbe 7(3): 479-504

Qi, L.; McMurry, P.H.; Norris, D.J.; Girshick, S.L. 2011: Impact dynamics of colloidal quantum dot solids. Langmuir: the Acs Journal of Surfaces and Colloids 27(20): 12677-12683

Cheng, X.; Gordillo, L.; Zhang, W.W.; Jaeger, H.M.; Nagel, S.R. 2014: Impact dynamics of granular jets with noncircular cross sections. Physical Review. E Statistical Nonlinear and Soft Matter Physics 89(4): 042201

Xu, Q.; Brown, E.; Jaeger, H.M. 2013: Impact dynamics of oxidized liquid metal drops. Physical Review. e Statistical Nonlinear and Soft Matter Physics 87(4): 043012

Chen, C.-C.; Chan, W.-H. 2009: Impact effects of puerarin on mouse embryonic development. Reproductive Toxicology 28(4): 530-535

Pumera, M. 2014: Impact electrochemistry: measuring individual nanoparticles. Acs Nano 8(8): 7555-7558

Mendel, D.A.; Ucar, Y.; Brantley, W.A.; Rashid, R.G.; Harrell, S.L.; Grentzer, T.H. 2009: Impact energy absorption of three mouthguard materials in an aqueous environment. Dental Traumatology: Official Publication of International Association for Dental Traumatology 25(1): 130-135

Lunt, D.R.; Mendel, D.A.; Brantley, W.A.; Michael Beck, F.; Huja, S.; Schriever, S.D.; Grentzer, T.H.; Alapati, S.B. 2010: Impact energy absorption of three mouthguard materials in three environments. Dental Traumatology: Official Publication of International Association for Dental Traumatology 26(1): 23-29

Knowlden, A.P.; Sharma, M.; Cottrell, R.R.; Wilson, B.R.A.; Johnson, M.Lee. 2015: Impact evaluation of Enabling Mothers to Prevent Pediatric Obesity through Web-Based Education and Reciprocal Determinism (EMPOWER) Randomized Control Trial. Health Education and Behavior: the Official Publication of the Society for Public Health Education 42(2): 171-184

Lv, B.-Y.; Xiang, Y.-X.; Zhao, R.; Feng, Z.-C.; Liang, S.-Y.; Wang, Y.-M. 2013: Impact evaluation of HIV/AIDS education in rural Henan province of China. Journal of Huazhong University of Science and Technology. Medical Sciences 33(6): 905-911

Aggarwal, A. 2010: Impact evaluation of India's 'Yeshasvini' community-based health insurance programme. Health Economics 19 Suppl: 5-35

Habigzang, Lísa.Fernanda.; Damásio, B.Figueiredo.; Koller, S.Helena. 2013: Impact evaluation of a cognitive behavioral group therapy model in Brazilian sexually abused girls. Journal of Child Sexual Abuse 22(2): 173-190

Morgaine, K.C.; Langley, J.D.; McGee, R.O.; Gray, A.R. 2014: Impact evaluation of a farm safety awareness workshop in New Zealand. Scandinavian Journal of Work Environment and Health 40(6): 649-653

Costello, M.; Taylor, J.; O'Hara, L. 2015: Impact evaluation of a health promotion-focused organisational development strategy on a health service's capacity to deliver comprehensive primary health care. Australian Journal of Primary Health 21(4): 444-449

Grim, M.; Hortz, B.; Petosa, R. 2011: Impact evaluation of a pilot web-based intervention to increase physical activity. American Journal of Health Promotion: Ajhp 25(4): 227-230

Fuller, D.; Gauvin, L.; Kestens, Y.; Daniel, M.; Fournier, M.; Morency, P.; Drouin, L. 2013: Impact evaluation of a public bicycle share program on cycling: a case example of BIXI in Montreal, Quebec. American Journal of Public Health 103(3): E85-E92

Singh, K.; Speizer, I.; Handa, S.; Boadu, R.O.; Atinbire, S.; Barker, P.M.; Twum-Danso, N.A.Y. 2013: Impact evaluation of a quality improvement intervention on maternal and child health outcomes in Northern Ghana: early assessment of a national scale-up project. International Journal for Quality in Health Care: Journal of the International Society for Quality in Health Care 25(5): 477-487

Shi, Y.; Guo, S.; Bo, F.; Zhang, X.; Cao, W.; Wang, P. 2013: Impact evaluation of a sexually transmitted disease preventive intervention among female sex workers in Hohhot, China. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 17(1): E59-E64

Gold, J.; Goller, J.; Hellard, M.; Lim, M.S.C.; Hocking, J.; Fairley, C.K.; Spelman, T.; McNamee, K.; Clift, P.; Guy, R. 2011: Impact evaluation of a youth sexually transmissible infection awareness campaign using routinely collected data sources. Sexual Health 8(2): 234-241

Tiwary, A.; Kumar, P. 2014: Impact evaluation of green-grey infrastructure interaction on built-space integrity: an emerging perspective to urban ecosystem service. Science of the Total Environment 487: 350-360

Ammenwerth, E.; Hackl, W.O.; Jensen, S.; Lawton, K.; Riedmann, D.; Jung, M. 2011: Impact evaluation of innovative technology: estimating the impact of the PSIP solutions. Studies in Health Technology and Informatics 166: 227-233

He, M.; Beynon, C.; Sangster Bouck, M.; St Onge, Rée.; Stewart, S.; Khoshaba, L.; Horbul, B.A.; Chircoski, B. 2009: Impact evaluation of the Northern Fruit and Vegetable Pilot Programme - a cluster-randomised controlled trial. Public Health Nutrition 12(11): 2199-2208

Sahu, K.Kumar. 2014: Impact evaluation of the community mental health program at habra. Indian Journal of Psychiatry 56(2): 143-149

Popadić, A.; Vidović, J.; Cosović, V.; Medaković, D.; Dolenec, M.; Felja, I. 2013: Impact evaluation of the industrial activities in the Bay of Bakar (Adriatic Sea, Croatia): recent benthic foraminifera and heavy metals. Marine Pollution Bulletin 76(1-2): 333-348

Chhetry, D.B.; Upreti, S.R.; Dangal, G.; Subedi, P.K.; Khanal, M.N. 2012: Impact evaluation of uterine prolapse surgery in Nepalese women. Journal of Nepal Health Research Council 10(21): 167-171

Gabor, N.M. 2013: Impact excitation and electron-hole multiplication in graphene and carbon nanotubes. Accounts of Chemical Research 46(6): 1348-1357

Shi, L.; Li, W.; Zhou, H.; Ding, L'en.; Zeng, H. 2013: Impact excitation of neon atoms by heated seed electrons in filamentary plasma gratings. Optics Letters 38(4): 398-400

Joy, E. 2010: Impact exercise and postmenopausal bone loss: a review. Clinical Journal of Sport Medicine: Official Journal of the Canadian Academy of Sport Medicine 20(6): 504-505

Launer, J. 2007: Impact factor. Qjm: Monthly Journal of the Association of Physicians 100(5): 315-316

Nicholls, J. 2008: Impact factor. Colorectal Disease: the Official Journal of the Association of Coloproctology of Great Britain and Ireland 10(7): 638

Jones, T.M. 2014: Impact factor. Clinical Otolaryngology: Official Journal of Ent-Uk ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology and Cervico-Facial Surgery 39(2): 77

Morais, A. 2013: Impact factor 0.562--the ultimate goal or the next step forward?. Revista Portuguesa de Pneumologia 19(5): 189

Morais, A. 2014: Impact factor 0.85--the ultimate goal or the next step forward? (II). Revista Portuguesa de Pneumologia 20(5): 233-234

van der Wall, E.E. 2013: Impact factor 2012 for cardiovascular journals: true impact?. Netherlands Heart Journal: Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 21(9): 377-378

Opthof, T. 2014: Impact factor 2013 of the Netherlands Heart Journal surpasses 2.0. Netherlands Heart Journal: Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 22(4): 137-138

García-Pachón, E.; Padilla-Navas, I. 2014: Impact factor and h index of Spanish biomedical journals. Medicina clinica 142(5): 226-227

Chamon, W.; Melo, L.Alberto.Soares. 2011: Impact factor and insertion of the ABO in the world scientific literature. Arquivos Brasileiros de Oftalmologia 74(4): 241-242

Leff, A.R. 2009: Impact factor and its role in academic promotion. Proceedings of the American Thoracic Society 6(4): 337

Levy, M.L. 2009: Impact factor and its role in academic promotion. Primary Care Respiratory Journal: Journal of the General Practice Airways Group 18(3): 127

Russell, R.; Singh, D. 2010: Impact factor and its role in academic promotion. International Journal of Chronic Obstructive Pulmonary Disease 4: 265-266

Brusasco, V.; Dinh-Xuan, A.T.; Leff, A.R.; Adler, K.B.; Glenny, R.W.; Dempsey, J.A.; Levy, M.L.; Panettieri, R.; Reddel, H.K.; Singh, D.; Virchow, J.C. 2010: Impact factor and its role in academic promotion. European Respiratory Journal 34(6): 1499-1500

Jiang, W.; Agrawal, D.K.; Boosani, C.S. 2018: Cell‑specific histone modifications in atherosclerosis (Review). Molecular Medicine Reports 18(2): 1215-1224

Hoerder-Suabedissen, A.; Korrell, K.V.; Hayashi, S.; Jeans, A.; Ramirez, D.M.O.; Grant, E.; Christian, H.C.; Kavalali, E.T.; Wilson, M.C.; Molnár, Z.án. 2019: Cell-Specific Loss of SNAP25 from Cortical Projection Neurons Allows Normal Development but Causes Subsequent Neurodegeneration. Cerebral Cortex 29(5): 2148-2159

Valverde-Molina, J. 2012: Impact factor and other quality indicators in Anales de Pediatría. Anales de Pediatria 77(3): 147-150

Mathur, V.Prakash.; Sharma, A. 2009: Impact factor and other standardized measures of journal citation: a perspective. Indian Journal of Dental Research: Official Publication of Indian Society for Dental Research 20(1): 81-85

Carabantes, D. 2010: Impact factor and quality of scientific publications on Microbiology: the example of the Spanish Journal of Chemotherapy. Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 23(3): 135-143

Murphy, E.J. 2013: Impact factor and science publishing: what impact should it have on selecting journals in which we publish?. Lipids 48(5): 431-433

Wolf, D.M.; Williamson, P.A. 2009: Impact factor and study design: the Academic Value of Published Research (AVaRes) score. Annals of the Royal College of Surgeons of England 91(1): 71-73

Bała, M.łg.M.; Sun, X. 2013: Impact factor and study quality. Polskie Archiwum Medycyny Wewnetrznej 123(3): 81-82

Brown, T. 2010: Impact factor and the Australian Occupational Therapy Journal: a notable achievement. Australian Occupational Therapy Journal 57(5): 283

Winck, J.C.; Morais, A. 2011: Impact factor and the Portuguese Journal of Pulmonology: knockin' on heaven's door?. Revista Portuguesa de Pneumologia 17(4): 151-152

Finding, E.J.T.; Lawson, C.; Elliott, J.; Harris, P.A.; Menzies-Gow, N.J. 2018: Cell specific microvesicles vary with season and disease predisposition in healthy and previously laminitic ponies. Veterinary Immunology and Immunopathology 202: 85-92

Gracza, T.ün.; Somoskövi, I.án.é 2007: Impact factor and/or Hirsch index?. Orvosi Hetilap 148(18): 849-852

Handwerker, H.O. 2010: Impact factor blues. European Journal of Pain 14(1): 3-4

Alberts, B. 2013: Impact factor distortions. Science 340(6134): 787

Cherubini, P. 2008: Impact factor fever. Science 322(5899): 191

Olanow, C.W.; Obeso, J.A. 2014: Impact factor for 2013. Movement Disorders: Official Journal of the Movement Disorder Society 29(9): 1091

Wirth, M.P.; Froehner, M. 2012: Impact factor for ranking academic urologic institutions. European Urology 61(3): 440

Abdullgaffar, B. 2012: Impact factor in cytopathology journals: what does it reflect and how much does it matter?. Cytopathology: Official Journal of the British Society for Clinical Cytology 23(5): 320-324

Gibson, J.C. 2011: Impact factor in general practice. Quality in Primary Care 19(1): 3-4

Aggarwal, R.; Bhatia, S.J. 2007: Impact factor of Indian Journal of Gastroenterology for the years 2005 and 2006. Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 26 Suppl. 1: S4-S6

Bae, C.Woo.; Choi, S.Hee.; Han, M.Yong.; Rha, Y.Ho.; Lee, Y.Jin. 2011: Impact factor of Korean Journal of Pediatrics on Korean Medical Citation Index and Science Citation Index of Web of Science. Korean journal of pediatrics 54(4): 152-156

Téllez-Zenteno, Jé.F.; Morales-Buenrostro, L.E.; Estañol, B. 2007: Impact factor of Latin American medical journals. Revista medica de Chile 135(4): 480-487

Ahmed, B.; Husain, A.Akhlaq.; Dossani, K. 2013: Impact factor of Pakistani medical journals. Jpma. Journal of the Pakistan Medical Association 63(1): 131

Villanueva López, I.S. 2008: Impact factor of a biomedical journal. Is it justified to look for it?. Acta Ortopedica Mexicana 22(3): 143-144

Shanta, A.; Pradhan, A.S.; Sharma, S.D. 2013: Impact factor of a scientific journal: Is it a measure of quality of research?. Journal of Medical Physics 38(4): 155-157

Opthof, T.; van der Heyden, M.A.G. 2008: Impact factor of the Chinese Journal of Physiology in 2007: building a strong foundation. Chinese Journal of Physiology 51(4): 259-260

van der Heyden, M.A.G.; Opthof, T. 2010: Impact factor of the Chinese Journal of Physiology in 2009: meet the readers. Chinese Journal of Physiology 53(4): 268-269

Amano, S. 2008: Impact factor of the Nippon Ganka Gakkai Zasshi?. Nippon Ganka Gakkai Zasshi 112(10): 909

Gao, Y.; Xie, Z.-k.; Zhou, F.; Zhu, X.-b.; Xie, H.-l.; Wang, Q.-m. 2013: Impact factor of timeliness lag for seeing a doctor about cataract patient in Wenzhou region of Zhejiang province. Zhonghua Yi Xue Za Zhi 93(41): 3312-3314

Derakhshan, N.; Luszczynska, A. 2012: Impact factor on the rise. Anxiety Stress and Coping 25(1): 1-2

Craig, I.D. 2009: Impact factor redux--new indicators, new challenges. Journal of Sexual Medicine 6(11): 2976-2978

Vinther, S.; Rosenberg, J. 2012: Impact factor trends for general medical journals: non-English-language journals are lacking behind. Swiss Medical Weekly 142: W13572

Fuster, V. 2014: Impact factor versus impact to readers: not necessarily at odds. Journal of the American College of Cardiology 64(16): 1753-1754

Brumback, R.A. 2009: Impact factor wars: Episode V--the empire strikes back. Journal of Child Neurology 24(3): 260-262

Meo, S.A. 2013: Impact factor went on a ventilator: Neither died nor buried. Saudi Journal of Anaesthesia 7(4): 363-364

Miró, O.; Martín-Sánchez, F.J. 2012: Impact factor, H-index and other variable to observe the relative importance of an investigator. Revista Clinica Espanola 212(1): 48-9; author reply 49

Rocha-e-Silva, M. 2010: Impact factor, Scimago Indexes and the Brazilian journal rating system: where do we go from here?. Clinics 65(4): 351-355

Fond-Harmant, L. 2010: Impact factor, a challenge for public health. Sante Publique 22(1): 3-5

Fernandez-Mondéjar, E.; Hugo Ceraso, D.; Gordo Vidal, F.; Guerrero López, F.; Colmenero Ruiz, M. 2010: Impact factor, an imperfect but essential tool. Medicina Intensiva 34(8): 493-494

Ascaso, F.J. 2011: Impact factor, eigenfactor and article influence. Archivos de la Sociedad Espanola de Oftalmologia 86(1): 1-2

Puche, R.C. 2011: Impact factor, its variants and its influence in academic promotion. Medicina 71(5): 484-489

Saleem, T. 2009: Impact factor--a pandora's box. Jpma. Journal of the Pakistan Medical Association 59(7): 499-500

Baethge, C. 2012: Impact factor--a useful tool, but not for all purposes. Deutsches Arzteblatt International 109(15): 267-269

Parse, R.Rizzo. 2012: Impact factor--one-size-fits-all: what's wrong with this picture?. Nursing Science Quarterly 25(3): 209-210

Grzybowski, A. 2010: Impact factor--strengths and weaknesses. Clinics in Dermatology 28(4): 455-457

Choi, J.; Kobayashi, H.; Okuda, H.; Harada, K.H.; Takeda, M.; Fujimoto, H.; Yamane, S.; Tanaka, D.; Youssefian, S.; Inagaki, N.; Koizumi, A. 2018: β-cell-specific overexpression of adiponectin receptor 1 does not improve diabetes mellitus in Akita mice. Plos one 13(1): E0190863

Jain, A.K. 2011: Impact factor: Measure of quality of research publication. Indian Journal of Orthopaedics 45(4): 289-290

Hernán, M.A. 2009: Impact factor: a call to reason. Epidemiology 20(3): 317-318; Discussion: 319-320

Lemaire, R. 2010: Impact factor: an achievement?. Acta Orthopaedica Belgica 76(6): 711-714

Manzar, N.; Manzar, B.; Manzar, S. 2009: Impact factor: does it have an impact?. Journal of Ayub Medical College Abbottabad: Jamc 21(2): 180

Szklo, M. 2008: Impact factor: good reasons for concern. Epidemiology 19(3): 369

Brumback, R.A. 2009: Impact factor: let's be unreasonable!. Epidemiology 20(6): 932-933

Kamath, P.S.; Bologna, G. 2009: Impact factor: misused and overhyped?. Hepatology 49(6): 1787-1789

Pêgo-Fernande, P.M.; Mariani, A.W. 2010: Impact factor: vitamin or poison?. Sao Paulo Medical Journal 128(4): 185-186

Citrome, L. 2007: Impact factor? Shmimpact factor!: the journal impact factor, modern day literature searching, and the publication process. Psychiatry ) 4(5): 54-57

Lintner, K.; Lane, M. 2014: Impact factors. International Journal of Cosmetic Science 36(5): 397

Li, Y.; Xu, Y.-s.; Xu, J.; Liu, X.-y.; Li, Y.-j. 2013: Impact factors analysis of standardized perioperative antibiotic application on nosocomial infection and drug-resistance bacteria. Chinese Journal of Ophthalmology 49(11): 1002-1005

Ketefian, Sé.; Freda, M.Comerford. 2009: Impact factors and citations counts: a state of disquiet. International Journal of Nursing Studies 46(6): 751-752

Hughes, G. 2007: Impact factors and consent to publish. Emergency Medicine Journal: Emj 24(6): 384

Smith, D.R. 2008: Impact factors and contact dermatitis. Contact Dermatitis 58(4): 191-192

Malay, D.Scot. 2013: Impact factors and other measures of a journal's influence. Journal of Foot and Ankle Surgery: Official Publication of the American College of Foot and Ankle Surgeons 52(3): 285-287

Haberhausen, M.; Bachmann, C. 2009: Impact factors and publication time spans of child and adolescent psychiatry journals. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie 37(1): 51-56

Labanaris, A.P.; Vassiliadu, A.P.; Polykandriotis, E.; Tjiawi, J.; Arkudas, A.; Horch, R.E. 2007: Impact factors and publication times for plastic surgery journals. Plastic and Reconstructive Surgery 120(7): 2076-2081

Behrens, R.H. 2009: Impact factors and the Journal of Travel Medicine. Journal of Travel Medicine 16(3): 226; Author Reply 226

Smith, D.R.; Leggat, P.A. 2009: Impact factors and the Journal of Travel Medicine. Journal of Travel Medicine 16(5): 368-369

Balandin, S.; Stancliffe, R.J. 2009: Impact factors and the h-index: what researchers and readers need to know. Augmentative and Alternative Communication 25(1): 1-3

Frank, J.F. 2012: Impact factors and the journal of food protection. Journal of Food Protection 75(1): 6

Flanagan, J. 2013: Impact factors and their relevance to journal quality. International Journal of Nursing Knowledge 24(3): 113-114

Liang, C.-M.; Chiu, Y.-C.; Wu, K.-L.; Tam, W.; Tai, W.-C.; Hu, M.-L.; Chou, Y.-P.; Chiu, K.-W.; Chuah, S.-K. 2012: Impact factors for difficult cecal intubation during colonoscopy. Surgical Laparoscopy Endoscopy and Percutaneous Techniques 22(5): 443-446

Liu, J.; Zhang, X.-B.; Feng, H.-Y.; Huang, J.-F.; Zhang, M.-Z.; Wang, L.-B. 2013: Impact factors for efficacy of specific immunotherapy in children with dust mite allergic asthma. Zhongguo Dang Dai Er Ke Za Zhi 15(10): 854-859

Gao, F.-q.; Li, Z.-j.; Zhang, K.; Liu, Y.-q.; Tian, H.; Liu, Y.; Liu, Z.-j. 2011: Impact factors for hidden blood loss after primary total knee arthroplasty. Zhonghua Wai Ke Za Zhi 49(5): 419-423

Bi, A.-H.; Zeng, Z.-C.; Ji, Y.; Zeng, H.-Y.; Xu, C.; Tang, Z.-Y.; Fan, J.; Zhou, J.; Zeng, M.-S.; Tan, Y.-S. 2010: Impact factors for microinvasion in intrahepatic cholangiocarcinoma: a possible system for defining clinical target volume. International Journal of Radiation Oncology Biology Physics 78(5): 1427-1436

Wang, M.-H.; Ji, Y.; Zeng, Z.-C.; Tang, Z.-Y.; Fan, J.; Zhou, J.; Zeng, M.-S.; Bi, A.-H.; Tan, Y.-S. 2010: Impact factors for microinvasion in patients with hepatocellular carcinoma: possible application to the definition of clinical tumor volume. International Journal of Radiation Oncology Biology Physics 76(2): 467-476

Loveland, J.A. 2012: Impact factors in biliary atresia. South African Medical Journal 102(11 Part 2): 863

Polit, D.F.; Northam, S. 2011: Impact factors in nursing journals. Nursing Outlook 59(1): 18-28

Izzi, B.; Noro, F.; Cludts, K.; Freson, K.; Hoylaerts, M.F. 2018: Cell-Specific PEAR1 Methylation Studies Reveal a Locus that Coordinates Expression of Multiple Genes. International Journal of Molecular Sciences 19(4)

Biteker, M. 2012: Impact factors of cardiovascular journals and ethics in 2010. Anadolu Kardiyoloji Dergisi: Akd 12(1): 80-82

Chen, L.; Zheng, R.-j.; Yu, C.-h.; Li, J.-y. 2014: Impact factors of distress in patients with lung cancer-associated pain. Sichuan da Xue Xue Bao. Yi Xue Ban 45(3): 471-475

Oermann, M.H.; Shaw-Kokot, J. 2013: Impact factors of nursing journals: what nurses need to know. Journal of Continuing Education in Nursing 44(7): 293-9; Quiz 300-1

Moverley, R.; Rankin, K.S.; McNamara, I.; Davidson, D.James.; Reed, M.; Sprowson, A.P. 2013: Impact factors of orthopaedic journals between 2000 and 2010: trends and comparisons with other surgical specialties. International Orthopaedics 37(4): 561-567

Feng, J.; Lu, W.; Wang, G.-Y.; Zhu, Z.-M.; Sun, Y.; Du, K.; Wang, J.-H. 2018: Cell-specific plasticity associated with integrative memory of triple sensory signals in the barrel cortex. Oncotarget 9(57): 30962-30978

Ren, Y.; Liu, Q.; Cao, C.; Lyu, J.; Li, L. 2014: Impact factors on physical activity level among the urban junior high school personnel in Hangzhou. Zhonghua Liu Xing Bing Xue Za Zhi 35(5): 537-541

Sun, L.-y.; Shen, Z.-y. 2008: Impact factors on reinfection after routine treatment and liver transplantation in hepatitis C patients. Zhonghua Gan Zang Bing Za Zhi 16(4): 259-260

Gölitz, P. 2012: Impact factors, open access, and 125 years of Angewandte Chemie. Angewandte Chemie 51(39): 9704-9706

Peters, T.J. 1999: Impact factors: believe them or not. Addiction Biology 4(2): 109-110

Hodos, R.; Zhang, P.; Lee, H.-C.; Duan, Q.; Wang, Z.; Clark, N.R.; Ma'ayan, A.; Wang, F.; Kidd, B.; Hu, J.; Sontag, D.; Dudley, J. 2018: Cell-specific prediction and application of drug-induced gene expression profiles. Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 23: 32-43

Bruining, N.; Cummins, P.; Serruys, P.W. 2011: Impact factors: scientific and career assessment by numbers. Eurointervention: Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 7(1): 143-147

Estevan, I.; Alvarez, O.; Falco, C.; Molina-García, J.; Castillo, I. 2011: Impact force and time analysis influenced by execution distance in a roundhouse kick to the head in taekwondo. Journal of Strength and Conditioning Research 25(10): 2851-2856

Araki, R.; Takita, A.; Ishima, T.; Kawashima, H.; Pornsuwancharoen, N.; Punthawanunt, S.; Carcasona, E.; Fujii, Y. 2014: Impact force measurement of a spherical body dropping onto a water surface. Review of Scientific Instruments 85(7): 075108

Silva, N.R.F.A.; Nourian, P.; Coelho, P.G.; Rekow, E.D.; Thompson, V.P. 2011: Impact fracture resistance of two titanium-abutment systems versus a single-piece ceramic implant. Clinical Implant Dentistry and Related Research 13(2): 168-173

Miller, P.W.; Ouellette, N.T. 2014: Impact fragmentation of model flocks. Physical Review. e Statistical Nonlinear and Soft Matter Physics 89(4): 042806

Asha, S.Edward.; Chan, A.Chiu.Fat.; Walter, E.; Kelly, P.J.; Morton, R.L.; Ajami, A.; Wilson, R.Denis.; Honneyman, D. 2014: Impact from point-of-care devices on emergency department patient processing times compared with central laboratory testing of blood samples: a randomised controlled trial and cost-effectiveness analysis. Emergency Medicine Journal: Emj 31(9): 714-719

Kettner, M.; Schmidt, A.; Windgassen, M.; Schmidt, P.; Wagner, C.; Ramsthaler, F. 2015: Impact height and wall distance in bloodstain pattern analysis--what patterns of round bloodstains can tell us. International Journal of Legal Medicine 129(1): 133-140

Oterino de la Fuente, D.; Baños Pino, J.F.; Fernández Blanco, V.; Rodríguez-Alvarez, A. 2007: Impact in Asturias of primary care emergencies on hospital emergencies for the 1994-2001 period. A time series cointegration analysis. Revista espanola de salud publica 81(2): 191-200

Vila-Carbó, J.J.; Hernández, E.; Ayuso, L.; Ibáñez, V. 2008: Impact in our environment of a gastroschisis therapeutic management protocol. Cirugia Pediatrica: Organo Oficial de la Sociedad Espanola de Cirugia Pediatrica 21(4): 203-208

Wang, H.-f.; Zhu, J.; Fang, Y.; Chen, X.; Zhang, H.-s.; Lu, J.-l. 2013: Impact in response control, attention and hyperactivity behavior on children with obstructive sleep apnea hypopnea syndrome by integrated visual and auditory continuous performance test. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 48(3): 213-217